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The 5’ untranslated region (UTR) in a messenger RNA (mRNA) can greatly influence translation. Depending on 
where the transcription starts, the 5’ UTR will contain (or not) regulatory elements that can modulate mRNA 
translation. Although studies have demonstrated the effect of differential transcription start sites (TSSs) usage on 
translation efficiency, these are mainly restricted to TSSs in different clusters many nucleotides apart. However, it 
is currently unknown if there is any relevance to the TSS variation within a single cluster. Here, we present our 
findings on single cluster TSS-mediated regulation of protein expression, using mainly AGAP2 as an example.  
Using 5’ RLM-RACE, we have identified different TSSs usage for AGAP2 mRNA in chronic myeloid leukaemia (CML) 
and prostate cancer (PC) cell lines, giving rise to populations of transcripts with variable lengths of 5’ UTR. The 
population of longer 5’ UTR were relatively higher in CML cell lines (P < 0.05), and those extra nucleotides 
contained the consensus sequence for a G-quadruplex (G4). The G4 formation was verified by CD spectroscopy. 
Additionally, we developed an immunoprecipitation method termed ‘GRIP’ [G4 RNA Immunoprecipitation] and 
demonstrated the existence of these RNA secondary structures in the living cells.  
To study the impact of the longer 5’ UTR and the G4 on translation efficiency, we cloned three 5’ UTR isoforms 
(shorter, longer and mutated-longer version) into a bicistronic plasmid and reported a significant decrease in 
luciferase activity by the G4 in the longer 5’ UTR (P < 0.001). This result coincides with the discrepancy noted in 
AGAP2 mRNA and protein levels in these cell lines. Furthermore, polysome fractionation studies also confirmed 
that mRNA with longer 5’ UTR associated less prominently with polyribosomes (P < 0.001).  
Our bioinformatics pipeline has identified 4,920 transcripts in the FANTOM database that contained putative G4 
sequences between the major and upstream TSSs within the same TSS cluster. By integrating the NCI-60 
microarray and SWATH-MS database, we curated a list of genes that displayed discrepancies in RNA and protein 
expression with a significantly higher level of G4 forming TSS; and validated our findings in another gene target 
(HK1). This highlights that the TSS-G4 mediated mechanism is not only limited to AGAP2 expression regulation but 
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Our group has been studying the role and the regulation of AGAP2 (ArfGAP with GTPase domain, ankyrin repeat 
and PH domain 2) gene in different diseases and cancers. Our previous work has highlighted that the levels of 
AGAP2 mRNA and protein are not always correlated. This thesis attempt to explain a novel mechanism responsible 
for regulating AGAP2 gene expression. The introduction chapter will cover the basics of eukaryotic gene expression 
and summarise up to date knowledge of all possible mechanisms involved in regulating gene expression. 
1.1 Eukaryotic gene expression  
Gene expression is a process by which the genetic code in the DNA is used to direct the synthesis of proteins or 
non-coding RNAs, shaping the cellular phenotype. In order for a protein-coding gene to express, the DNA code is 
first transcribed to a messenger RNA (mRNA) intermediate which is subsequently translated to protein. The process 
of gene expression is complex and comprise of different stages including regulatory processes that convert the DNA 
signal into the protein product. The genetic code (DNA) is first converted to a pre-mRNA which undergoes 
processing that include splicing, capping, and polyadenylation to name a few. The mature mRNA is subsequently 
exported from the nucleus into the cytoplasm where it is converted to protein in a process called translation, using 
the mRNA code to link the constituent amino acids to form a protein. The process of gene expression is non-linear 
and is regulated at different stages during the process and include transcriptional regulation (section 1.2.1), post-
transcriptional regulation (section 1.2.2), and translational regulation and post-translational processing (section 
1.2.3). The process of gene expression and the detail of the regulatory mechanisms taking place are described in 
detail below and also overviewed in Figure 1.1.  
The eukaryotic gene expression is a complex and highly regulated process and is far more complicated compared 
to prokaryotic organisms. In eukaryotic organisms, the process of transcription and translation are separated 
spatially and temporally due to the presence of a nuclear membrane. Moreover, the regulation may occur at 
different levels during the gene expression process. The introduction section presented here will primarily focus on 





Figure 1.1: Overview of eukaryotic gene expression. Steps involved in the expression of protein-coding genes. The 
genetic code in the DNA (base sequence) is first transcribed into pre-mRNA which undergo extensive processing 
before export to the cytoplasm and is used to direct protein synthesis. The regulation taking place at different levels 
of gene expression process is also depicted. Image adapted from Halbeisen et al. (2007) (CC BY-NC). 
 
1.1.1 Mechanism of Transcription: 
The process of gene expression starts with transcription which is a multistep process that involves the unwinding 
of the double-stranded DNA and conversion of the DNA sequence, in either of the two strands of the genomic DNA, 
into mRNA transcript. The transcription of all the protein-coding genes (mRNA) and non-coding genes (most snRNA 
and miRNA) are mediated by RNA polymerase II (RNA Pol II) (Reviewed in Miglani, 2014). The RNA Pol II along with 
accompanying protein complexes assembles on the DNA sequence at the 5’ end of a gene, called the promoter, 
where the transcription begins. The transcription typically initiates at a defined position referred to as the 
transcription start site (TSS) which is embedded within the core promoter region. The phases of transcription can 
be divided into preinitiation, initiation, elongation, and termination. 
1.1.1.1 Preinitiation: 
Preinitiation is the first phase of transcription and involves the formation of the preinitiation complex (PIC). The PIC 
consists of general and specific transcription factors (TFs), coactivators, and RNA pol II enzyme and is formed at the 
gene promoter region that serves as a binding platform for the assembly of these components (Hampsey, 1998). 
Different eukaryotic promoter sequences are known and contain certain consensus patterns such as TATA, CAAT, 
and GC boxes. The TATA box has the consensus sequence of TATAWAAR [W = (A/T), R = (A/G)], where the 5’ T is 
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located at -30 or -31 bp upstream of the TSS (Reviewed in Danino et al., 2015). The TATA box is bound by the general 
transcription factor TFIID and in some cases requires TFIIA to facilitate TFIID binding with the TATA box (Butler and 
Kadonaga, 2002). The CAAT box is usually found between -80 and -60 nucleotides upstream of the TSS and has the 
consensus GGNCAATCT [N = (A/T/G/C)], which is bound by the transcription factor CTF (CAAT box transcription 
factor) (Miglani, 2014). The GC box has the consensus GGGCGG which is often present in multiple copies and is 
recognised and bound by the SP1 transcription factor (Miglani, 2014). The core promoter is a short (+/- 50 bp) 
region around the TSS that contain the cis-acting elements including the short sequence elements (TATA box) and 
an Initiator (Inr) element that encompasses the TSS and mainly bound by TAF1 and TAF2 subunits of TFIID 
(Kaufmann and Smale, 1994, Smale, 2001, Smale and Baltimore, 1989). 
The assembly of the PIC begins when the activator binds to one of the promoter sequences and recruit coactivators 
and complexes that mediate ATP dependant chromatin relaxation. The TFIID which contain the TATA-binding 
protein (TBP) subunit binds to the TATA box, serving as a nucleation point for PIC assembly (Buratowski et al., 1989). 
In absence of the TATA box, other subunits of TFIID associate with the promoter region and facilitate the formation 
of PIC (Ranish et al., 1999). The binding of TFIID is followed by the recruitment of general transcription factors 
including TFIIA, TFIIB, TFIIE, TFIIF, and TFIIH. The TFIIB subsequently binds to basal recognition elements which are 
located immediately upstream and downstream of the TATA box (Deng and Roberts, 2007). The TATA–TBP–TFIIB 
complex provides support for the binding of the TFIIF–Pol II complex. The TFIIF escorts the RNA pol II to the complex 
and recruits TFIIE and TFIIH which complete PIC assembly (Reviewed in Ghosh and Van Duyne, 1996) (Figure 1.2). 
The TFIIE and TFIIH are involved in unwinding the promoter region, transcription initiation and promoter clearance 





Figure 1.2: Schematic summary of transcription initiation in eukaryotes. The eukaryotic transcription is initiated 
by binding of TBP subunit of TFIID to the TATA box. It is followed by the binding of general transcription factors 
(TFIIB, Pol II-TFIIF complex, TFIIE and TFIIH) in a stepwise fashion. The RNA pol II promoter elements (TATA, CAT, GC 
box) are shown with their location relative to TSS (+1). INR: initiator element; RNA pol II: RNA polymerase II; TF: 
transcription factor; TBP: TATA-binding protein. Image adapted and modified from Avissar et al. (2018) (CC BY 4.0). 
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1.1.1.2 Initiation, elongation, and termination:  
After the formation of PIC, the DNA strands at the TSS are separated to generate an open promoter complex. The 
RNA transcription is initiated beginning with two initiating NTPs dictated by the DNA base pairing and formation of 
the first phosphodiester bond leading to the initial transcribing complexes (ITC). The ITC proceed into the gene 
through a DNA scrunching mechanism (unwinding DNA and pulling strands into itself) before reaching a critical 
length (Cheung et al., 2011). After transcribing about 20-30 nucleotides downstream of the TSS, the RNA pol II 
pauses and disconnects from the promoter elements with partial disassembly of PIC in a process called the 
promoter escape or clearance (Reviewed in Gupta et al., 2016). It is followed by the formation of transcription 
elongation complex on the RNA pol II which commence productive elongation facilitated by a wide variety of 
elongation factors (Reviewed in Sims et al., 2004). The termination usually occurs downstream of the 3’ end of the 
gene, releasing the nascent RNA and disassembly of elongation machinery. The transcription termination factor 2 
(TTF2) is a well-characterized factor associated with RNA pol II that disassemble the elongating complex using ATP 
hydrolysis (Jiang et al., 2004). The termination of transcription is functionally connected to cleavage and 
polyadenylation.  
1.1.1.3 Co-transcriptional events: 
During the transcription, the protein complexes (including the capping enzyme complex, spliceosome, and 3′ end 
processing machinery) approach the primary transcript to facilitate the mRNA maturation process. The pre-mRNA 
undergoes two important processing steps including modifying both ends of mRNA and selective elimination of the 
intronic fragments within the coding sequence. The modification at the 5’ end includes the addition of a 7-
methylguanosine (m7G) cap structure to the first nucleotide at the 5’ termini of the elongating mRNA. The 5’ cap 
structure plays an important role in RNA stability, resistance from exonucleases, nuclear export, and translation 
initiation (Shimotohno et al., 1977). The 3’ end of the pre-mRNA is modified by the addition of 40–200 adenine 
residues to generate a poly-A tail. The tailing reaction is facilitated by poly-A polymerase and catalysed by cleavage 
and polyadenylation specificity factor (CPSF) and cleavage stimulation factor (CSTF) that guide AAUAAA dependent 
poly(A) tail addition (Colgan and Manley, 1997). The poly-A tail acts as a stabiliser of intact mRNA and also impact 
translation and localisation (Reviewed in Yuan et al., 2021). The pre-mRNA also undergoes splicing to remove any 
introns. The RNA splicing is mediated by a multi-subunit complex called spliceosome that detects the consensus 
region at 5’ donor and 3’ acceptor end, releasing the introns (Reviewed in Matera and Wang, 2014). The alternative 
splicing produces multiple mRNA isoforms from a single gene and can regulate protein composition by changing 
the coding sequences between the isoforms, generating proteomic diversity (Reviewed in Stamm et al., 2005). The 
mature mRNA is then exported from the nucleus by forming messenger ribonucleoprotein (mRNP) complexes that 




1.1.2  Mechanism of Translation: 
The translation is a process by which the information contained in mRNA is used to direct the synthesis of 
polypeptides. The genetic code in the mRNA consists of triplets of adjacent ribonucleotides called codon that are 
recognised by transfer RNAs (tRNAs) which incorporates a specific amino acid depending on the codon seqeunce. 
The ribosomes are the central multi-subunit complex for translation which facilitate the interpretation of the 
codons in the mRNA and form peptide bonds between amino acids. The process of translation generally entails 
three stages: initiation, elongation, and termination.  
1.1.2.1 Translation Initiation:  
As reviewed in Haimov et al. (2015), Hinnebusch and Lorsch (2012), and Sonenberg and Hinnebusch (2009), the 
initiation of translation begins with the formation of 43S PIC which is formed by the binding of the ternary complex 
(TC) to 40S ribosomal subunit. The TC is composed of initiator methionyl-tRNA (Met-tRNAi) and the GTP-bound 
form of eukaryotic initiation factor 2 (eIF2). The multiprotein eIF3 complex, together with eIF1, eIF1A and eIF5, 
promotes the binding of the 40S ribosomal subunit to the mRNA. This complex is recruited to the mRNA 5’ cap by 
poly(A)-binding protein (PABP), eIF3, eIF4B, eIF4H, and heterotrimeric factor eIF4F. The eIF4F complex is composed 
of eIF4E (cap-binding protein), eIF4G (scaffold protein), and eIF4A (RNA helicase). The recruitment of 43S PIC to 5’ 
mRNA cap is followed by a scanning process that involves the unwinding of secondary structures in 5’ termini of 
mRNA region by the eIF4A, whose helicase activity is enhanced by eIF4B and eIF4H. Subsequently, the initiation 
complex scans the 5’ untranslated region (UTR) of mRNA in the 5’ to 3’ direction until it encounters the start codon. 
The recognition of the start codon triggers the hydrolysis of the GTP bound to eIF2, displacement of the initiation 
factors and concomitant joining of 60S ribosomal subunit to complete the assembly of the 80S translating ribosome 
(Figure 1.3). This process is catalysed by eIF5B that triggers the GTP hydrolysis and release of eIFs. The PABP at the 
3’ end interacts with the eIF4E and eIF4G at the 5’ mRNA cap to form a closed-loop configuration that enhances 
translation (Tomek and Wollenhaupt, 2012). Although most of the mRNAs are translated using the canonical cap-
dependant scanning mechanism, alternative non-canonical translation initiations are also been reported 
demonstrating scanning-free translation initiation and cap-independent translation through internal ribosome 
entry sites (IRES) (Haimov et al., 2015, Komar et al., 2012). 
1.1.2.2 Translation Elongation: 
The translation initiation culminates with the formation of 80S ribosome with the Met-tRNAi base-paired to AUG in 
the P (peptidyl) site of the ribosome and the second codon in the A (aminoacyl) site ready to accept the aminoacyl-
tRNA carrying the next amino acid guided by the codon context. It is followed by the formation of a peptide bond 
between the first two amino acids in the P site catalysed by the peptidyl transferase. The deacylated tRNA is 
accommodated at the E (exit) site of the ribosome before being released and recycled. The elongation continues 
with the translocation of the ribosome to the next codon and delivery and shuttling of the tRNA through A, P, and 
E sites. The elongation, in contrast to translation initiation, requires a minimal set of elongation factors that are 
well-conserved between prokaryote and eukaryotes (Reviewed in Dever et al., 2018). Certain antibiotics and 
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compounds including cycloheximide have shown to inhibit translation elongation (Schneider-Poetsch et al., 2010). 
Cycloheximide-mediated elongation inhibition has been used by different techniques to evaluate ribosome density 
and their distribution profiles (Chassé et al., 2016, Duncan and Mata, 2017). 
1.1.2.3 Translation termination:   
The translation terminates when the ribosome reaches the stop codon (UAG, UAA, and UGA). The process of 
termination includes the recognition of a stop codon in the A ribosomal site and hydrolysis of peptidyl-tRNA in the 
P site, releasing the nascent polypeptide chain. The process is mediated by the release factors (RF), eRF1 and eRF3, 
which disassemble the complex, followed by the recycling of its constituents to participate in the next rounds of 





Figure 1.3: Overview of eukaryotic translation initiation. The eukaryotic translation begins with the formation of 
the 43S preinitiation complex (ternary complex [eIF2/GTP/Met-tRNAi), 40S ribosomal subunit, and other eIFs]. The 
complex is recruited to the mRNA 5’ cap structure and associate with eIF4F forming initiation complex that scan 
the mRNA until it encounters the start codon. The 60S ribosomal subunit then joins the mRNA bound 40S ribosomal 
subunit, facilitated by eIF5B, to form 80S translating ribosome with dissociation and recycling of eIFs. The three 




1.2 Regulation of gene expression  
The regulation of gene expression is a highly sophisticated, multi-step, and non-linear process that controls the 
output of a gene. It is an intricate mechanism fundamental to all biological processes and involves dynamic 
coordination between multiple events, shaping the gene’s functional product. A regulated gene expression is 
essential for the specialised cell states in a multicellular organism that contains the same genetic material but 
displays differing phenotypes. The gene regulation occurs at multiple levels including transcription, post-
transcriptional, translation, and post-translational processing.  
1.2.1 Transcriptional regulation: 
Transcription is the first level of gene expression control and is likely the most regulated and evolutionary conserved 
step (Schena, 1989). The regulation of transcription occurs primarily at two distinct interconnected levels involving 
the interaction between specific DNA motifs and DNA binding protein (transcription factors) and three-dimensional 
folding of the chromatin and its regulators.  
The transcription factors (TFs) are proteins that recognise and bind to the specific DNA sequence in the promoter 
region and regulate gene expression. These TFs plays an important role in patterning cell types and orchestrating 
specialised cell programs (Lee and Young, 2013). A variety of TFs have been classified that regulate the initiation 
and elongation steps of the transcription and could be broadly grouped into general and specific TFs (Reviewed in 
Lee and Young, 2013). Most of the eukaryotic TFs also associate with other protein complexes called cofactors that 
do not display DNA-binding properties and either stimulate (coactivators) or suppress (corepressors) gene 
expression through TF binding. These cofactors include the mediator complex, P300, and general TFs that regulate 
transcription via different mechanisms (Conaway and Conaway, 2011, Juven-Gershon and Kadonaga, 2010, Malik 
and Roeder, 2010). The DNA sequence context is equally important as it guides the binding of TF and serves as a 
gateway to transcription. These cis-acting sequence elements (promoters, enhancers, silencers and insulators) are 
usually present in the proximity of the gene transcription initiation site and facilitate binding of TFs and assembly 
of the transcription machinery. Conversely, these binding motifs could be also present in the distal region away 
from the gene and cooperatively bind TFs and recruit cofactors to mediate long-range interaction with the 
promoter, modulating its activity (Krivega and Dean, 2012).   
The chromatin structure significantly impacts all the aspects of transcription and is tightly regulated by a variety of 
mechanisms including chromatin remodelling, modification of histone, nucleosome dynamics, and chromosomal 
interactions (Reviewed in Li et al., 2007). The accessibility of the DNA for transcription is dependent on its 
nucleosome packaging. The histone tails in the nucleosome complex are subjected to a wide range of modifications 
including lysine (K) acetylation in histone 3 (H3K27) and di/tri-methylation (me) of H3K4 that are associated with 
transcriptional activation (euchromatin state) (Bonn et al., 2012). On the other end, the tri-methylation on histone 
3 (H3K27me3, H3K9me3) suppresses transcription (heterochromatin state) (Nakayama et al., 2001, Simon and 
Kingston, 2009). The regulation also occurs by protein complexes that alter the chromosome architecture and 
consequently lead to transient unwrapping of the DNA from histone octamer and nucleosome sliding (Smith and 
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Peterson, 2005). These remodelling complexes including ATP-dependent complexes (SWI/SNF, CHD1, ISWI protein 
family) and histone chaperone proteins (FACT), cooperatively facilitate chromosome remodelling along with 
modifications in the histone tail. Additionally, long-range chromosome interaction mediated by chromosome 
structure proteins (e.g. cohesion) also shapes gene expression (Xu et al., 2016). 
DNA methylation also plays an important role in controlling gene expression by inhibiting the binding of TFs and 
recruiting proteins that silence gene expression. The majority of DNA methylation occurs on cytosines in the CpG 
context and around 70% of promoters are associated with a CpG island (Saxonov et al., 2006). The methylation of 
DNA contributes to the spatiotemporal regulation of gene expression with dense promoter methylation associated 
with transcriptional repression (Reviewed in Moore et al., 2013). However, in some cases, promoter 
hypermethylation also enhances the transcriptional activity (Smith et al., 2020). 
1.2.2  Post-transcriptional regulation: 
The post-transcriptional control of gene expression is mediated by the regulatory elements in the transcribed 
mRNA. It plays an important role in diverse cellular processes such as development (Kuersten and Goodwin, 2003), 
metabolism (Kim and Kyung Lee, 2012), and cell division (Hengst and Reed, 1996). These post-transcriptional 
regulatory mechanisms create a mismatch between mRNA and protein levels, setting the protein level 
independently from their mRNA concentration. The technological advances in the recent decades have 
characterised multiple post-transcriptional regulatory elements that regulate gene expression, some of these 
processes also occur co-transcriptionally and determine the nature and translational potential of the mRNA 
(Merkhofer et al., 2014). The major post-transcriptional regulatory mechanisms include alternative splicing and 
polyadenylation, mRNA decay, and regulation mediated by elements encoded in the mRNA 5’ and 3’ UTR. The 
section presented here further details the regulatory features embedded in the mRNA UTRs. These elements 
variably impact the mRNA translational potential and are group according to the 5’ and 3’ region of the mRNA. The 




Figure 1.4: Post-transcriptional regulatory elements in the mRNA UTR. The general structure of eukaryotic mRNA, 
highlighting some post-transcriptional regulatory features in the 5’ and 3’ UTR of the mRNA that affects gene 
expression. ARE: AU-rich element; GRE: GU-rich element; IRES: internal ribosome entry site; miRNA: microRNA; 
PTC: premature termination codon; RBP: RNA binding protein; uAUG: upstream start codon; uORF: upstream open 
reading frame.  
 
 
1.2.2.1 5’ UTR regulatory elements: 
The 5’ UTR is the area between the mRNA cap structure and the start codon and serves as a platform for different 
regulatory features that impact translation initiation and scanning. The median length of 5’ UTR is longer in humans 
(218 nucleotides) compared to other higher eukaryotes (Leppek et al., 2018). The length of 5’ UTR tends to be 
longer for transcripts that presumably have a regulatory role such as mRNA encoding for TFs, protooncogenes and 
growth factors (Davuluri et al., 2000). The prominent regulatory elements in the 5’ UTR include RNA binding 
proteins (RBP) domain, upstream open reading frame (uORF), upstream start codon (uAUG), RNA secondary 
structures, and internal ribosome entry sites (IRES). 
The RBP recognise specific motifs in the 5’ UTR and interact with the translational apparatus to modulate gene 
expression. These RBP also recognise binding motifs in the 3’ UTR to regulate mRNA stability and localisation. The 
classical example of regulation by RBP is the iron response elements (IREs) in the 5’ UTR that control the ferritin 
mRNA translation according to the intracellular iron level (Reviewed in Goss and Theil, 2011). In response to low 
intracellular RNA levels, the iron regulatory proteins (IRP1 and IRP2) bind to the specific stem-loop structures called 
IRE (Iron Response Element) that are located in the 5’ UTR of mRNAs including ferritin light and heavy chain and 
mitochondrial aconitase, thereby preventing their translation. The RBP, unlike their DNA counterpart (TFs), binds 
to secondary structures in addition to the primary sequence. The RBPs have shown to be involved in various aspects 
of RNA metabolism including RNA maturation, biogenesis, localisation, and turnover (Reviewed in Hentze et al., 
2018). A study by Keene and Tenenbaum (2002) has proposed a model of post-transcriptional gene expression in 
which RBP regulate a group of functionally related genes, contributing to the specification of cellular state and 
identity. An interesting example is the regulation of P21 expression by two antagonising RBPs (CUGBP1 and 
calreticulin) which establishes the final level of p21 mRNA and determine if the cell would proliferate or undergo 
senescence (Iakova et al., 2004). Likewise, Kumar et al. (2021) have demonstrated that RBP (La and HuR) 
cooperatively modulate translation repression of PDCD4 mRNA. In addition to the cytoplasmic post-transcriptional 
regulation, RBPs also assist in splicing the pre-mRNA and 3’ end processing, as part of a heterogeneous nuclear 
ribonucleoproteins complex (Xu et al., 2001).  
The uAUG and uORF are the major regulatory elements in the 5’ UTR. Studies have shown that approximately 50% 
of the 5’ UTR isoforms contain single or multiple uORFs (Davuluri et al., 2000, Ingolia et al., 2011). The uORF is 
defined by a start codon that is out-of-frame and upstream of the main coding sequence with an in-frame stop 
codon. In contrast, the uAUG is upstream, out-of-frame start codon without a downstream stop codon. Both uORF 
and uAUG primarily function as a translation repressor by limiting the ribosome access to the downstream AUG of 
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the principal ORF (Matsui et al., 2007). The translation of a wide variety of mRNAs is tightly controlled by the 
presence of uORF in the mRNA 5’ UTR (Reviewed in Chatterjee and Pal, 2009). The amplitude of repression 
mediated by these elements depends on the sequence context of the uAUG (Morris and Geballe, 2000). In addition 
to acting as a decoy, the short peptide translated from uORF may act in a cis-fashion and stall the ribosome at the 
uORF, reducing initiation from the downstream principal ORF (Oyama et al., 2004). The stalled ribosome at the 
uORF can also undergo reinitiation and access the downstream main AUG to begin translation. The mechanism of 
delayed reinitiation has been noted for different genes under various conditions including stress response, amino 
acid starvation, and apoptosis (Beznosková et al., 2015, Dever et al., 1992, Proud, 2005, Szamecz et al., 2008). 
High ordered structures, including G quadruplexes, are also prevalent in the 5’ UTR and frequently noted in genes 
with regulatory functions (Reviewed in Araujo et al., 2012). Davuluri et al. (2000) performed a regression tree 
analysis and noted that a large majority of transcripts (>90%) that were highly regulated also contained stable 
secondary structures in their 5’ UTR. These structures when present near the 5’ cap rendering the 5’ cap less 
accessible and blocking the formation of the PIC (Pickering and Willis, 2005). These structures could also impede 
the scanning process and studies have shown that a 5’ UTR structure with the minimum free energy of -50 kcal/mol 
is sufficient to impact the 43S ribosome scanning process (Kozak, 1989, Pelletier and Sonenberg, 1985). Other than 
inhibiting translation, the secondary structures (stem-loops) also associate with RBP to modulate gene expression 
(Fraser et al., 2008, Goss and Theil, 2011). These secondary structures in the 5’ UTR are unwinded by cellular RNA 
helicases including eIF4A, RNA helicase A, DDX3, and DHX29, to name a few (Bourgeois et al., 2016). The RNA 
helicases play an important role in gene expression and their aberrant expression has been linked to different 
pathologies including cancers (Robert and Pelletier, 2013).  
The 5’ UTR could fold into an extended and multidomain structure that serves as an internal site for ribosomal 
recruitment, mediating cap-independent translation (Reviewed in Kozak, 2001). These IRES elements, discovered 
initially in viruses, are also reported in mammalian mRNA with more than 10% of mRNAs described in the literature 
found to contain an IRES element (Spriggs et al., 2008, Weingarten-Gabbay et al., 2016). The IRESs are implicated 
in facilitating translation initiation during stress conditions when the cap-mediated translation is compromised 
(Spriggs et al., 2009). The IRES containing mRNAs have been shown to encode regulatory proteins such as TFs, 
growth factors, protooncogene, and homeodomain proteins (Lacerda et al., 2017). The IRES trans-acting factors 
(ITAFs) have been shown to remodel cellular IRESs and act as a chaperone to induce structural changes in the mRNA 
following cellular stress to activate IRES-mediated translation. This mechanism of regulation has been reported for 
several mRNAs including MYC (Cobbold et al., 2010), APAF1 (Mitchell et al., 2003), and BAG1 (Pickering et al., 2004).   
1.2.2.2 3’ UTR regulatory elements: 
The 3’ UTR plays an important role in mRNA localisation, stability, and translation. The 3’ UTR also act as a scaffold 
to facilitate protein-protein interactions (Berkovits and Mayr, 2015). Studies have shown that more than 50% of 
the genes generate 3’ UTR isoforms using alternative cleavage and polyadenylation (Reviewed in Mayr, 2016). The 
length of the 3’ UTR has dramatically increased during evolution with a median length of 1200 bp noted in humans 
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(Lianoglou et al., 2013). The longer 3’ UTRs contain diverse regulatory elements including the binding sites for 
miRNAs and RBPs.  
miRNAs are class of short non-coding RNA that are on average 22bp in length. The mature miRNAs are incorporated 
into the multimeric protein–RNA complex called RNA-induced silencing complex (RISC) that regulate gene 
expression. In most cases, the miRNA interacts with the 3’ UTR of the target mRNA and induces mRNA degradation 
and translation repression (Huntzinger and Izaurralde, 2011, Ipsaro and Joshua-Tor, 2015). The 3’ UTR contains a 
seed region that binds with partial complementarity to the miRNA. Friedman et al. (2009) reported that more than 
60% of human protein-coding genes could be potentially regulated post-transcriptionally by miRNA. The miRNA 
suppresses the mRNA expression by recruiting RISC (RNA-induced silencing complex) that degrade the target 
transcript (Kawamata and Tomari, 2010). miRNA binding sites have been also identified in the 5’ UTR and the coding 
region (Xu et al., 2014). The miRNAs are generally repressive; however, translational activation has been also 
reported in some cases (O'Brien et al., 2018).  
In addition to miRNA binding sites, the 3’ UTR also contain AU-rich and GU-rich elements that negatively affect gene 
expression (Barreau et al., 2005, Vlasova et al., 2008). These elements bind to RBPs and have shown to destabilize 
mRNAs, repress translation, and has been also noted in some cases to increase protein synthesis (Kontoyiannis et 
al., 1999, Lindstein et al., 1989). Studies have identified various RBPs such as AUF1, KSRP, and TTP that promote 
the decay of AU-rich containing mRNAs (Liao et al., 2007, Stoecklin et al., 2003). The 3’ UTR also encompasses mRNA 
localisation signal (zip codes) which are short repetitive sequences or stem-loop structures that bind to 
ribonucleoprotein (RNP) complexes to assist their export to specific cytoplasmic locations (Jansen, 2001).  
1.2.3 Translation regulation and post-translational processing: 
Translational control plays an important role in regulating gene expression and defining the proteome. The 
translational regulation can occur at different steps during the translation process, but the majority of regulation 
takes place at the initiation phase (Reviewed in Lackner and Bähler, 2008). The process of translation could be 
globally regulated by modulating one or more components of the core translation machinery. Such global changes 
in the profile and activation states of key eIFs have been frequently noted in cancers (Bjornsti and Houghton, 2004). 
One such example has been reported by Boussemart et al. (2014) who showed an increased expression of eIF4F, 
leading to therapy resistance and metastasis in BRAF-mutated tumours. However, changes in the levels of certain 
general translation initiation factors do not always affect the global translation pattern. In the case of eIF4E, only 
the translation of a specific subset of eIF4E-sensitive mRNAs is affected: those that contain long, highly structured 
5’ UTR (Boussemart et al., 2014, Roux and Topisirovic, 2018). The specific translational control is induced by the cis 
and trans-acting factors in the selected mRNA. Some of the cis and trans-acting elements in the 5’ and 3’ UTR have 
been described above (Figure 1.4). Moreover, the codon usage bias has been exhibited to locally exert their effect 
on the gene’s expression level. A positive correlation has been noted between the expression level of a gene and 
the degree of its codon bias (Plotkin and Kudla, 2011). The differential codon usage has been also shown to 
influence the accuracy and efficiency of protein synthesis (Tuller et al., 2010, Zhou et al., 2009).   
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Long noncoding RNA (lncRNA) have been shown to play a role in protein translation and are also implicated in 
regulating mRNA stability and transcription (Reviewed in Song et al., 2021). LncRNAs have been shown to interact 
with RBPs to modulate translation of specific mRNA, for example, lncRNA AFAP1-AS1 has been observed to 
associate with AUF1 to promote translation of ERBB2 that encode for HER-2 protein (Han et al., 2020). The lncRNA 
also interact with the component of translational apparatus to modify their phosphorylation status (Xu et al., 2020). 
Moreover, the lncRNA acts as a molecular sponge or decoy for miRNA to regulate protein expression (Sun et al., 
2016, Xu et al., 2019). 
Post-translational modifications (PTMs) have been shown to increase the diversity of the proteome by covalent 
addition, removal or folding of functional groups in the protein that drastically change their functional properties 
(Higgins and Hames, 1999). Currently, more than 3 X 106 experimentally verified PTMs of more than 69 types have 
been defined for greater than 1 X 106 proteins in the PTMcode2 database (Minguez et al., 2012, Minguez et al., 
2014). Some of these modifications include phosphorylation, methylation, acetylation, ubiquitination, and 
glycosylation. The covalent attachment of the small ubiquitin protein (76 amino acid) targets the substrate protein 
for degradation by the 26S proteasome complex (Hershko and Ciechanover, 1998). The protein regulation by 
ubiquitin-mediated degradation contributes to the vital cellular processes including transcription, cell-cycle 
regulation, signal-transduction, and antigen presentation (Reviewed in Zheng and Shabek, 2017). The combination 
of multiple PTMs on a protein surface constitutes a PTM code that is recognised by different effectors, stimulating 
or inhibiting downstream events (Lothrop et al., 2013). Moreover, different PTM modifications interact with each 
other and the crosstalk between PTMs are essential for optimal gene expression, DNA damage response, and 
chromatin organisation (Badeaux and Shi, 2013, Parkes and Niranjan, 2019, Venne et al., 2014). 
Post-translational modification has been also shown to influence chromatin folding and modulate DNA accessibility. 
A wide variety of PTM modifications of histone tail has been described in the literature and include acetylation, 
ubiquitination, sumoylation, phosphorylation, and methylation (Reviewed in Tolsma and Hansen, 2019). These 
modifications stimulate structural and dynamic changes in the nucleosome, impacting the accessibility of DNA 
sequences near the nucleosome region and thus affect the DNA dependent processes such as transcription, 
replication, and DNA repair (Radman-Livaja and Rando, 2010). The PTM code of the histone shapes the chromatin 
state at a given locus. Certain PTM signatures at histone tails such as acetylation (H3K9ac, H3K27ac, H4K16ac, 
H3K14ac, H3K18ac), phosphorylation (H3S10ph), and methylation (H3K4me1, H3K4me2, H3K4me3, H3K79me1, 
H3K36me3) are associated with relaxed or open chromatin conformation (euchromatin states). On the other hand, 
certain histone PTM signatures including methylation at certain regions (H3K9me3, H3K9me2, H3K27me3, 
H4K20me3) and ubiquitination (H2Aub) are repressive and associated with compact or closed chromatin 






1.3 Relevance of Transcription Start Site selection 
The TSS is described as a position at the 5’ end of a gene sequence from where the transcription begins. It defines 
the 5’ gene boundary and the beginning of the 5’ UTR. Identifying the TSS is crucial for the characterisation of 
putative promoter motifs and provides important information about the gene expression pattern and regulation. 
The transcription of protein-coding genes is initiated by RNA Pol II in the core promoter region that is +/-50 
nucleotides with respect to the TSS (Hampsey, 1998). The core promoter directs the initiation of transcription at 
the TSS.  
The examination of the pattern of transcription initiation identified two different modes of initiation namely 
focused and dispersed (Lenhard et al., 2012, Kadonaga, 2012). In the focus mode of initiation, the transcription 
begins at a single predominant TSSs or within a small region of few nucleotides. In contrast, the dispersed initiation 
demonstrates multiple weak initiation sites spread over a broad region of 50-100 nucleotides within the core 
promoter. Carninci et al. (2006) have noted that the TATA boxes are overly represented in the promoters that show 
the focus mode of initiation. A majority of TATA boxes (>70%) are situated within a tightly defined region with a 
preferred position of -31 or -30 relative to the TSS (Carninci et al., 2006). Structural studies also confirmed this 
finding and reported a distance of 30 nucleotides from the TATA box to the active centre of RNA Pol II (Smale and 
Kadonaga, 2003). The precise selection of the TSSs could be predicted in the case of promoters with TATA boxes, 
with the TATA box being the anchor of PIC and guiding the polymerase to the predicted transcription starting site. 
However, the factors that decide the TSSs in the dispersed mode of initiation are not yet known.  
The understanding of the exact position of the TSS is critical for two reasons. Firstly, mapping the TSS identifies the 
regulatory regions in the core promoter that immediately flank the TSS. Secondly, the TSSs determine the nature 
of the 5’ UTR and the regulatory features present in the alternative TSS isoforms. Alternative transcription initiation 
producing multiple TSS isoforms has been frequently reported in the literature and create diversity in the human 
transcriptome (Davuluri et al., 2008, Landry et al., 2003).  
1.3.1 Alternative Transcription Initiation (ATI) and gene expression:  
In the mammalian genome, greater than 50% of the genes have alternative promoters (Kimura et al., 2006). In 
humans, about 30% to 50% of the genes use alternative promoters, with on average 4 TSSs per gene (Forrest et al., 
2014, Davuluri et al., 2008). Alternative transcription initiation and termination contribute more to genomic 
diversity than alternative splicing (Reyes and Huber, 2018). The selective use of alternative transcript isoforms has 
been shown to play a significant role in regulating gene expression during development, cell differentiation, and 
cell specialisation (Ding et al., 2007, Pozner et al., 2007, Vu and Hoffman, 1994). The transcription initiation from 
alternative promoters could follow two patterns: initiation from alternative promoters that changes the ORF (Figure 





Figure 1.5: Transcription initiation patterns from alternative promoters. (A) Initiation from multiple promoters 
that change the ORF leading to the production of distinct proteins. The example shows alternative transcription 
initiation from a distal and intronic promoter. The protein isoform generated from the intronic promoter lacks the 
N terminal coding sequence (in blue). (B) Transcription initiation from alternative promoters that do not change 
the ORF but changes the nature of the 5’ UTR. Both the TSS isoforms encode for the identical protein but differ in 
their translational potential due to the presence of the regulatory elements in the longer 5’ UTR isoform. The 
structure of the protein is shown for illustrative purpose and to highlight that missing N terminal (in blue). The 
regulatory elements in the longer 5’ UTR from left to right: binding domain for RNA binding protein, upstream open 
reading frame/start codon (AUG), secondary structures, and internal ribosome entry sites (IRES). 
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The ATI from the distal promoters could change the ORF and generate the mRNA isoform that encodes novel 
proteins. For example, the transcription initiation of RUNX1 (runt-related transcription factor 1), an important 
regulator of early haematopoiesis, is mediated by two functionally distinct promoters that differ in their coding 
region, producing protein isoforms that differ in their biological functions (Pozner et al., 2007). Likewise, LEF1 
(Lymphoid Enhancer Binding Factor 1), which regulate the transcription of Wnt/β-catenin target genes, is 
transcribed using two alternative promoters. The earlier promoter produces a full-length functional protein, 
whereas the intronic promoter produces a non-functional protein, which lacks the β-catenin binding domain and 
suppresses Wnt-mediated regulation of target genes (Arce et al., 2006). Other related examples include HOMER1 
(Goossens et al., 2007), GNAS (Weinstein et al., 2007), and CDKN2A (Quelle et al., 1995). The use of alternative 
promoters could also generate protein isoforms with truncated peptide sequence at the N-terminal, for example, 
the CTNNA3 (catenin-cadherin associated protein, α3) in which the smaller isoform is deficient in the β-catenin 
binding domain and is unable to restore cell-cell adhesion (Goossens et al., 2007). 
The ATI also produce mRNA isoforms that encode for identical protein but differing in their 5’ UTR region and affects 
the mRNA translational potential. The human BBOX1 gene, which produces a key enzyme for fatty acid metabolism, 
is transcribed from three distinct promoters generating heterogeneous tissue-specific 5’ UTRs (Rigault et al., 2006). 
Similarly, SHOX (short stature homeobox), involved in bone growth and development, uses two alternative 
promoters, one of them producing an alternative longer 5’ UTR containing seven uAUGs that suppress mRNA 
translation (Blaschke et al., 2003). Interestingly, the distinct 5’ UTR of the XIAP mRNA (X-chromosome linked 
inhibitor of apoptosis) contains an IRES. The shorter XIAP 5’ UTR maintains basal expression under normal growth 
conditions. On the other hand, the longer IRES-containing isoform is implicated in cap-independent translation 
during stress (Riley et al., 2010). The FGF1 (fibroblast growth factor 1) mRNA is another example of alternative IRES 
encoding 5’ UTR that regulate mRNA expression during cellular stress (Martineau et al., 2004). Additionally, the 
alternative 5’ UTR could also contain secondary structures and uORF that strongly inhibit translation. Altered 
expression of the longer 5’ UTR of tumour suppressor BRCA1 (Breast Cancer gene 1) mRNA could decrease the 
expression and contribute to the sporadic ovarian cancers and breast cancers (Sobczak and Krzyzosiak, 2002). 
1.3.2 Transcription start site selection within a single promoter region: 
Previous studies examining ATI have evaluated TSSs derived from multiple promoter regions. These TSSs are usually 
separated by a significant genomic space and encode distinct 5’ UTR regions that harbour regulatory elements. 
However, the work of Carninci et al. (2006), Forrest et al. (2014), Karlsson et al. (2017), Kawaji et al. (2006), and 
Suzuki et al. (2001) have identified the presence of multiple TSSs within a given core promoter region. Forrest et al. 
(2014), as part of the FANTOM consortium, have mapped TSSs and their usage in a large subset of human and 
mouse primary cells, cell lines and tissues. The authors documented that a large set of promoters displayed several 
closely spaced TSSs with independent cell type specific expression profiles. Kawaji et al. (2016) have also 
demonstrated the regional and positional bias in TSS distribution, highlighting that the TSSs are ‘tissue-specifically’ 
utilised. These findings suggested a potential regulatory role of multiple TSS within a promoter region and their 
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tissue-specific TSSs distribution patterns. These multiple TSSs, which are separated by just a few nucleotides, could 
impact the translational potential of the mRNA isoform. 
The landmark study by Rojas-Duran and Gilbert (2012) has shown that the transcript isoforms derived from 
alternative starting sites that are separated by only 50-200 bp showed large differences in translational activity. The 
authors have demonstrated that a seemingly minor change in transcription initiation could have a major impact on 
mRNA translational potential. Likewise, a study by Wang et al. (2016) has reported isoform-specific translational 
differences by combining polysome profiling with high throughput 5’ mRNA end sequencing. Although most of the 
transcript isoforms analysed by the study were presumably derived from alternative promoters, some of the TSSs 
analysed were separated by less than 200 bp and showed a significant difference in polysome association (isoform-
divergent translation). It signifies that the minor changes in TSS selection within a single promoter, like ATI from 
multiple promoters, could incorporate regulatory elements which significantly impact translational potential.  
The studies highlighted above point to the functional role of multiple TSSs within a single promoter region. The 
selection of alternative TSSs within a single promoter region could change the 5’ UTR by few nucleotides and 
incorporate regulatory elements that affect mRNA translatability. Despite their existence, the consequences of 
differential TSS selection are not yet known. The dominant starting sites (major TSS) have usually been the focus of 
studies that analysed ATI-mediated regulation (Arribere and Gilbert, 2013, Dieudonné et al., 2015, Li et al., 2019). 
A recent study by Xu et al. (2019) underestimates the role of multiple TSSs and have argued that there is only one 
optimal TSS per gene and alternative TSSs within the promoter region are the products of molecular errors. 
However, single-cell analysis of TSSs by Karlsson et al. (2017) have shown that the multiple TSSs in the promoter 
region are coregulated and are not stochastically expressed. Moreover, the study by Wang et al. (2016) have also 
showed differential isoform-specific polysome association. The study by Wang et al. (2016) together with the 
findings of Kawaji et al. (2016) and Rojas-Duran and Gilbert (2012) highlight the potential regulatory role of multiple 
TSSs in the single promoter region and the need to further study their functional significance.  
There is a gap in the literature regarding the functional consequences of ATI within a single promoter. The alternate 
TSSs within a core promoter could also produce divergent 5’ UTR isoforms, differing by only a few nucleotides, 
without changing the ORF and would yield identical protein products. Further studies are required to understand 
the impact of TSS selection within the promotor region and would generate novel insights.  
1.3.3 Mapping transcription initiation sites: 
Given the significance of TSS selection in the gene regulation process, several attempts have been made to map the 
TSSs at individual or genome-wide levels. The main methods used in the literature are cap analysis of gene 
expression (CAGE) (Takahashi et al., 2012), oligo-capping (Hashimoto et al., 2004), robust analysis of 5′-transcript 
ends (5′-RATE) (Gowda et al., 2006), rapid amplification of 5’ cDNA ends (Frohman et al., 1988), and their variations.  
CAGE is a commonly used method for high-throughput profiling of the TSSs and is based on the specific chemical 
oxidation of the 2',3'-diol structure at the 5’ ends on the cap nucleotide. It is followed by biotinylation that enables 
selective capture of the capped message using streptavidin immunoprecipitation and purification of full-length 
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RNA-cDNA hybrid. Subsequently, single-stranded DNA is released and ligated to linkers containing recognition sites 
for MmeI endonuclease that produces 20 bp CAGE tags. The tags are amplified, concatenated, cloned and 
sequenced (Kodzius et al., 2006). In the oligo-capping approach, the 5’ mRNA cap structure is removed and replaced 
with oligoribonucleotides to specifically amplify 5’ end sequences of mRNAs (Maruyama and Sugano, 1994). The 
ligation reaction is made cap-specific by removing the 5’ phosphate group from the uncapped mRNA using alkaline 
phosphatase. In the 5’ RACE technique, the 5’ end of the selected mRNA is amplified using a gene-specific 
oligonucleotide primer (Frohman et al., 1988). The technique has been subsequently improved by incorporating an 
RNA-ligase mediated oligo-capping step to specifically amplify selected full-length mRNA (Maruyama and Sugano, 
1994, Volloch et al., 1994) (section 2.2.5, Figure 2.3). 
The high-throughput mapping of TSSs has facilitated the development of TSS databases that characterise the 
dynamically changing TSS landscape in a diverse range of samples. The three notable TSS databases include the 
Functional Annotation of Mammalian Genomes 5 (FANTOM5) project (Forrest et al., 2014), DataBase of 
Transcription Start Sites (DBTSS) (Suzuki et al., 2002), and the Encyclopedia of DNA Elements (ENCODE) project 
(Dunham et al., 2012). The TSSs in the FANTOM database are identified using CAGE technology adapted for single-
molecule sequencing with a median depth of 4 million mapped tags per sample to precisely detect transcription 
initiation activities (Kanamori-Katayama et al., 2011). The FANTOM edition 5 contains the TSS data across 975 
human samples and 399 mouse samples. The human samples included 573 primary cell lines, 152 human post-
mortem tissues and 250 different cancer cell lines covering distinct cancer subtypes (Lizio et al., 2015). The DBTSS 
is based on the oligo-capping approach adapted to massively parallel NGS (Tsuchihara et al., 2009). The recent 
version of the DBTSS contains the TSS profile from 20 tissues and 7 cell cultures (Yamashita et al., 2012). The DBTSS 
database has been recently expanded to include the genomic and epigenome variation dataset of the Japanese 
population (Suzuki et al., 2018). The ENCODE project has profiled the TSS of 36 cell lines using CAGE sequencing 
(Batut et al., 2013, Dunham et al., 2012). The FANTOM database is clearly the largest available collection of TSS 
profiles on a single platform.  
The TSS distribution profiles of the samples in the FANTOM database was produced using modified CAGE protocol 
optimised for single-molecule sequencing (Kanamori-Katayama et al., 2011). In the protocol used by the authors, 
the RNA was first reverse transcribed, and the mRNA cap was biotinylated and captured on magnetic streptavidin 
beads. Subsequently, the RNA/cDNA hybrid molecules were washed to remove unbound molecules and the single-
stranded cDNA was released following treatment with RNase H and RNase I. The released cDNA was poly-A tailed, 
blocked, and loaded onto the HeliScope flow cell channel for high-precision sequencing (Figure 1.6). The sequencing 
data was analysed, and library sizes were adjusted by relative log expression. The CAGE peaks were annotated to 
determine promoter region, gene associations, ontology, co-expression, and motif analysis. To identify the CAGE 
peaks across the genome, the authors employed decomposition-based peak identification, where the CAGE tags 
were first clustered based on proximity and the tags wider than 49 bp were decomposed into non-overlapping 




Figure 1.6: Schematics of HeliScopeCAGE for high-throughput determination of TSSs in the FANTOM database. 
The RNA is reverse transcribed using random primers and the mRNA cap is oxidised with sodium peroxide (Na₂O₂) 
and biotinylated with biotin hydrazine. It is followed by the digestion of single-stranded RNA, that are not reverse 
transcribed, using RNase I. The biotinylated RNA/cDNA hybrid molecules are captured using magnetic streptavidin 
beads and unbound molecules are washed away. Next, the single-stranded cDNA is released using RNase H and 
RNase I followed by heat treatment. The release cDNA is polyA tailed using terminal deoxynucleotidyl transferase 
and dATP and then blocked using biotin- dideoxy ATP. The blocked tailed cDNA is loaded on the HeliScope flow cell 
channel and anneals with the dT50 surface and sequenced. Figure adapted from Kanamori-Katayama et al. (2011) 
(CC BY-NC 4.0).   
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1.4 G-quadruplex structure and gene regulation 
G-quadruplexes (G4) are non-canonical, four-stranded, secondary structures that are formed by sequences rich in 
guanine nucleic acid (Smith and Feigon, 1992). These guanine-rich sequences spontaneously fold into a cyclical 
planar arrangement held together by Hoogsteen base pairing (N1–N6 and N2–N7) to form a G-quartet (Figure 1.7). 
Three or more G-quartet stack onto one another, separated by ~3.3 Å in vertical stacking, and form a stable right-
handed helical G4 structure (Forman et al., 2000). These structures are stabilised by monovalent cations (K+ > 
NH4+> Na+ > Li+) which interact with the negatively charged carbonyl oxygen atom placed at the centre of the G4 
(Burge et al., 2006, Hardin et al., 1992). Studies have found that a classical consensus sequence capable of forming 
G4 can be described as G3+N1–7G3+N1–7G3+N1–7G3+ where N corresponds to any nucleotide (A, G, T, C, or U) (Huppert 
and Balasubramanian, 2005, Todd et al., 2005). However, recent studies have shown the classical consensus 
definition is flexible and imperfect G quadruplex with longer loop and interrupted G runs also exists (Puig Lombardi 
and Londoño-Vallejo, 2019, Varizhuk et al., 2017). 
The capacity of guanosine monophosphate to self-aggregate into a four-stranded helical structure has been known 
since the early 19th century (Bang, 1910). Then, 50 years later, the work of Gellert et al. (1962) using fibre diffraction 
revealed the aggregation of guanosine monophosphate into a gelatinous substance in the aqueous solution. 
Subsequent biophysical studies using conserved DNA sequence of telomeric repeats or immunoglobulin switch 
regions have shown the formation of stable G4 structures in vitro (Sen and Gilbert, 1988, Sundquist and Klug, 1989). 
Since then, numerous sequences have been identified in DNA and RNA that folds into a stable G4. The G4 can adopt 
a wide variety of topological conformations depending on inter or intramolecular folding of G rich strands. The 
intermolecular folding can arise from different combinations of strand orientation resulting in a parallel or anti-
parallel G4 structure (Burge et al., 2006, Banco and Ferré-D'Amaré, 2021).   
The G4 structures are found in both DNA and RNA. The fundamental difference between the DNA and RNA G4 is 
the presence of ribose sugar and uracil instead of thymine residue in the RNA G4. The RNA G4 are 
thermodynamically more stable and less hydrated compared to their DNA G4 counterpart (Joachimi et al., 2009). 
The presence of the 2’OH group in the ribose sugar enhances the stability of RNA G4 due to the increase in 
intramolecular interactions. It also restricts the RNA G4 topology to a parallel conformation, where all the strands 






Figure 1.7: Structure of G quadruplex. Chemical structure of G-quartet with a metal ion (M+) coordinated to 
carbonyl oxygen atoms. G-quartets are stabilized by Hoogsteen hydrogen bonding (N1–N6 and N2–N7). Three or 
more planar G-quartets stacks on top of one another, forming four-stranded helical structures. 
 
 
1.4.1 Functional consequence of DNA G4:  
A seminal study by Huppert and Balasubramanian (2005) demonstrated more than 3.7 x 105 G4 forming sequences 
in the human genome. Recently, a high-throughput study has identified a further 4.5 X 105 previously 
uncharacterized putative G4-forming sequences with long loop and bulges (Chambers et al., 2015). The Genome-
wide bioinformatics analysis has shown that G4s are non-randomly distributed, correlating with important genomic 
regions including promoters of proto-oncogenes, mutational hotspots, and immunological switch regions (Huppert 
and Balasubramanian, 2005, Simonsson, 2001). The DNA G4 have been also reported in other genomic regions 
including ribosomal DNA (Drygin et al., 2009), mitochondrial DNA (Wanrooij et al., 2010), the region of replication 
initiation (Besnard et al., 2012), and retrotransposon elements (Lexa et al., 2014).    
The earliest biologically relevant G4 sequences were observed in the telomeric repeat region (Sen and Gilbert, 
1988). The G4 formation by the consensus sequence (GGGGGAGCTGGGGAAGGTGGG) in the telomeric repeat 
region was shown to inhibit telomerase activity (Sen and Gilbert, 1988). It establishes a mechanistic link between 
G4 formation and telomere maintenance. As reviewed in Fouquerel et al. (2016), a G4 stabilising ligand could 
interfere with telomere repair and inhibit the growth of cancer cells. The work of Vannier et al. (2012) supported 
this notion and demonstrated that the mouse regulator of telomere elongation helicase 1 (RTEL1) unwinds the 
telomeric G4 to ensure the stability of the telomere. The impaired regulation of the G4 structures has been also 
shown to promote genomic instability. The G4 stabilisation has been shown to hamper Pif1 helicase activity that is 
responsible for DNA resection and homologous recombination (Jimeno et al., 2018). Moreover, the G4 structures 
function as a potential sensor of oxidative damage to the DNA by reactive oxygen species and mediate 
transcriptional activation (Fleming et al., 2017). Furthermore, the G4 motifs have been proposed to have a 
biological role in DNA replication. These structures have been shown to stall the progression of the DNA replication 
fork in absence of G4-unwinding helicases (Lopes et al., 2011). 
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The G4s have been reported in the promoter region of many important genes including c-MYC, VEGF, BCL2, KRAS, 
c-KIT, and TERT (Reviewed in Yang, 2019). G4 structures in the promoter region have been shown to have a 
regulatory role. In the case of c-MYC and KRAS, stabilisation of G4 using a ligand resulted in reduced mRNA 
transcription (Cogoi and Xodo, 2006, Siddiqui-Jain et al., 2002). The link between G4 and transcription has been 
also exhibited by Nguyen et al. (2014), showing that impaired function of G4-unwinding helicases (BLM and WRN) 
alters the expression profiles of genes containing G4 motifs in the promoter region (Johnson et al., 2010, Nguyen 
et al., 2014). A study by Mao et al. (2018) have provided evidence that the G4 structures in the promoter region 
decrease the local methylation at the CpG island by inhibiting DNA methyltransferase 1 enzymatic activity, 
contributing to elevated gene expression.  
1.4.2 Functional consequence of RNA G4:  
RNA G4 sequencing has revealed the widespread formation of G4 in the human transcriptome. The rG4-seq 
pioneered by Kwok et al. (2016a) has indicated more than 3000 putative RNA G4, mapped to more than 2000 genes, 
that increased to greater than 11000 presumed RNA G4 motifs upon treatment with G4 stabilising ligand 
(pyridostatin). The RNA G4 has been shown to be enriched in the mRNA 5’ and 3’ UTR (Beaudoin and Perreault, 
2013, Bugaut and Balasubramanian, 2012), R loop (RNA:DNA hybrid) (Xiao et al., 2013), non-coding RNA (Rouleau 
et al., 2018), ribosomal RNA (Mestre-Fos et al., 2019), IRES (Morris et al., 2010), and RNA introns (Weldon et al., 
2018, Marcel et al., 2011).   
The RNA G4, like DNA G4, plays an important role in regulating gene expression. These structures have been shown 
to modulate transcriptional and co-transcriptional regulation. The RNA G4 consensus sequence in the nascent RNA 
could form complementary base pairing with the non-template DNA strand, resulting in the RNA:DNA hybrid-
containing G4s in the R loop (Skourti-Stathaki and Proudfoot, 2014). Recently, Ribeiro de Almeida et al. (2018) has 
demonstrated the unique mechanism of post-transcriptional formation of hybrid G4 in the R loop of mouse 
immunoglobulin heavy chain (IHC) that promote class switching in the IHC locus. Intronic RNA G4s have been shown 
to regulate the alternative splicing of pre-mRNA. In a study by Weldon et al. (2018), the authors have reported a 
restrictive set of G4 ligands that interact with the G4 forming sequence of the Bcl-X pre-mRNA and shift the splicing 
from the dominant Bcl-XL (anti-apoptotic isoform) to the Bcl-XS (pro-apoptotic isoform). Likewise, the G4 motifs in 
the TP53 intron region 3 regulate the splicing of intron 2, producing distinct p53 isoforms (Marcel et al., 2011). 
RNA G4s in the 3’ UTR have been shown to play an important role in mRNA localisation. A study by Subramanian et 
al. (2011) has demonstrated that RNA G4 serve as a neurite localisation signal and deletion of the G4 sequence 
from αCaMKII and PSD-95 resulted in the loss of mRNA translocation to dendrites. Ishiguro et al. (2016) has 
reported a TAR DNA-binding protein (TDP-43) capable of binding G4-containing mRNAs and facilitate their 
intracellular transport to distal neurite for local translation. Moreover, the presence of G4 in the 3’ UTR of FADS2 
was shown to impede the binding of miRNA mir331-3p, regulating RNA interference (Rouleau et al., 2017). Although 
the RNA G4 forming sequence are depleted in the coding region, their presence in the coding region is generally 
associated with translational suppression (Reviewed in Kharel et al., 2020). The translation inhibition is mediated 
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by obstructing the elongating ribosomes that cause ribosome stalling and dissociation (Murat et al., 2014). The RNA 
G4 are also indicated in different lncRNAs (Reviewed in Jayaraj et al., 2012). In the lncRNA TERRA (telomeric repeat-
associated RNA), its presence has been demonstrated to contribute to the telomere homeostasis by interacting 
with telomeric protein TRF2 (Biffi et al., 2012). 
1.4.2.1 Regulatory role of 5’ UTR G4: 
Huppert et al. (2008) revealed about 4,141 potential G4 motifs in the 5’ UTR region of human mRNA. The 
overrepresentation of G4 in the mRNA 5’ UTR points towards the important regulatory role of RNA G4. A variety of 
studies, using a cell-free system and cell-based reporter assay, have highlighted that the 5’ UTR G4 are generally 
associated with a reduction in translational efficiency (Table 1). However, in some instances, a contrasting role for 
G4 has been noted. A study by Bonnal et al. (2003) showed that the formation of G4 motifs in the FGF2 (fibroblast 
growth factor 2) IRES promoted translation. Likewise, Agarwala et al. (2013) noted the activating role of RNA G4 in 
the translation of TGFβ2 (transforming growth factor β2). In addition, the stable G4 structure in the 5’ UTR could 
also promote the formation of 80S translating ribosome on upstream AUG, reducing the translation from 
downstream principal ORF (Murat et al., 2018). Recently, the 5’ UTR G4 has been also indicated to facilitate distal 
localisation of the mRNA for local translation, contributing to distinctive regional proteomes (Maltby et al., 2020). 
The 5’ UTR G4s could also regulate the translational output of the alternative TSS isoforms. The differential TSS 
selection could incorporate these secondary structures in the gene isoforms and control their translational output. 
However, the significance of alternatively transcribed G4 in the context of TSS selection within the core promoter 
is not yet defined. 
 
Table 1.1: Translational impact of 5’ UTR G4 in cell-free and cell-based reporter assay. 
Gene Protein Product RNA G4 Sequence (5’ to 3’) Change in protein 
expression* 
Reference 
NRAS GTPase NRAS GGGAGGGGCGGGUCUGGG ~ 70% decrease (Kumari et al., 2007) 
ZIC1 Zinc finger protein 1 GGGUGGGGGGGGCGGGGGAG
GCCGGGG 





GAGGGAGGGAGGGAGAGGGA ~ 55% decrease (Morris and Basu, 
2009) 
ERS1 Estrogen receptor α GGGUAGGGGCAAAGGGGCTG
GGG 
~ 85% decrease (Balkwill et al., 2009) 
EBAG9 Estrogen receptor 
binding site 




~ 45% decrease (Beaudoin and 
Perreault, 2010) 
















~ 35% decrease (Beaudoin and 
Perreault, 2010) 




~ 50% decrease (Shahid et al., 2010) 
TRF2 Telomeric repeat 
binding factor 2 
CGGGAGGGCGGGGAGGGC ~ 65% decrease (Gomez et al., 2010) 





~ 35% decrease (Beaudoin and 
Perreault, 2010) 
*Percent change in protein expression of reporter gene induced by the G4 consensus sequence relative to the 



















1.5 Tools for detecting G4 
The significance of G4 structures and their role in regulating cell processes in the context of health and disease has 
necessitated the generation of tools to predict and demonstrate their formation in the genome and transcriptome.  
A variety of biophysical techniques have been developed to validate the G4 formation by specific sequences 
including nuclear magnetic resonance (NMR) (Mathad and Yang, 2011), circular dichroism (CD) spectroscopy (Del 
Villar-Guerra et al., 2018), x-ray crystallography (Campbell and Parkinson, 2007), thermal stability analysis (UV 
melting) (Rachwal and Fox, 2007), and fluorescence resonance energy transfer (FRET) (Mergny et al., 2001). 
However, these techniques are not suitable for high-throughput detection of G4 motifs on a genomic level as they 
can interrogate only a single stretch of sequence for G4 identification in a single run.  
1.5.1 Computational approaches for G4 prediction: 
To scan the G4 motif on a larger scale, numerous predictive algorithms have been developed in the last decades. 
These algorithms were guided by biophysical and biochemical techniques that defined the rules and criteria of G4 
folding. Table 2 presents the list of different computational, open-source, prediction tools to detect G4 forming 
sequence.   
The earlier approaches were based on an expression matching algorithm that searches for sequences strictly 
following the classical G4 motif sequences (GX-N1-7-GX-N1-7-GX-N1-7-GX). The recent approaches allow for 
greater flexibility and imperfection tolerance (longer loops, mismatches, incomplete G-runs, bulges) while 
searching for G4 forming sequence. The computational approaches to identify putative G4 sequences can be 
categorised into four groups, namely, classical expression matching, sliding windows, scoring-based, and machine 
learning approaches. In the sliding windows approach, the density of G-runs is calculated in a given sequence 
window to generate a score. Other scoring-based approaches use a flexible motif definition to produce a score. The 
score computed indicates the propensity of the input sequence to form G4. More recently, machine learning 
approaches have been developed that are motif independent and do not rely on predefined motif definitions. 
  
Table 1.2: Selected computational prediction tool to detect G4 motif in DNA/RNA. 
Name Salient features Language Reference 
Classical expression matching 







ImGQfinder Facilitate detection of imperfect G4 that contain 
interrupted or truncated G-runs. 
Web (Varizhuk et al., 
2017) 
Sliding window approach  
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G4P calculator Compute G4 forming potential based on G-run density in a 
sequence. 
Criteria used: G-run length = ≥ 3; number of G-runs per 
window = ≥4; window length = 100 bp; and sliding interval 
length = 20 bp. 
C Sharp (Eddy and 
Maizels, 2006) 
G4Hunter Accounts for the G-richness and G-skewness in the input 
sequence and output a score that indicates the propensity 
to form G4.  
Each position in a sequence is given a score between −4 
and 4 (0 for A and T, negative for C, and positive for G 
(G=1, GG=2, GGG=3, GGGG=4).  
Python/R (Bedrat et al., 
2016) 
Scoring based approaches  
QGRS Mapper Motif definition: GxNy1GxNy2GxNy3Gx where X ≥ 2, default 
maximum length of 30 bp, default minimum G size =2. The 





(Kikin et al., 
2006) 
pqsfinder The algorithm has three logical steps: identification of all 
possible G-run quartets, assignment of a score, and 
overlap resolution. 
Web, R (Hon et al., 2017) 
Machine learning 
G4RNA screener Artificial neural network-based algorithm that evaluates 
the similarity of the input sequence to known RNA G4 
motif and output a score. 
Python (Garant et al., 
2017) 
Quadron Modelling based on tree-based gradient boosting 
machines that predict the intramolecular G4 formation. 
R (Sahakyan et al., 
2017) 
Complementary tool 
Vienna RNA (RNA 
fold) 
Estimate RNA G4 folding energy and examine the 
competition between RNA G4 and other secondary 
structures by comparing minimum free energy. 








1.5.2 Biochemical and molecular approaches to detect G4 structures: 
Different molecular and biochemical approaches, in addition to the biophysical techniques described above, have 
been used to examine the formation of G4 structures in vitro and in cellula. Attempts have been made to interrogate 
the G4 folding by the G4 consensus sequences in the DNA and RNA for the selected targets and on a genome-wide 
scale. 
For DNA G4, biochemical techniques including electrophoretic mobility shift assay (EMSA), dimethylsulfate (DMS) 
footprinting, and DNA polymerase stop assay have been used to demonstrate the in vitro formation of G4 structure 
(Reviewed in Sun and Hurley, 2010). The first line of evidence for the formation of DNA G4 in vivo was presented 
by Schaffitzel et al. (2001) using a G4 structure-specific antibody that stained the G4 in the telomeres of ciliates. 
Subsequently, G4 formation has been demonstrated in mammalian cells using different antibodies (BG4, 1H6) 
combined with complementary approaches such as the use of stabilising ligand and depletion of the G4 helicase 
FANCJ (Biffi et al., 2013, Henderson et al., 2013). Besides antibody and stabilising ligands, small molecules and 
probes with fluorescent properties have been developed and employed for real-time monitoring of G4 in the living 
cells after treatment with a G4 stabilising ligand (pyridostatin) (Shivalingam et al., 2015, Zhang et al., 2018). The G4 
mapping was also adapted to next-generation sequencing (NGS) to identify G4-specific polymerase stalling sites in 
the purified human genomic DNA under different stabilising conditions (Chambers et al., 2015). Moreover, the G4 
landscape in celluo has been also determined using BG4-mediated chromatin immunoprecipitation followed by 
NGS sequencing (ChIP-seq) (Hänsel-Hertsch et al., 2018). 
The G4 formation in the RNA has been reported in vitro using different biochemical approaches including in-line 
probing (Beaudoin et al., 2013), structural analysis using selective 2'-hydroxyl acylation or dimethyl sulphate 
coupled with lithium ion-based primer extension (SHALiPE/ DMSLiPE) (Kwok et al., 2016b), and RNase T1 
footprinting assay in which guanine in the G4 is protected against the RNase T1 digestion (Morris and Basu, 2009). 
The Dominguez group has developed a new strategy to confirm the formation of G4 by using a 7-deazaguanine 
analogue that contains carbon, instead of nitrogen, at position 7 and is no longer able to form Hoogsteen base 
pairing to yield a stable G4 (Figure 1.8A). The authors performed RNA footprinting of long 7-deazaguanine-
substituted RNAs (FOLDeR) to confirm the formation of RNA G4 in the entire functional pre-mRNA and identified 
differences in the native and deazaguanine-substituted analogue by footprinting assay and RNase H cleavage 
patterns (Weldon et al., 2016, Weldon et al., 2017). In addition, Kwok and Balasubramanian (2015) have also 
described a novel approach wherein RNA G4-induced reverse transcriptase stalling is coupled to ligation-mediated 
PCR to positionally map RNA G4 in selected mRNA transcripts (Figure 1.8B). This method has been also adapted to 
high-throughput RNA sequencing (rG4-seq) to generate an in vitro transcriptome-wide map of canonical and 
noncanonical RNA G4 structures (Kwok et al., 2016a).  
The formation of RNA G4 inside the cell has been suggested by different studies. The work of Guo and Bartel (2016), 
using complementary structural probing approaches (DMS and SHAPE), has demonstrated more than 10,000 RNA 
G4 putative sites. However, the authors noted that most of the RNA G4 at these sites are globally unfolded in the 
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cells. Biffi et al. (2014) have visualised RNA G4 in the cytoplasm that could be selectively stabilised using RNA G4 
specific ligand (carboxypyridostatin) (Figure 1.8C). Chen et al. (2018) have developed an RNA-G4 specific fluorescent 
probe (QUMA-1) that could be used for real-time visualization of RNA G4 in living cells. Likewise, Laguerre et al. 
(2015) have designed a Naphtho-template-assisted synthetic G-quartet (N-TASQ) fluorescent probe for the 
detection of RNA G4 motifs in the live cells. The TASQ ligands (BioTASQ) have been also recently used by the same 
group for transcriptome-wide detection of RNA G4 in human cells (Yang et al., 2018). The authors have developed 
BioTASQ-mediated G4 RNA immunoprecipitation and sequencing protocol (G4RP-seq), also comprising of a 
crosslinking step, to capture the transient RNA G4 landscape of the human transcriptome (Figure 1.8D). Recently, 
work by Lat et al. (2020) has evidenced self-biotinylation of DNA/RNA G4 structures, facilitated by the peroxidase 
activity of hemin complexed to them, that could facilitate tagging of G4-containing RNA and DNA in the living cells. 
Even though numerous studies highlighted above have supported the formation of RNA G4 inside the cell, there is 




Figure 1.8: Selected techniques to map and detect RNA G4 motif. (A) Footprinting of long 7-deazaguanine-
substituted RNAs (FOLDeR). The long functional pre-mRNA is transcribed in vitro using either guanosine or 7-
deazaguanosine analogue. The 7-deazaguanosine has N7 substituted to Carbon [C] and is unable to form Hoogsteen 
base pairing to yield a stable G4. The G4 structured regions are subsequently mapped using ribonucleases (RNases). 
(B) G4-induced reverse transcriptase stalling (rG4-seqRNA). Two consecutive sequencing runs are performed, under 
stabilising (K+ and pyridostatin-PDS) or non-stabilising (Li+) conditions to detect G4 dependent polymerase stalling. 
(C) RNA G4 visualisation in the cytoplasm using structure-specific BG4 antibody in combination with fluorophore 
tagged secondary antibodies. (D) G4-RNA-specific precipitation (G4RP) using affinity capture by small-molecule 
ligand (BioTASQ). The cells were crosslinked and lysed and the RNA G4 in the lysate was captured using template-
assisted synthetic G-quartets coupled to biotin. The BioTASQ bound to RNA G4 was pull-downed using streptavidin-
coated magnetic beads and sequenced to determine transiently folded G4-RNAs.    
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1.6 Discrepancy in RNA and protein levels 
The complex interplay between a variety of regulatory elements that act at different levels of gene expression 
results in discordant mRNA and protein expression profiles. As anticipated, a variety of studies have demonstrated 
a weak correlation between mRNA and protein levels (Reviewed in Vogel and Marcotte, 2012). Different studies 
examining the correlation between mRNA and protein abundance in both prokaryotic and eukaryotic systems have 
reported a correlation of about 0.40, implying that mRNA concentration could only explain 40% of the differences 
in the protein levels (Maier et al., 2009, de Sousa Abreu et al., 2009). Despite such a weak correlation, mRNA has 
been widely used as a proxy of their protein product. The undue reliance on the RNA measurement to predict gene 
expression could be explained by the relative effortless acquisition of transcriptomic profiles compared to the 
obtention of the proteomic data that is technically more challenging. The mRNA expression alone provides an 
incomplete picture and the higher mRNA levels might not correlate to the increase in protein concentration due to 
the sophisticated post-transcription, translation, and post-translational regulatory processes.  
1.6.1 AGAP2 as a case study: 
AGAP2 (Arf GAP with GTP-binding protein-like domain, ankyrin repeat and PH domain 2, where Arf is ADP 
ribosylation factor and GAP is GTPase activating protein) is a member of the centaurin gamma 1 GTPase 
superfamily. It is transcribed from the CENTG1 gene locus located on chromosome 12 in reverse orientation 
(O'Leary et al., 2016). AGAP2 belongs to the Arf GAP protein family and act as a GTPase switches for Arfs and 
regulate Arf-mediated signalling (Navarro-Corcuera et al., 2020). AGAP2 was initially identified by Ye et al. (2000) 
and further characterised by Xia et al. (2003). Previously, it was referred as GGAP2 (GTP-binding and GTPase-
activating protein 2) because of its bifunctional GTP-binding and GTPase-activating activities. It was also showed 
that unlike other Arf GAPs, AGAP2 can intrinsically activate its GTPase activity either via intermolecular or 
intramolecular interactions and the Arf GAP domain is essential for GTPase activation (Xia et al., 2003).   
Alternative splicing results in two isoforms namely isoform 1 (PIKE-L) and isoform 2 (PIKE-A or centaurin gamma 1) 
(Kahn et al., 2008). These two isoforms share most of their DNA sequences except for the sequences in the first 
exon and intron. The start of isoform 1 (PIKE-L) is located downstream to the first exon in isoform 2 (PIKE-A) and 
lacks the initial sequences present in the N-terminus of isoform 2 (Figure 1.9). The expression of isoform 1 has been 
noted to be brain-specific (Ye and Snyder, 2004), possibly due to the methylation of the CpG islands in the promoter 





Figure 1.9: Isoforms for AGAP2. Alternative splicing produces two isoforms for AGAP2. Isoform 1 (PIKE-L) and 
isoform 2 (PIKE-A). The first exon for isoform 2 is located upstream of the first exon for isoform 1. The promoter 




The isoform 2 (hereafter referred to as AGAP2) is ubiquitously expressed with increased expression noted in the 
brain followed by spleen, thymus and peripheral blood leukocyte (Elkahloun et al., 1997, Nagase et al., 1996). 
AGAP2 is a potent activator of Akt, a major downstream effector of the PI3K-Akt signalling pathway, and stabilises 
AKT in active conformation (Ahn et al., 2004b). AGAP2 also interact with insulin receptor tyrosine kinase (IRTK), 
suppressing AMP-activated protein kinase (AMPK) phosphorylation. This association enhances hepatic IRTK and 
plays a key role in mediating insulin signal transduction and regulating hepatic glucose homeostasis (Chan et al., 
2011). The physiological interactions of AGAP2 are summarised in Table 3.   
Table 1.3: AGAP2 interacting proteins and their functions. 
Interacting Protein Functions Reference 
Akt Enhancing Akt kinase activity  (Ahn et al., 2004b) 
Insulin receptor Inhibiting AMPK phosphorylation and enhance hepatic IRTK activity  (Chan et al., 2011) 
STAT5A Enhancing STAT5A phosphorylation and mediate prolactin induced 
mammary gland development   
(Chan et al., 2010) 
AP1 Regulating the intracellular distribution of AP1 and affects 
AP1/RAB4 endosomal compartment 
(Nie et al., 2005) 
Fyn Preventing PIKE-A degradation (Tang et al., 2007) 
FAK Increasing the activity of FAK and results in dissolution of the focal 
adhesions 
(Zhu et al., 2009) 
β2-AR Signalling and recycling of β2-ARs (Wu et al., 2013) 
Arf1  Increase GTPase activity of Arf1 (Nie et al., 2005) 
AMPK Regulating AMPK activity (Chan et al., 2011) 
UNC5B Inhibits UNC5B-induced apoptosis (He et al., 2011) 
TGFβ1 Regulate TGFβ1-receptor 2 (TGFR2) trafficking to the membrane (Navarro-Corcuera 
et al., 2019)  
AMPK: AMP-activated protein kinase; AP1: Clathrin adaptor protein activator protein 1; β2-AR: 2-adrenoreceptor; FAK: 
Focal adhesion kinase; RAB4: Ras-related protein 4A; STAT5A: Signal transducer and activator of transcription 5A; 
TGFβ1: Transforming growth factor beta-1; UNC5B: Unc-5 Netrin Receptor B.  
 
 
The diverse interactome of AGAP2 has been implicated in cell survival, apoptosis, cell motility, and lipid metabolism 
(Tse et al., 2013, Ahn et al., 2004a). AGAP2 is also classified as a protooncogene with increased expression noted in 
several cancers including brain, breast, ovarian, stomach, lung, kidney, bladder, prostate, uterine, thyroid, 
testicular, and skin cancer (Cai et al., 2009, Ahn et al., 2004a). Additionally, our group has also recently 
demonstrated the role of AGAP2 in hepatic fibrosis (Navarro-Corcuera et al., 2019).   
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1.6.2 Regulation of AGAP2 expression: 
AGAP2 expression is modulated by different mechanisms. Liu et al. (2007) have linked AGAP2 overexpression with 
the amplification of the CDK4 amplicon, as the gene is located on chromosome 12 adjacent to the CDK4 gene. The 
co-expression of AGAP2 and CDK4 has been implicated in glioblastoma progression (Qi et al., 2017). AGAP2 can be 
also overexpressed without an alteration in the gene copy number, indicating other possible mechanisms. Recently, 
our group has characterised the promoter and transcriptional activity of AGAP2 (Doush et al., 2019). Using the 
reporter assay, we have identified that the -246/+36 in the AGAP2 DNA sequence contain the 
minimal AGAP2 promoter region. It drives AGAP2 expression in prostate cancer and chronic myeloid leukaemia cell 
lines and binds to Specificity protein 1 (SP1) transcription factor, which is required for AGAP2 expression in these 
cell lines. Furthermore, we have also reported that the -475/-246 fragment in the AGAP2 DNA sequence contains a 
DR5 binding site with a functional retinoic acid response element (RARE), inducing AGAP2 promoter activity and 
expression on treatment with ATRA (all-trans retinoic acid).   
Post-translational modification of AGAP2 has been also shown to regulate AGAP2 expression and activity and has 
been implicated in multiple signalling pathways and disease processes (Reviewed in Navarro-Corcuera et al., 2020). 
Several serine and tyrosine residues in different domains of AGAP2 protein could be targeted for phosphorylation 
by multiple kinases and affect AGAP2 activity. Phosphorylation of AGAP2 at Ser-279 by Cyclin-dependent kinase 5 
(Cdk5) increase its GTPase activity and has been also shown to further activate AKT kinase activity, leading to 
increase cell migration and invasion in human glioblastoma (Liu et al., 2008). Likewise, AGAP2 phosphorylation on 
Ser-351 and Ser-377 by AMP-activated protein kinase (AMPK) stimulate AGAP2 interaction with anchor protein (14-
3-3β) and promote its translocation to the nucleus (Zhang et al., 2019). The phosphorylation of different domains 
of AGAP2 and their impact on signalling pathways, cellular processes, and disease pathogenesis are depicted in 




Figure 1.10: Post-translational modifications of AGAP2 and their impact:   Effect of phosphorylation of serine and 
tyrosine residues in different domains of AGAP2 and their impact on AGAP2 protein activity. The consequences of 
phosphorylation on different signalling pathways and disease processes are highlighted by the green (induction) 
and red (inhibition) arrows. The different domains of AGAP2 depicted include GTPase domain (G domain), pleckstrin 
homology (PH) domain, GTPase-activating proteins (GAP domain), and ankyrin (ANK) repeats. AMPK: AMP-
activated protein kinase; Cdk5: Cyclin-dependent kinase 5; UNC5B: Uncoordinated-5 netrin receptor B. Figure 
adapted and modified from a previously published paper by our group Navarro-Corcuera et al. (2020) (CC BY). 
 
 
1.6.3 Correlation between AGAP2 mRNA and protein levels: 
Preliminary work in our lab has revealed a mismatch between AGAP2 mRNA and protein levels in a subset of Chronic 
Myeloid Leukaemia (CML) and Prostate cancer (PC) cell lines (section 3.1.1). The observed discrepancy in the mRNA 
and protein level has captured our attention and persuaded us to explore the gene regulatory mechanisms 
responsible for mediating such inconsistency. Our preliminary experiments have also displayed differential usage 
of AGAP2 TSSs in PC and CML cell lines with a G4 consensus sequence between the two TSSs (section 3.1.1). 
Provided the relevance of 5’ UTR G4 in regulating gene expression, we aimed to explore the contribution of 5’ UTR 
G4 forming sequence, that is incorporated by the selection of alternate TSS, in regulating AGAP2 expression in PC 
and CML cell lines. It would constitute an alternative mechanism of gene regulation that would involve regulation 
of the gene output by the selection of TSS-isoforms harbouring elements that impact mRNA translation output.  
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1.7 Aims of the thesis 
The general aim of this research is to examine the discrepancy in AGAP2 mRNA and protein levels found in PC vs. 
CML cell lines. We planned to achieve this aim through the following: 
• The characterisation of the TSSs within the AGAP2 core promoter region of PC and CML cell lines. 
• The study of AGAP2 mRNA 5’ UTR and its influence on protein expression, with an interest in the potential 
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2.1 Materials  
The Key resource table below details all the reagents and resources used in the current study: 
Table 2.1: Key Resource Table. 
Reagent or Resource Source Identifier 
Chemicals and Reagents 












Absolute Ethanol for molecular biology Fischer Scientific Cat#10644795 
2-Propanol for molecular biology Sigma-Aldrich Cat#278475 
TWEEN 20 Sigma-Aldrich Cat#P1379 
Nuclease free water Promega Cat#P1193 
MG132, proteasome inhibitor Sigma-Aldrich 
Cat#474790; 
CAS:133407-82-6 
Bortezomib, proteasome inhibitor Santa Cruz 
Cat#sc-217785; 
CAS:179324-69-7 
Sodium Deoxycholate Sigma Aldrich 
Cat#30970-25G; 
CAS: 302-95-4 
30% Hydrogen peroxide solution Sigma Aldrich 
Cat#H1009; 
CAS: 7722-84-1 
Cyclohexamide Santa Cruz 
Cat#sc-3508; 
CAS:66-81-9 
DNase I (RNase-free) ThermoFisher Cat#AM2222 
Complete EDTA-free protease inhibitor cocktail Roche Cat#5056489001 
SureBeads Protein G Biorad Cat#161-4023 
Ampicillin sodium salt Sigma-Aldrich Cat#A9518 
Glycogen ThermoFisher Cat#AM9510 
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NheI restriction endonuclease Promega Cat#R6501 
XhoI restriction endonuclease Promega Cat#R6161 
Taq DNA polymerase Promega Cat#M7841 
LB Broth powder Sigma-Aldrich Cat#L3522 
Alkaline calf intestinal phosphatase Promega Cat#M1821 
T4 DNA Ligase Promega Cat#M1801 
TRIzol Reagent ThermoFisher Cat#15596026 
RNasin Ribonuclease Inhibitor Promega Cat#N2511 






Precision Plus Protein™ Dual Colour Standards Biorad Cat#1610374 
30% Acrylamide Severn Biotech 
Cat#20-2100-10 
CAS:79-06-1 
1kb DNA Ladder Promega Cat#G5711 
100bp DNA Ladder Promega Cat#G2101 
DNA Gel Loading Dye (6X) ThermoFisher Cat# R0611 
Precision Plus Protein™ Dual Color Standards Biorad Cat#1610374 
Nitrocellulose membrane GE Healthcare Cat#10600006 
SYBR Safe DNA Gel Stain ThermoFisher Cat#S33102 
RPMI 1640 cell culture Media Gibco Cat#52400025 
Dulbecco's Modified Eagle Medium with GlutaMAX Gibco Cat#10566016 
Dulbecco's Modified Eagle Medium/Nutrient Mixture F-
12 
Gibco Cat#11320033 
Iscove's Modified Dulbecco's Medium Gibco Cat#12440053 
Opti-MEM Reduced-Serum Medium Gibco Cat#31985062 
Fetal Bovine Serum Biosera Cat#FB1090/500 
Human Recombinant Insulin Sigma Aldrich Cat#91077C 





Dimethyl Sulfoxide (DMSO) Sigma Aldrich 
Cat#D2650 
CAS:67-68-5 
2-mercaptoethanol Sigma Aldrich 
Cat#M6250 
CAS:60-24-2 
L-Glutamine (200 mM) ThermoFisher Cat#25030149 
Trypsin-EDTA (0.25%) ThermoFisher Cat#25200056 
Trypan blue Sigma Aldrich Cat#T8154 












2 mL Cryovials Sarstedt Cat#72.379 
Mr. Frosty™ Freezing Container ThermoFisher Cat#5100-0001 
Amersham Protran 0.2 µm nitrocellulose membrane GE Healthcare Cat#GE10600001 
4–20% Mini-PROTEAN Precast Protein Gels Biorad Cat#4561094 
Critical Commercial Assays 
Dual-Luciferase Reporter Assay System Promega Cat#E1910 
ReliaPrep RNA Miniprep Systems Promega Cat#Z6011 
NucleoSpin Plasmid Columns Fischer Scientific Cat#11932392 
5' RACE System for Rapid Amplification of cDNA Ends, 
version 2.0 
ThermoFisher Cat#18374058 
GeneRace Kit with SuperScript III RT and TOPO TA 
Cloning for 5’ RLM-RACE 
ThermoFisher Cat#L150201 
Amaxa Cell Line Nucleofector Kit V Lonza Cat#VCA-1003 
Pierce™ BCA Protein Assay Kit ThermoFisher Cat#23227 
M-MLV Reverse Transcriptase Promega Cat#M1701 
TOPO TA Cloning Kit ThermoFisher Cat#K4575J10 
GoTaq® qPCR SYBR master mix Promega Cat#A6001 
mMESSAGE mMACHINE T7 Transcription Kit ThermoFisher Cat#AM1344 
ECL Western Blotting Substrate Promega Cat#W1001 
Flexi Rabbit Reticulocyte Lysate System Promega Cat#L4540 
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Wizard SV Gel and PCR Clean-Up System Promega Cat#A9281 
jetPRIME DNA/siRNA transfection reagent Polyplus Cat#114-01 
DNeasy Blood & Tissue Kit Qiagen Cat#69504 
EZ-PCR Mycoplasma Test Kit Biological Industries Cat#20-700-20 
Equipment 
Countess 3 Automated Cell Counter Fischer Scientific Cat#15397802 
Tube Rotator Grant Bio Cat#PTR-35 
Bio-Rad Mini-Protean II system Biorad Cat#1653308 
Rotor-Gene Q 2plex Platform QIAGEN Cat#9001550 
Bio-Rad T100 thermocycler Biorad Cat#186-1096 
BMGLabtech CLARIOSTAR plate reader BMG labtech Cat#430-501S-F 
Nanodrop 8000 spectrophotometer ThermoFisher Cat#ND-8000-GL 
Bioanalyzer System Agilent CAT#G2939BA 
ImageQuantTM LAS 4000 GE healthcare  
Class II (laminar flow) biological safety cabinet Walker Safety Cabinets  
Syngene™ G:BOX Chemi XX9 Syngene Cat#DRXX6/1100 
Soniprep 150 plus (MSE) 
Measuring and Scientific 
Equipment (MSE) 
Cat#MSS150 
Nucleofector 2b Device Lonza Cat#AAB-1001 
iMark Microplate Absorbance Reader Biorad Cat#1681135 
Refrigerated Centrifuge Eppendorf Cat#5418-R 
Mini Dry Bath AccuBlock Cat#D0100 
Bacterial Strains 
DH5α Thermo-Fisher Cat#18265017 
One Shot TOP10 Chemically Competent E. coli Thermo-Fisher Cat#C404010 
Recombinant DNA 
pcDNA3 RLUC POLIRES FLUC Addgene,  




Software and Algorithms 
GraphPad Prism 8 GraphPad Software, Inc. https://www.graph
pad.com/scientific
-software/prism/  





MetaCore Pathway Analysis Clarivate Analytics https://portal.gene
go.com/  
BaseSpace Sequence Hub Illumina https://basespace.
illumina.com/  










Rstudio Rstudio team https://www.rstudi
o.com/ 








Python programming language Version 3.6.8 https://www.pytho
n.org/  
Multiple sequence alignment (Corpet, 1988) http://multalin.toul
ouse.inra.fr/multal
in/  












2.2 Methods  
2.2.1 Cell Culture: 
The following cell lines were used in the study. The source, identifier, and growth conditions are detailed below in 
Table 2.2. (Note: No antibiotics were added to the growth medium). 
 
Table 2.2: List of cell lines, their identifiers and culture conditions used in the study. 
Cell line Source/identifier Growth medium 
KU812  
(Human chronic myelogenous leukaemia) 
ATCC 
(RRID:CVCL_0379) 
Kindly Provided by 
Dr Felipe Prosper 
RPMI supplemented with 2 mM 
L-Glutamine and 10% FBS 
TCCS  
(Human myelogenous leukaemia) 
(Van et al., 2005) 
Kindly Provided by 
Dr Felipe Prosper 
RPMI supplemented with 2 mM 
L-Glutamine and 10% FBS 
KCL-22  
(Human myelogenous leukaemia) 
ATCC 
Kindly Provided by 
the John van Geest 
Cancer Research 
Centre 
RPMI supplemented with 2 mM 
L-Glutamine and 10% FBS 
DU145  
(Human prostate cancer) 
ATCC 
(RRID:CVCL_0105) 
Kindly Provided by 
the John van Geest 
Cancer Research 
Centre 
DMEM GlutaMAX supplemented 
with 10% FBS 
PC3  
(Human prostate adenocarcinoma) 
ATCC 
(RRID:CVCL_0035) 
Kindly Provided by 
the John van Geest 
Cancer Research 
Centre 
DMEM/F12 containing 2 mM L-
Glutamine and 10% FBS 
LNCaP  
(Human prostate cancer) 
ATCC 
Kindly Provided by 
the John van Geest 
Cancer Research 
Centre 
RPMI supplemented with 2 mM 







Kindly Provided by 
Dr Maria 
Hatziapostolou 
DMEM GlutaMAX supplemented 
with 10% FBS 
HuH7 
(Human liver cancer) 
JCRB 
(RRID:CVCL_0336) 
DMEM GlutaMAX supplemented 
with 10% FBS 
MCF-7  
(Human breast adenocarcinoma) 
ATCC 
(RRID:CVCL_0031) 
Kindly Provided by 
the John van Geest 
Cancer Research 
Centre 
DMEM GlutaMAX supplemented 
with 10% FBS and 0.01 mg/mL 
human recombinant insulin 
PA-1  
(Human ovary teratocarcinoma) 
ATCC 
(RRID:CVCL_0479) 
Kindly Provided by 
the John van Geest 
Cancer Research 
Centre 
DMEM GlutaMAX supplemented 
with 10% FBS 
SK-OV-3  
(Human ovary adenocarcinoma) 
ATCC 
(RRID:CVCL_0532) 
Kindly Provided by 
the John van Geest 
Cancer Research 
Centre 
McCoy's 5a medium 
supplemented with 2 mM L-
Glutamine and 10% FBS 




DMEM GlutaMAX supplemented 
with 10% FBS 
RAJI  
(Human Burkitt′s lymphoma) 
ATCC 
(RRID:CVCL_0511) 
RPMI supplemented with 2 mM 
L-Glutamine and 10% FBS 
KG1  
(Human acute myelogenous leukaemia) 
ATCC 
(RRID:CVCL_0374) 
Kindly Provided by 
the John van Geest 
Cancer Research 
Centre 
Iscove's Modified Dulbecco's 
Medium, 2mM Glutamine, and 
20% FBS 
Kasumi-1 
(Human acute myeloblastic leukaemia) 
ATCC(RRID:CVCL_
0589) 
Kindly Provided by 
the John van Geest 
Cancer Research 
Centre 
RPMI supplemented with 2 mM 
L-Glutamine and 10% FBS 
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2.2.1.1 Maintenance and passaging of human cell lines: 
The cells were maintained in the growth medium as outlined in Table 2.2. Upon reaching 80-90% confluence, cells 
were passaged. In the case of adherent cell lines, the old medium was removed followed by washing the culture 
with phosphate buffered saline (Lonza) to remove traces of serum and dead cells. The cells were incubated with 
Trypsin-EDTA (1 mL per 50 cm2 of surface area) and incubated in a 5% CO2 incubator at 37°C for 5 minutes. After 
incubation, when the cells became rounded and detached, 5 volume of fresh complete medium was added to 
inactivate Trypsin-EDTA. The cells were then centrifuged at 300 x g for 5 minutes at room temperature and 
resuspended in a complete growth medium and split 1:5 into a new cell culture flask. In the case of suspension cell 
lines, the cells in media were directly collected for centrifugation without washing and trypsinisation steps. The 
cells were centrifuged at 200 x g for 5 minutes. The cell pellet was resuspended in a fresh medium and seeded at a 
density of 1 x 106 cells/mL in a new cell culture flask. 
2.2.1.2 Cell counting: 
The cells were counted using the automated cell counter (Fischer Scientific). After passaging the cells, as described 
previously, the cells were resuspended in 3 mL of fresh medium. A volume of 10 µL of cell suspension is mixed with 
10 µL of Trypan blue and pipetted into a disposable counting chamber slide (ThermoFisher) and loaded onto the 
cell counter. The live cell count/mL was used to determine the volume of cell suspension needed to achieve the 
required cell density in the growth medium. 
2.2.1.3 Cryopreservation and thawing: 
The cells were kept in a culture for a maximum of 15 passages to prevent phenotypic and global gene expression 
changes associated with long-term serial passaging (Mouriaux et al., 2016). The frozen stocks of low passage cells 
were prepared by collecting and counting 1 x 106 cells per mL, as described above, and resuspending the pellet in a 
complete growth medium (Table 2.2) with 5% DMSO (Sigma Aldrich). The cells were transferred into  2 mL cryovials, 
appropriately labelled, and cooled at a steady rate of -1°C/minute in a freezing container (ThermoFisher) at -80°C 
for 24 hours. The cells were then transferred to liquid nitrogen storage.  
To revive the cells from the frozen stock, the cryovials were thawed at 37°C for 1-2 minutes and added to the 
prewarmed medium. The cells were centrifuged to remove DMSO and reconstituted in a fresh complete medium 
(Table 2.2) and transferred to a T25 flask. After 24 hours, the cells were examined under the microscope to monitor 
cell health and were checked for mycoplasma contamination (see below 2.1.4). 
2.2.1.4 Mycoplasma testing: 
All cell lines used in the study were regularly checked for mycoplasma contamination, particularly after thawing, 
using the EZ-PCR mycoplasma test kit (Biological Industries) by following the manufacturer’s protocol. Briefly, after 
reviving and reaching 70-80% confluence, 1 mL of supernatant from cell culture medium was centrifuged at 250 x 
g for 1 minute to pellet cell debris and then centrifuged at a higher speed (16,000 x g for 10 minutes) to sediment 
mycoplasma. The pellet (not easily visible) was resuspended in the supplied buffer solution and heated at 95°C for 
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3 minutes. The sample was then amplified by PCR using the provided primers to detect the 16S mycoplasma specific 
rRNA region. The reaction was carried out alongside the positive template control to ensure that the PCR is working 
correctly. The PCR products were resolved on a 2% agarose gel [2g (w/v) agarose in TAE buffer (See below 2.2.3)] 
and visualised using G:BOX Chemi XX9 gel imaging system (Syngene). A representative gel showing mycoplasma 
testing for the main cell lines used in the study is depicted below (Figure 2.1). As shown in the figure, TCCS culture 
(lane 5) was contaminated with mycoplasma. The cell culture flasks were appropriately discarded, and a new frozen 
stock of TCCS was thawed and rechecked for mycoplasma contamination. 
  
 
Figure 2.1: Mycoplasma testing. Agarose gel electrophoresis of PCR products was to detect mycoplasma 
contamination. Supernatant media was taken from the cell culture after reaching 70-80% confluence and 
centrifuged at high speed to sediment mycoplasma and amplified by PCR using supplied primers. A band at 270 bp 
is consistent with mycoplasma contamination. Lane M: 100 bp DNA ladder; Lane 1-6: DU145, PC3, LNCaP, KU812, 
TCCS (mycoplasma positive), KCL-22; Lane P: positive template control.     
 
2.2.2 Gene expression analysis: 
2.2.2.1 RNA extraction: 
The RNA was extracted using the ReliaPrep RNA Miniprep Systems (Promega) according to the manufacturer’s 
instruction. Briefly, the cell pellet was lysed in the supplied BL buffer with 1-thioglycerol added. The lysate was then 
passed through a 20-gauge needle (3-4 times) to shear the genomic DNA. 100% isopropanol (35 µL per 100 µL of 
the BL buffer) was added to the lysate and the mix was carefully transferred to a ReliaPrep minicolumn and 
centrifuged at 14,000 x g for 1 minute. The sample flowthrough was discarded, and the columns were washed with 
the provided RNA wash solution. The on-column DNase treatment was then performed for 15 minutes with the 
DNase I enzyme provided with the kit. The columns were subsequently washed with column wash solution and RNA 
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wash solution to remove DNase I and transferred to a fresh 1.5 mL collection tube. Finally, 20 µL of nuclease-free 
water was added to the column and centrifuged at 14,000 x g for 1 minute to elute the RNA. The RNA concentration 
was quantified using Nanodrop 8000 spectrophotometer (ThermoFisher) and samples were either used 
immediately for cDNA synthesis or stored at -80°C until further use. 
2.2.2.2 cDNA synthesis: 
The RNA was reverse transcribed using M-MLV Reverse Transcriptase (Promega). 2 µg of RNA was added to a tube 
containing 1 µg of random primers (Promega) and nuclease-free water up to a volume of 15 µL.  The mixture was 
heated at 65°C for 5 minutes to melt the secondary structures in the RNA. After incubation, the mixture was 
immediately cooled on ice for 2 minutes to prevent the reforming of secondary structures. The following 
components were then added to the mixture: 
 
Table 2.3: Component compositions for cDNA synthesis from RNA templates using M-MLV Reverse    
Transcriptase. 
Reagents Final Concentration Volume (µL) 
MMLV 5X Reaction Buffer 1X 5 
dATP (10 mM) 500 µM 1.25 
dGTP (10 mM) 500 µM 1.25 
dCTP (10 mM) 500 µM 1.25 
dTTP (10 mM) 500 µM 1.25 
Recombinant RNasin Ribonuclease Inhibitor  25 units 0.625 
M-MLV Reverse Transcriptase  200 units 1 
Nuclease free water to a final volume - 25 µL 
 
The complete reaction mix was incubated in a thermocycler (Biorad) using the following settings: Priming at 25°C 
for 10 minutes, reverse transcription at 37°C for 60 minutes, and reverse transcriptase inactivation at 85°C for 5 
minutes. The newly synthesized cDNA was stored at -20°C until required.  
2.2.2.3 Quantitative reverse transcription PCR (qRT-PCR) 
The quantitative reverse transcription PCR (qRT-PCR) was performed using SYBR-green fluorescence in a Rotor-
Gene Q real-time PCR cycler (Qiagen). The list of primers and their concentration and annealing temperature are 
presented in Table 2.4. The PCR reaction was carried out in a total volume of 10 µL containing GoTaq qPCR SYBR 
master mix (Promega), forward and reverse primers, and cDNA (1-100 ng). The thermal cycler reaction conditions 
were as follow: initial denaturation for 5 minutes at 95°C; followed by 40 cycles, consisting of 30 seconds 
denaturation at 95oC, 30 seconds primer annealing at described temperature (Table 2.4), and 30 seconds template 
extension at 72oC. The melt-curves analysis was performed for each run to verify the specificity of amplicons. All 
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reactions were performed in triplicate and the expression levels of the target transcripts were normalised using a 
housekeeping gene (HPRT). Data was analysed using the comparative Ct method (2−ΔΔCt) (Livak and Schmittgen, 
2001).  
 
Table 2.4: Primer sequences and related information for quantitative reverse transcription PCR (qRT-PCR) 
Primer name NCBI accession 
number 





Outer long AGAP2 Forward  
XM_005268626.2 
GACAGACGGAAGGGCGG 500 60°C 
Outer long AGAP2 Reverse ACAACGAACTGCCTCTGGGC 500 60°C 
Inner long AGAP2 Forward 
XM_005268626.2 
GCAGGGGCGGGGAGTTCT 100 63°C 
Inner long AGAP2 Reverse CTTGCCAGGCTAACAACCAC 100 63°C 
Outer short AGAP2 Forward 
NM_014770.4 
TCTGAGGTTTGGGGGCTGTA 500 60°C 
Outer short AGAP2 Reverse CAGGCGCAGTTCAGGAATGG 500 60°C 
AGAP2 Forward 
NM_014770.4 
CCAGAGGTGGTTGTTAGCCTG 500 65°C 
AGAP2 Reverse GCGGCTCAAAGTCCATTCCT 500 65°C 
Long HK1 Forward 
NM_033496.3 
AGGTTGCATGAGGGGTTGG 250 60°C 
Long HK1 Reverse TTTTGAGCCAGGACTCCAGC 250 60°C 
Short HK1 Forward 
NM_033496.3 
TACCACAACCTGACACTGGG 250 60°C 
Short HK1 Reverse CACCTCGACAGGGCAAACTC 250 60°C 
Renilla Luciferase Forward  
- 
ATAACTGGTCCGCAGTGGTG 300 63°C 
Renilla Luciferase Reverse TAAGAAGAGGCCGCGTTACC 300 63°C 
NRAS Forward  
NM_002524.5 
CAGAGGCAGTGGAGCTTGA 500 65°C 
NRAS Reverse  GCTTTTCCCAACACCACCT 100 65°C 
MM16 Forward  
NM_005941.5 
GCTCGTCCATCCATTGAAGC 500 60°C 
MM16 Reverse  TGCACGAAATCCAACCGTCT 100 60°C 
PON2 Forward  NM_001018161.1 
NM_000305.3 
GACTCCACAGCTTTGCACC 500 60°C 
PON2 Reverse GGCCAAATCAAACCCACGAC 250 60°C 
CKDN2A Forward 
NM_001195132.2 
CCCTTTGGTTATCGCAAGCTG 500 60°C 
CKDN2A Reverse CCCTGTAGGACCTTCGGTGA 250 60°C 
HPRT Forward 
NM_000194.3 
ATGCTGAGGATTTGGAAAGG 500 60°C 
HPRT Reverse AATCCAGCAGGTCAGCAAAG 500 60°C 
TBP Forward NM_001172085.2 
NM_003194.5 
TTCGGAGAGTTCTGGGATTG 500 65°C 
TBP Reverse GGATTATATTCGGCGTTTCG 500 65°C 
AGAP2 Genomic Forward - TTAGGATTGCACCTCGGACC 500 60°C 
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AGAP2 Genomic (-218) 
Reverse: 
CAAGCTAGGTCCGAGGTGC 500 60°C 
 
2.2.2.4 Primer optimisation and efficiency testing: 
The optimal concentration of a primer pair was determined using a primer matrix, keeping the annealing 
temperature at 60°C (Figure 2.2A). The lowest concentration of primer pair yielding the best Ct value (lower number 
of cycles to reach the detection threshold) was selected. The selected primer pair was checked for the formation 
of primer dimer using a no template control (NTC). When amplification was detected in NTC, the primer pair was 
further optimised by selecting a higher annealing temperature. The specificity of amplification was determined by 
a melt curve analysis and checking the size of the amplicon using agarose gel electrophoresis (see section 2.2.3) 
and Sanger sequencing of the product. The efficiency of each primer pair was determined using a ten-fold dilution 
series (Figure 2.2B). A standard curve analysis was performed to determine the reaction efficiency with a goal of 
90-110% reaction efficiency and R2 values >0.98.   
As a representative example, the optimisation of primer pair amplifying HK1 (NM_033496.3) is shown in Figure 2.2. 
The optimal primer concentration was determined using a primer matrix (Figure 2.2A). The primer efficiency was 
subsequently determined by plotting the standard curve of the dilution series and reaction efficiency was found to 
be 93% and R2 value of 0.99.  
 
 
Figure 2.2: Schematics and representative example for primer optimisation and efficiency testing. (A) Primer 
optimisation matrix. (B) Schematics of 10-fold dilution series to plot standard curve for primer efficiency testing. 
(C) Optimisation of primer pair to amplify HK1 using primer matrix. (D) Representative standard curve to determine 
primer efficiency for the primer pair to amplify HK1. 
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2.2.3 Agarose gel electrophoresis: 
Agarose gel electrophoresis was used in the project for the following applications: resolving the DNA fragments 
following PCR amplification, 5’ Rapid amplification of cDNA ends (RACE), and restriction endonuclease digestion. 
The required percentage of gel (depending on the size of the amplicon) was cast in Tris-acetate-EDTA (TAE) buffer 
(40 mM Tris, 20 mM acetic acid, 1 mM EDTA) supplemented with SYBR safe DNA gel stain (1:10,000). The sample 
was mixed with DNA gel loading dye (1:6) (ThermoFisher) before loading onto the gel. An appropriate size marker 
(1Kb or 100bp) was also used alongside the sample. Electrophoresis was carried out at 100V for 1 hour and 
visualised using G:BOX Chemi XX9 gel imaging system (Syngene).  
 
2.2.4 SDS-PAGE and Western blotting: 
2.2.4.1 Preparation of cell lysate: 
The cells were lysed in radio-immunoprecipitation assay (RIPA) buffer [50 mM (v/v) Tris-Cl (pH 8.0), 1% (v/v) NP-40, 
1% (v/v) sodium deoxycholate, 0.1% (v/v) SDS, 150 mM (v/v) NaCl], containing protease inhibitors (Roche). The 
lysate was then incubated on ice for 30 minutes and sonicated with ice-cooling for 3 × 5 sec pulses at a frequency 
of 5 microns using a Soniprep 150 plus (MSE) followed by centrifugation at 13,000 x g for 10 min at 4°C. The lysates 
were used immediately for protein estimation or stored at -20°C until further use. 
2.2.4.2 Protein quantification: 
The concentration of protein in the lysate was determined using the BCA Protein Assay Kit (ThermoFisher) based 
on the bicinchoninic acid assay by Smith et al. (1985). Bovine serum albumin (BSA) was used to produce a standard 
curve and the protein concentration was determined using a straight-line equation. Protein standards were 
prepared using dilutions of BSA as detailed in Table 2.5. 20 µL of standard and samples (1:10 diluted) were added 
to a well in a 96-well plate (Sarstedt) in triplicate and 160 µL of BCA reagent (1:50, reagent A and B) was then added 
to each well. The plate was then incubated at 37°C for 30 mins and absorbance was measured at 562 nm. The 
standard curve having an R2 value (linearity) > 0.98 were used for protein quantitation.  
 
Table 2.5: BSA standard curve. 
Protein concentration (mg/mL) 2mg/mL BSA (μl) RIPA buffer (μL) 
0 0 20 
0.2 2 18 
0.4 4 16 
0.6 6 14 
0.8 8 12 
1.2 12 8 
64 
 
1.6 16 4 
2.0 20 0 
 
2.2.4.3 SDS-PAGE (Sodium dodecyl sulphate-polyacrylamide gel electrophoresis): 
The SDS-PAGE was performed in reducing conditions. Typically, 50 μg of protein were mixed with 4X Laemmli buffer 
[2% SDS, 10% (v/v) glycerol, 50 mM Tris-HCl (pH 6.8), bromophenol blue 0.02% (w/v), 1% β-mercaptoethanol (v/v)] 
and incubated at 95°C for 5 minutes. Total protein was separated by sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) consisting of 10% resolving gel [9.6 mL of dH2O, 6 mL of resolving buffer (1.5 M Tris 
base, 0.4% w/v SDS, pH 8.4), 8 mL of 30% (w/v) acrylamide/bis solution, 8 μL of TEMED, and 90 μL of freshly 
prepared 10% (w/v) ammonium persulphate] and 5% stacking gel [2.1 mL of dH2O, 0.5 mL of stacking buffer (0.5 
M Tris base, 0.4% w/v SDS, pH 6.8), 0.38 mL of 30% (w/v) acrylamide/bis solution, 30 μL 10% SDS, 3 μL of TEMED, 
and 30 μL of freshly prepared 10% (w/v) ammonium persulphate]. Electrophoresis of 25 µL sample/well was carried 
out at 100 V for 2 hours in running buffer (3 g Tris base, 14.4 g Glycine, 1 g SDS). Precision Plus Protein Dual Colour 
Standards (BioRad) was used as a molecular weight marker. 
2.2.4.4 Immunoprobing:  
Proteins were subsequently transferred to Amersham Protran 0.2 µm nitrocellulose membrane (GE Healthcare) at 
100 V for 90 mins in transfer buffer (3 g Tris base, 14.4g Glycine, 200 mL methanol). The membrane was then 
blocked with 5% (w/v) skimmed milk powder in TBST (2.42 g Tris base, 8.78 g NaCl, 300 µL Tween20) for 1 hour at 
room temperature with agitation. Subsequently, the membrane was incubated with primary antibody (Table 2.4) 
diluted in 5% milk in TBST overnight at 4°C with agitation. After this, the membrane was washed with TBST three 
times for 10 min at room temperature followed by incubation with the appropriate secondary antibody (Table 2.4). 
Next, the membrane was washed as previously described and signals were detected by incubating the membrane 
with 1 mL Clarity ECL Western Blot Substrate (BioRad). Exposure and imaging were carried out using a luminescent 
image analyser LAS-4000 (GE healthcare).  
 
Table 2.6: Antibodies used for Western blotting.  
Antibody Type Specificity Host Concent
ration 
Supplier 
Anti-AGAP2  Polyclonal Detect amino acid sequence 
CQASLDSIREAVINSQ specific 
to PIKE-A/isoform 2 
Goat 1:1000 Sigma-Aldrich 
Cat#SAB2501250; 
RRID:AB_10620617 
Anti-HK1 Monoclonal Detect amino acids 316-410 
of HK1 of human origin 
Mou
se 

































Anti-Caveolin 1  Polyclonal Detect Peptide with 
sequence C-DELSEKQVYDAH 
specific to Caveolin 1 





Monoclonal Detects amino acids 
61-113 mapping to an 








Anti-β-Tubulin Monoclonal Detects β tubulin, types I, II, 
III, and IV of bovine, rat, 










Detects N-terminal end of 








Monoclonal Detects residues 
surrounding Met316 of 
human eIF4A protein 
Rabb
it 




Anti-eIF4A1 Polyclonal Detects residues 








Anti-eIF4B Polyclonal Detects residues at the 












Monoclonal eIF4AE protein Rabb
it 






Monoclonal Detects residues 










Monoclonal eIF4AH protein Rabb
it 




Anti-Rabbit IgG HRP 
 




Anti-Mouse IgG HRP  Mouse IgG Hors
e 





Anti-Goat IgG HRP 
(A8919) 








2.2.4.5 Reprobing and stripping: 
In order to detect another protein of different molecular weight, the previously immunoprobed membrane was 
treated with 30% hydrogen peroxide (Sigma Aldrich) for 15 minutes, followed by re-blocking and re-probing with 
another antibody (Sennepin et al., 2009). To detect proteins having approximate molecular weight, the membrane 
was stripped by incubating with 0.5M NaOH for 8 minutes under gentle agitation. It was followed by washing with 
distilled water and TBST for three times (5 minutes each) and blocking and re-probing the membrane again, as 
described above.  
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2.2.4.6 Densitometry analysis 
For quantitative analysis of protein expression, the digital images obtained by chemiluminescence imaging systems 
were analysed using Image Studio Lite (Licor). The background was subtracted using a median intensity of pixel 
around the band area and the background-subtracted band intensity was normalised for protein loading by the 
corresponding loading control intensity values (β-Actin/β-tubulin). 
2.2.5 5’ Rapid amplification of cDNA ends (5’ RACE): 
The Rapid Amplification of cDNA Ends (RACE) is a technique for amplifying a nucleic acid sequence of mRNA 
between a defined internal site and the unknown region at either 5’ or 3’ end of the mRNA (Frohman et al., 1988). 
The technique was initially employed to obtain full-length cDNA clones for novel transcripts (Han et al., 2001) and 
has been optimised over the last two decades to facilitate precise identification of transcription start sites (TSS) and 
locating promoter region (Tillett et al., 2000). The 5’ RACE utilises gene-specific and complementary adapter 
primers to amplify the 5’ end of the mRNA of interest which is sequenced to determine TSSs or to identify 
neighbouring promoter elements.   
Two variations of 5’ RACE was used during the PhD project namely the homopolymeric tailing and ligation mediated 
oligo-capping.  
2.2.5.1 5’ RACE with homopolymeric tailing: 
2.2.5.1.1 Principle (Figure 2.3A): 
The method has been pioneered by Frohman and colleagues (Frohman, 1993, Frohman et al., 1988). The first strand 
cDNA is reverse transcribed from the total RNA using a gene-specific primer. The reverse transcriptase with reduced 
RNase H activity is used to capture the entire 5’ end of the mRNA. The original mRNA template is then removed by 
the RNase H enzyme which cleaves RNA in RNA:DNA duplex. A deoxyadenosine homopolymeric tail (dA-tail) is then 
added to the 3' end of the cDNA using terminal deoxynucleotidyl transferase (TdT). It is followed by second strand 
cDNA synthesis using oligo(dT) primer containing priming site for abridged universal amplification primer (AUAP). 
Subsequently, the cDNA is amplified using an abridged primer and a second gene-specific primer. If required, nested 
amplification is performed to detect rare mRNA transcripts. The PCR products are resolved by agarose gel 
electrophoresis and sequenced using Sanger sequencing (Source Bioscience).  
2.2.5.1.2 Methodology: 
5' RACE System version 2.0 (ThermoFisher) was used as per the manufacturer’s guideline. Briefly, the first-strand 
cDNA was synthesised using a gene-specific primer 1 by reverse transcribing 3 µg of RNA with the supplied 
SuperScript II Reverse Transcriptase. The RNase mix was added to the reaction and incubated at the indicated 
temperature. The reaction mix was then purified using the provided SNAP column and a deoxyadenosine tail was 
added to the first strand cDNA using TdT. The second-strand synthesis was performed by SuperScript II RT using a 
3' RACE Adapter primer and amplified using gene-specific primer 2 and supplied AUAP. The list of primers used is 
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presented in Table 2.7. The steps of first-strand cDNA synthesis and amplification of second-strand cDNA were 
further optimised during the study (section 3.2).  
 
Table 2.7: List of primers used for 5’ RACE 
Primer Sequence 5’ 3’ 
Gene-specific primer 1 (AGAP2) CAGGCGCAGTTCAGGAATG 
Gene-specific primer 2 (AGAP2) GAGCGGCTCAAAGTCCATTCCT 
Abridged universal amplification primer (AUAP) GGCCACGCGTCGACTAGTAC 
RLM-RACE 5’ Forward primer CGACTGGAGCACGAGGACACTGA 
RLM-RACE 5’ Nested Forward GGACACTGACATGGACTGAAGGAGTA 
Gene-specific Nested Reverse GCTATTGATCACAGCCTCTCGA 
RLM-RACE Control Primer B.1 GACCTGGCCGTCAGGCAGCTCG 
 
 
2.2.5.2 5' RNA ligase-mediated rapid amplification of cDNA ends (5’ RLM-RACE): 
2.2.5.2.1 Principle (Figure 2.3B): 
This method is based on the work of Maruyama and Sugano (1994) and Volloch et al. (1994). The technique involves 
the removal of 5’ phosphate group using calf intestinal phosphatase (CIP) from truncated mRNA and non-mRNA 
that are not protected by 5’ cap structures. The RNA is treated with tobacco acid pyrophosphatase (TAP) to remove 
the 5’ cap from intact full-length mRNA, leaving a phosphate group at the 5’ end that is required for ligation to the 
RNA oligo. Next, the RNA oligo containing a known priming site is ligated with the 5’ end of the mRNA using a T4 
RNA ligase. It is followed by reverse transcribing the mRNA of interest using a gene-specific primer and amplifying 
the first-strand cDNA using a primer complementary to the priming site on the RNA oligo and another gene-specific 
primer. If needed, nested amplification could be performed with nested primers. The PCR products are purified and 
inserted into an appropriate cloning vector for sequencing.  
2.2.5.2.2 Methodology: 
The 5’ RLM-RACE (ThermoFisher) was performed following the manufacturer’s instructions. Briefly, 3 µg of total 
RNA were treated with CIP and TAP to dephosphorylate and remove the 5’ mRNA cap structure, respectively. The 
RNA was then ligated to 250 ng of GeneRacer RNA adaptor by T4 RNA ligase. After each step, the RNA was 
precipitated using phenol/chloroform. The dephosphorylated, decapped, and ligated RNA was reverse transcribed 
using gene-specific primer 1. The cDNA was amplified using the RLM-RACE 5’ forward primer and gene-specific 
primer 2. The PCR product was diluted 50-fold and amplified again using nested RLM-RACE and gene-specific nested 
primers and purified by 2% agarose gel electrophoresis. The purified product was cloned for sequencing using TOPO 
TA Cloning Kit (ThermoFisher) and transformed into TOP10 chemically competent E.coli (ThermoFisher) and 
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cultured in LB medium containing 100 µg/mL ampicillin (Sigma-Aldrich); at least, ten independent clones were 
chosen and sequenced for each cell line by Sanger sequencing (Source Bioscience) and aligned using MultAlin 
(Corpet, 1988). The list of primers used is presented in Table 2.7.  
  
 
Figure 2.3: Overview of the 5' RACE Procedure. Schematic representation of 5’ RACE with homopolymeric tailing 
(A) and 5' RNA ligase-mediated RACE (B). AUAP: Abridged universal amplification primer; CIP: calf intestinal 
phosphatase; dA: deoxyadenosine; GSP: gene-specific primer; RT: reverse transcriptase; TAP: tobacco acid 
pyrophosphatase. 
 
2.2.6 Dual luciferase Reporter assay: 
2.2.6.1 Plasmid Construction: 
The plasmid (pcDNA3 RLUC POLIRES FLUC) was a gift from Nahum Sonenberg (Addgene pcDNA3; RRID: 
Addgene_45642). The bicistronic reporter plasmid expresses Renilla luciferase (Rluc) and Firefly luciferase (Fluc) 
(Figure 2.4A). Translation of the Rluc cistron is cap-dependent and mediated by an upstream cloned fragment under 
the control of the CMV promoter, whereas the Fluc cistron is directed by the poliovirus IRES (cap-independent) and 
serves as an internal control. The 5’ UTR isoforms (shorter, longer and mutated longer) were designed and 
purchased from GeneScript (Hong Kong) (Table 2.8) and were inserted at the unique NheI restriction site proximal 
to Rluc ORF (Figure 2.4B). The 5’ UTR isoforms and the plasmid were digested with the NheI restriction enzyme 
(Promega) and the products were separated on a 1% agarose gel, purified with Wizard SV kit (Promega), and treated 
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with alkaline phosphatase (Promega) to prevent self-ligation. The purified digested plasmid and the 5’ UTR inserts 
were ligated using T4 DNA ligase (Promega). The constructs were transformed into DH5α competent cells (Thermo-
Fisher) and cultured in LB medium containing 100 µg/mL ampicillin (Sigma-Aldrich). Positive clones were chosen, 
purified using NucleoSpin Plasmid Columns (Fischer Scientific), and confirmed by Sanger sequencing (Source 
Bioscience). 
 
Table 2.8: Sequence of 5’ UTR isoforms used in the study.  









(mutations represented by 






2.2.6.2 Plasmid Transfection: 
2.2.6.2.1 Transfection of Prostate cancer cell line (adherent): 
High quality reporter constructs (with A260/A280 ratio ~ 1.8 and A260/A230 ratio > 2) were transfected into the PC 
cell line (DU145) using the JetPRIME transfection reagent (Polyplus) according to the manufacturer’s protocol. The 
quality of the transfected DNA was examined using Nanodrop 8000 spectrophotometer (ThermoFisher). Briefly, 
cells were seeded at a density of 2.5 x 105 cells/well in 6-well plates for 24 hours before transfection. 2 µg of plasmid 
constructs were diluted into 200 µL of supplied jetPRIME buffer and mixed by vortexing. 4 µL of jetPRIME 
transfection reagent was then added to the mixture, briefly vortexed, and incubated for 10 minutes at room 
temperature to allow the formation of transfection complexes. After incubation, the transfection mixture was 
added dropwise to the cells in serum-containing medium and cells were incubated with the transfection mix at 37°C 




2.2.6.2.2 Transfection of Chronic Myeloid Leukaemia cell line (suspension): 
The transient transfection of the CML cell line (KU812) was carried out using electroporation. The optimal 
conditions for electroporation that resulted in the highest transfection efficiency using the GFP plasmid and the 
lowest cell death rate were determined previously in our lab (Doush, 2015). The cells were prepared at a density of 
2 X 106 and resuspended in 100 µL Amaxa Cell Line Nucleofector solution V. Next, 1 µg of high-quality plasmid DNA 
was added to the transfection mixture. The mixture was transferred into an electroporation cuvette and was 
electroporated using the Nucleofector device (program X-001). Immediately after electroporation, 500 µL of 
complete medium was added to the cuvette and the cells were transferred to a well of 24-well plate. The cells were 
collected after 6 hours for dual luciferase reporter assay.  
2.2.6.3 Luciferase assay: 
After the indicated time points, cells were lysed with Passive Lysis Buffer (Promega) and the luciferase activity was 
measured using the Dual-Luciferase Reporter Assay System (Promega) on a CLARIOstar microplate reader (BMG 
Labtech). The plate reader uses two precision injectors to introduce reagents into the sample and record 
luminescence. Luciferase assay reagent – LAR II (to detect Firefly luciferase) and Stop & Glo® Reagent (to detect 
Renilla luciferase) was primed into the injectors. For measurements, 100 µL of LAR II was added to the lysate and 
Firefly luminescence was measured for 10 sec. After that, 100 µL of Stop & Glo® Reagent was dispensed and the 




Figure 2.4: Plasmid map of dual luciferase reporter plasmid (pcDNA3 RLUC POLIRES FLUC). (A) Schematic 
representation of bicistronic Luciferase reporter (pcDNA3 RLUC POLIRES FLUC) plasmid. (B) The AGAP2 5’ UTR 
fragments (shorter 5’ UTR, longer 5’ UTR with G4 consensus, and longer 5’ UTR with G4 consensus destroyed) were 




2.2.7 In vitro Transcription and Translation:   
To analyse the influence of different 5’ UTR isoforms (Table 2.8) in a cell-free system, the plasmid constructs were 
transcribed in vitro by T7 RNA polymerase using mMESSAGE mMACHINE Transcription Kit (Thermo Scientific) 
following the manufacturer’s guidelines. Briefly, the plasmid was linearised using XhoI restriction endonuclease 
(Promega) by incubating with the restriction enzyme at 37°C for 2 hours. The linearised plasmid was then incubated 
with the supplied reaction mix at 37°C for 1 hour to produce a large amount of capped RNA using T7 RNA 
polymerase promoter in the plasmid. The lithium chloride precipitation was subsequently used to purify the cap 
RNA, separating proteins and unincorporated nucleotides including cap free analogues in the reaction mix. The 
resulting RNA was translated in vitro using Flexi Rabbit Reticulocyte Lysate Translation System (Promega). The RNA 
was incubated with the provided reaction mix and translated at 30°C for 90 min. The luciferase activity of the 
translation products was analysed using Dual-Luciferase Reporter Assay, as described above (section 2.2.6). 
 
2.2.8 Polysome fractionation: 
2.2.8.1 Principle:  
Polysome fractionation is a technique to evaluate the density of polyribosomes that form on a given mRNA (Warner 
et al., 1963). This technique has been extensively used to analyse the translation efficiency at the level of individual 
mRNA and the whole transcriptome to elucidate different factors responsible for modulating translational output 
(Reviewed in Kuersten et al., 2013, Chassé et al., 2016).  It is based on stalling the translating ribosome on mRNA 
using cycloheximide treatment that prevents translocation of elongating ribosomes. A sucrose density gradient is 
used to separate messenger ribonucleoprotein complexes (mRNP) based on the number of bound ribosomes, with 
transcripts associated with polyribosomes sediment at a higher density in the gradient relative to mRNP with lower 
ribosome density. The distribution of mRNA in each fraction could be determined by qRT-PCR and high throughput 
technology including microarray and RNA sequencing. The translational efficiency of mRNA is inferred from its 





Figure 2.5: Schematic of polysome fractionation. A linear sucrose density gradient was prepared by underlaying 
10-50% sucrose solutions and incubating it overnight at 4°C. The cytoplasmic lysate was then applied to the linear 
gradient and centrifuged to separate the polysomes based on their density. The gradients were fractionated while 
measuring absorbance at 254 nm to generate polysome distribution profiles. The RNA was isolated from each 




2.2.8.2.1 Preparation of cell lysate: 
The number of cells used per gradient was optimised for different cell line used in the study. The cell concentration 
yielding clear and distinct peaks in the polysome profile was selected. Typically, 2.5-5 x 107 cells were used per 
gradient. The cells were treated with 100 μg/mL cycloheximide and incubated at 37°C and 5% CO2 for 10 min. It 
was followed by washing and resuspending the cells in the lysis buffer (100 mM KCl, 5 mM MgCl2, 20 mM HEPES 
(pH 7.4), 0.5% NP-40, 100 μg/mL CHX, 2 mM DTT, 40 U/ml RNase inhibitor, and 1x protease inhibitor cocktail) and 
then incubating on ice for 10 minutes, vortexing briefly every 2 minutes. The cells were subsequently centrifuged 
at 2,000 x g for 5 minutes at 4°C to pellet the nuclei and larger debris. The supernatant was transferred to a fresh 
tube and again centrifuged at 13,000 x g for 5 minutes to collect smaller debris. The supernatant lysate was 
collected and used immediately for polysome fractionation or stored at -80°C. The lysates were prepared by Dr 
Cristina Montiel-Duarte. 
2.2.8.2.2 Preparation of sucrose gradients and fractionation: 
The steps of sucrose gradients preparation, loading, ultracentrifugation, polysome gradient profiling, and collection 
of fractions were performed by Dr Keith Spriggs from the University of Nottingham. Briefly, sucrose solutions of 
different concentrations ranging from 10% to 50% were prepared, underlaid in the order of increasing 
concentration, and left overnight at 4°C to yield a linear sucrose gradient. The lysate obtained in the above step 
was layered on top of the prepared 10-50% linear gradient and centrifuged at 190,000 x g for 90 minutes at 4°C. 
The gradients were then fractionated from top to bottom while measuring absorbance at 254 nm to generate 
polysome profiles. 500 µL of each sucrose fractions were collected and RNA was isolated using TRIzol extraction or 
stored at -80°C until use. 
2.2.8.2.3 RNA purification from polysome fractions: 
500 µL of TRIzol (ThermoFisher) and 200 µL of chloroform (Sigma-Aldrich) was added to each fraction and mixed by 
shaking vigorously for 10 seconds followed by centrifugation at 13,000 x g for 15 min at 4°C to separate the mixture 
into 3 layers. The RNA in the top aqueous layer was precipitated by adding 1 mL 100% ethanol and 40 µL of 3M 
sodium acetate (pH5.2), and incubated overnight at -20°C. Each fraction was spiked with 500 ng of in vitro 
transcribed luciferase RNA control to normalise for differences in RNA recovery. The exogenous luciferase RNA was 
prepared from pcDNA3 RLUC POLIRES FLUC plasmid (Addgene pcDNA3; RRID: Addgene_45642) using mMESSAGE 
mMACHINE Transcription Kit, as described above (section 2.2.7). After overnight incubation, the RNA was 
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precipitated by centrifugation at 12,000 x g for 30 minutes at 4°C. The supernatant was removed, and the pellet 
was washed with 800 µL of 75% ethanol and centrifuged again at 7,500 x g for 5 minutes at 4°C. The ethanol was 
carefully removed, and the pellet was air dried at room temperature for 2-3 minutes and resuspended in 50 µL of 
nuclease-free water. The RNA was further cleaned and concentrated using ReliaPrep RNA Miniprep Systems 
(section 2.2.2.1). The samples were reverse transcribed (section 2.2.2.2) and amplified using qPCR (section 2.2.2.3), 
as mentioned above.   
2.2.8.2.4 Analysis of polysome profiling data: 
The polysome fractionation data was processed using the protocol published by Pringle et al. (2019). The Ct value 
of target mRNA transcript amplified in each fraction was subtracted from the luciferase RNA spike [Ct = Ctluc - 
Cttarget]. The Ct for each fraction was then calculated by subtracting the first (lightest) fraction from each 
fraction [Ct = Ctn - Ct1]. The expression of the target transcript in the given fraction was determined by 
2Ct [En = 2Ctn]. Subsequently, the expression values for all the fractions were added together [Etotal = E1 + E2 + E3 
+ ….. + En]. Finally, the proportion of the target transcript in each fraction was determined by [P = 100 x En/Etotal] 
and plotted as a line graph illustrating the distribution of the proportions recovered in each fraction.  
 
2.2.9 RNA sequencing:   
RNA sequencing was performed to examine differentially expressed genes in PC and CML cell lines, and to identify 
genes with differential TSS distribution profiles. The sequencing was performed for the main cell lines included in 
the study (PC: DU145, PC3, LNCap; CML: KU812, TCCS, KCL-22), and the sequencing data for PC and CML cell lines 
were grouped together and considered as biological replicates.  
For RNA sequencing, the RNA was extracted as described above (section 2.2.2.1). The RNA quality was assessed 
using a bioanalyser (Agilent) and samples with RNA integrity number (RIN) > 8 were considered optimal for RNA 
sequencing. 2 μg total RNA was used for library preparation with TruSeq Stranded mRNA Sample Prep Kit (Illumina). 
The library preparation and next generation sequencing were outsourced to the Edinburgh Clinical Research 
Facility. The RNA sequencing was performed using the HiSeq2500 instrument (Illumina), with over 45 million, 
paired-end, 75 base pair reads per sample.  
The post-processing and alignment of the sequencing reads were performed using BaseSpace (Illumina) platform. 
Sequencing reads were mapped to the GRCh38 human reference genome assembly using STAR aligner (Dobin et 
al., 2013). Differentially expressed genes were identified using the DESeq2 package in R (Love et al., 2014). 
Heatmaps [based on FPKM values] were generated using the Complex heatmaps package in R (Gu et al., 2016). A 
volcano plot was used to visualise significant genes and the magnitude of their fold change and was created using 
the Enhanced volcano package (Blighe et al., 2020). The script to perform DESeq2 analysis and generate heatmap 











# For DESeq2 
data1 <- read.table("RNA-seq raw count.txt", header = TRUE, sep = "\t") 
Data <- as.matrix(data1[ , -1]) 
rownames(Data) <- data1[ , 1] 
colData <- DataFrame(condition=factor(c("ctrl","ctrl","ctrl", "treat", "treat", 
"treat"))) 
dds <- DESeqDataSetFromMatrix(countData=Data,  
                              colData=colData,  
                              design=~condition) 
dds <- DESeq(dds) 
res <- results(dds) 
head(results(dds, tidy=TRUE)) 
write.table(res,"DESEQ2 ARIF.txt",sep = "\t" ,col.names=T, row.names = F) 
resOrdered <- res[order(res$padj),] 
sig <- resOrdered[!is.na(resOrdered$padj) & 
                    resOrdered$padj<0.10 & 
                    abs(resOrdered$log2FoldChange)>=1,] 
write.table(sig,"DESEQ2 sig.txt",sep = "\t" ,col.names=T, row.names = F) 




my_Data <- read.table("Heatmap.tsv", sep="\t", stringsAsFactors=FALSE, header=TRUE)                                  
my_data <- data.matrix(my_Data[ , -1]) 
rownames(my_data) <- my_Data[ , 1] 
Heatmap(my_data) 
col_fun = colorRamp2(c(-2, 0, 2), c("red", "black", "green")) 
Heatmap(my_data, cluster_columns=TRUE,row_labels = rownames(my_data, 
        row_names_side = "left",show_row_names = FALSE,column_dend_side ="top", 
        column_names_side = "top", cluster_rows = TRUE, show_row_dend = FALSE, 
        name = "Row Z-Score", col = col_fun, column_names_rot = 360, 
        column_names_centered = TRUE,column_dend_height = unit(25, "mm"), 
        heatmap_legend_param = list(legend_height = unit(4, "cm"), 
                               color_bar = "continuous", 
                               title_position = "leftcenter-rot"), 





2.2.10  Statistical analysis: 
All statistical analysis was performed using GraphPad Prism 8.4 software (GraphPad, Inc, USA). For experiments 
where two groups were compared, a two-tailed Student’s t-test was performed in case of normalised data and 
Mann-Whitney U-test was used for the analysis of non-parametric data. Normality was evaluated using the Shapiro-
Wilk test. For comparison of three or more groups, a one-way ANOVA was performed followed by post-hoc Sidak's 
multiple comparison tests. For non-parametric data, Kruskal-Wallis followed by uncorrected Dunn’s test was used. 
Unless otherwise stated, histogram columns represent the mean and error bars indicate the standard deviation 
(SD). The standard error of mean (SEM) was used to displayed variance in the polysome results. The number of 
replicates (n) for each experiment is stated in the figure legend. The data is considered to be statistically significant 







final <- read.table("G4 DESEQ2 all .txt", header = TRUE, sep = "\t") 
rownames(final) <- final[ , 1] 
final$X = NULL 
keyvals <- ifelse( 
  final$log2FoldChange < -1 & final$padj <10e-2, 'blue', 
  ifelse(final$log2FoldChange > 1 & final$padj <10e-2, 'red', 
         'grey')) 
keyvals[is.na(keyvals)] <- 'grey' 
names(keyvals)[keyvals == 'blue'] <- 'DE in PC cell lines' 
names(keyvals)[keyvals == 'grey'] <- 'NS' 
names(keyvals)[keyvals == 'red'] <- 'DE in CML cell lines' 
EnhancedVolcano(final, lab = rownames(final), 
                x = 'log2FoldChange', y = 'padj',selectLab =  
                c("CDKN2A","PXDN","FERMT2","ITGA3", 
                  "CASK","ITGB5","DUSP3","HK1", "AGAP2"), 
                xlab = bquote(~Log[2]~ 'fold change'), 
                ylab = bquote(~-Log[10]~ "(adjusted"~~ italic("P")~ "value)"), 
                axisLabSize= 14, pCutoff = 10e-2,FCcutoff = 1, ylim = c(0, 10), 
                title = NULL, subtitle = NULL, gridlines.major = FALSE,  
                gridlines.minor = FALSE, pointSize = 3.0, hline = 0.1, 
                hlineCol = c("black"), vline = c(-1, 1),vlineCol = c("black"), 
                labSize = 3.5,labCol = 'black', labFace = 'bold', 
                boxedLabels = TRUE, colAlpha = 3/5, legendPosition = 'bottom',  
                legendLabSize = 12,legendIconSize = 3, colConnectors = 'black',   
                typeConnectors = "open", caption = NULL,  
                colCustom = keyvals, cutoffLineType= "blank") + 
                ggplot2::coord_cartesian(xlim=c(-12, 12)) 




3 Chapter 3:                           
Role of Transcription Start 













3.1.1 AGAP2 regulation in PC and CML cell lines: 
Our group, led by Dr Cristina Montiel-Duarte, has been studying the role of AGAP2 (Arf GAP with GTP-binding 
protein-like domain, Ankyrin repeat and PH domain 2) (section 1.61) in different cancers and liver fibrosis (Doush 
et al., 2019, Navarro-Corcuera et al., 2020, Navarro-Corcuera et al., 2019). Recently, we have elucidated the 
regulation of AGAP2 expression in Prostate Cancer (PC) and Chronic Myeloid Leukaemia (CML) cell lines and have 
identified a novel role for SP1 and RARα on AGAP2 transcription activation (Doush et al., 2019).   
To get insights into the factors that regulate AGAP2 expression in PC (DU145) and CML (KU812) cell lines, we cloned 
and characterised AGAP2 promoter region in the reporter vector to determine the minimal promoter region used 
in these cell lines. We noted a comparable minimal promoter region in both the cell lines and identified sequence 
elements sufficient to induce reporter activity (Figure 3.1A). The analysis of these sequence features revealed the 
presence of SP1 binding sites and a DR5 (a retinoic acid response element). Using siRNA (Figure 3.1B), specific 
inhibitors (Figure 3.1C), and chromatin immunoprecipitation (Figure 3.1D, 1E), we highlighted the role of these 
transcription factors in regulating AGAP2 expression.  
 
 
Figure 3.1: The role of SP1 and RARα in regulating AGAP2 expression in PC and CML cell line (Doush et al., 2019). 
(A) AGAP2 promoter deletion fragments generated from human genomic DNA (Promega) and cloned into the 
promoter-less Firefly luciferase vector pGL4.10 (Promega). The AGAP2-luciferase constructs were transfected into 
DU145 (PC) and KU812 (CML) cell lines using CalPhos Mammalian Transfection kit (Clontech) and electroporation 
(Nucleofector 2b Device), respectively. The luciferase activity was measured using Dual-Light Luciferase & β-
Galactosidase Reporter Gene Assay System (ThermoFisher) and normalised to the corresponding β-galactosidase 
values. The luciferase activity in KU812 (left) and DU145 (right) are presented relative to the values obtained for 
the full-length AGAP2 −1023/+36 plasmid. (B) KU812 and DU145 cells were transfected with either scramble or SP1 
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siRNA. In the case of KU812, 67 nM of siRNA was transfected, and cells were collected 48 hours after transfection; 
for DU145 5 nM of siRNA was transfected followed by the collection of cells after 72 hours. After indicated time 
points, the cells were lysed and 10 μg of total protein were resolved using 10% SDS-PAGE followed by 
immunoblotting with SP1 isoform-specific antibody (Cell Signaling, RRID:AB_11220235). β-Actin levels were used 
as a loading control. Densitometry values (mean ± SD) for the relative protein expression are represented below 
the blots. (C) Detection of AGAP2 protein levels in DU145 (top) and KU812 (bottom) after 24 hours treatment with 
1 μM ATRA and 9-cis RA in DU145 cells or 1 μM ATRA in KU812 cells, β-Actin was used as a loading control. (D) 
DU145 and KU812 cells were grown to 80% confluency under normal serum conditions and were fixed and sheared 
using the Ultra-sonicator (Covaris). The chromatin was immunoprecipitated with 1 μg of rabbit IgG or anti-SP1 
antibody (Cell Signalling) and amplified with primers for the AGAP2 promoter region. (E) DU145 cells grown, fixed 
and sheared as in (D) and immunoprecipitated using 2 μg of rabbit IgG (negative control) or anti-RNApol II (positive 
control) or anti-PCAF antibody and amplified with primers to detect AGAP2 promoter region. Data in [D, E] are 
presented as fold enrichment relative to IgG Ct values. Note: Experiments for Figure B, C (below) and D were 
performed as part of the current PhD project. Experiments in (A) were performed by Dr Yegor Doush and 
experiment in (E) was performed by Dr Amaia Navarro-Corcuera. 
 
 
Interestingly, we also noted large differences in AGAP2 mRNA levels between PC and CML cell lines (Figure 3.2A). 
Preliminary analyses done by Dr Cristina Montiel-Duarte had also demonstrated inconsistency in AGAP2 mRNA and 
protein expression levels (Figure 3.2B). We noted a higher relative AGAP2 mRNA level in CML cell lines with lower 
protein expression, and the opposite was observed in PC cell lines: lower mRNA and higher protein expression. 
Intriguingly, we also noted differential usage of TSSs for AGAP2 in these cell lines. In the CML cell line (KU812), the 
transcription starts 36 bp earlier compared to the PC cell line (DU145) and encoded an extra region in the 5’ UTR of 
AGAP2 mRNA that contained a consensus for a G quadruplex. Given the differential TSS selection in the PC and CML 
cell lines, with earlier TSS selection in CML cell lines that encode G4 consensus in the 5’ UTR, we were curious to 
examine if it could explain the discrepancy observed in AGAP2 mRNA and protein levels noted in these cell lines. 
These preliminary findings formed the basis of the current work and drew our attention to the potential regulatory 





Figure 3.2: AGAP2 expression in PC and CML cell lines. (A) AGAP2 mRNA basal levels were measured by qRT-PCR 
in CML (KU812, KCL, TCC-S, CML-T1) and PC cell lines (DU145, PC3 and LNCaP).  The values presented are normalised 
against the levels of the housekeeping gene (HPRT and TBP) and shown relative to the CML cell line (KU812) (Doush 
et al., 2019). (B) Preliminary experiment (n=1) showing the inconsistency in AGAP2 mRNA and protein levels. The 
mRNA levels (left) were quantified by qRT-PCR and protein (right) were detected by immunoblotting with PIKE-A 
isoform-specific antibody. β-Actin was used as a loading control. (C) TSS (n =1) were identified using the 5’ RACE 
system with deoxyadenosine homopolymeric tailing (ThermoFisher). KU812 (CML) cell line exhibit an upstream TSS 
that produces a longer AGAP2 mRNA 5’ UTR containing extra nucleotides (36bp) relative to DU145 (PC). Note: 
Preliminary experiments were conducted by Dr Cristina Montiel-Duarte. 
 
3.1.2 TSS-mediated gene regulation: 
The crucial step in the gene regulation process takes place at the level of transcription initiation and is modulated 
by alternative promoter usage, differential splicing, transcription start site selection, and epigenetic factors, 
producing a heterogeneous population of mRNA isoforms from a single gene locus ( Andersson and Sandelin, 2020, 
Baralle and Giudice, 2017, Danino et al., 2015, Davuluri et al., 2008). The complex transcriptional regulation also 
impacts the translation potential of the transcribed mRNA isoforms by encoding regulatory elements in the 5’ and 
3’ UTR that variably influence mRNA maturity, stability, localisation, and translation efficiency (Culjkovic-Kraljacic 
and Borden, 2018, Curran and Weiss, 2016, Wilkie et al., 2003). Given the impact of transcriptional and post-
transcriptional processes on modulating protein translation, an inconsistency in mRNA and protein levels could be 
observed because the transcribed mRNA might not efficiently translate into protein.  
A discrepancy in mRNA and protein levels has been observed in a variety of studies (Edfors et al., 2016, Greenbaum 
et al., 2003, Guo et al., 2008, Maier et al., 2009, Vogel and Marcotte, 2012). The contribution of mRNA 
concentration (transcription) and mRNA features (post-transcriptional) accounted for 36% variation in protein 
abundance (Vogel et al., 2010). Taking into consideration the processes related to translation and protein 
degradation, about two-thirds of the variations in protein abundance could be explained overall (de Sousa Abreu 
et al., 2009, Plotkin, 2010, Vogel et al., 2010). In a study by Vogel et al. (2010), the author used experimental and 
computational approaches to measure cognate mRNA and protein levels of more than 1,000 genes and showed 
that regulatory features in the UTR, amino acid properties and coding sequence length were the strongest 
correlating factors for protein levels.  Most of these features are dictated by the transcription start site selection 
(TSS) which determines the 5’ gene boundary and encode regulatory features in the 5’ leader sequence that could 
affect the translational potential of the mRNA transcript.  
Our understanding of transcription initiation and selection of TSS is far from complete. It has been shown that the 
transcription does not initiate at a single discrete site and each gene, on average, displayed 4 robust TSSs (Forrest 
et al., 2014). Alternative transcription initiation (ATI) has been shown to affect gene expression at multiple levels. 
It could change the 5’ gene boundary and encode regulatory features in the transcript leader that influence mRNA 
translation (Wang et al., 2016). Studies have shown that alternative initiation and termination have a higher 
contribution to tissue dependent isoform-specific diversity compared to alternative splicing (Reyes and Huber, 
2018). The ATI is driven by multiple promoter usage, and it has been reported by different studies that 30-50% of 
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human genes are regulated by alternative promoters which are utilised depending on cell type, developmental 
stage, cellular environment, and diseased states including cancers (Reviewed in Davuluri et al., 2008). The usage of 
alternative promoters for many genes does not change the principal ORF and thus do not impact the composition 
of protein products (Studies reviewed in Davuluri et al., 2008, Landry et al., 2003). 
Given the role of ATI and its effects in modulating mRNA translation efficiency, several attempts have been made 
in the last decade to precisely identify TSS which would enable characterisation of core promoter features and 
defines the potential regulatory elements encoded in the 5’ UTR of TSS isoforms. Notably, two databases namely 
FANTOM and DBTSS have comprehensively captured the dynamically changing landscape of TSS selection in 
different tissue, cell types, conditions, cancers, and development phases using mRNA cap-guided deep sequencing 
technologies (Forrest et al., 2014, Yamashita et al., 2010) (section 1.3.2). These and other relevant studies have also 
identified the presence of multiple TSSs within a given core promoter and highlighted the widespread use of 
differential TSS selection within a single core promoter region. (Carninci et al., 2006, Forrest et al., 2014, Karlsson 
et al., 2017, Kawaji et al., 2006, Suzuki et al., 2001). The cluster of closely spaced TSSs within a core promoter is 
principally different from alternative promoters where the transcription initiation is separated by a wide genomic 
space. 
The alternative TSS selection has been shown to significantly influence mRNA translation activity (Rojas-Duran and 
Gilbert, 2012). These heterogenous TSS isoforms exhibit differences in the length of 5’UTR and encode regulatory 
elements that might contribute towards the observed translation differences (Rojas-Duran and Gilbert, 2012, 
Suzuki et al., 2001). Moreover, the distribution of start sites in a TSS cluster linked to a core promoter was found to 
differentially expressed in various cell lines (Ohmiya et al., 2014), highlighting a novel layer of gene expression 
regulation. Despite their existence, the consequences of differential TSS selection have not been studied thus far. 
The dominant starting sites (major TSS) have usually been the focus of studies and was analysed in the context of 
ATI-mediated regulation, representing the translational impact of transcript isoforms derived from multiple closely 
situated promoters (Arribere and Gilbert, 2013, Dieudonné et al., 2015, Li et al., 2019, Rojas-Duran and Gilbert, 
2012, Wang et al., 2016, Zeitz et al., 2019, other studies reviewed in Davuluri et al., 2008). The data on the 
contribution of minor TSSs within the core promoter is currently lacking and the regulatory elements encoded by 









3.1.3 Aims of chapter 3: 
Our previous published work focused on the regulation of AGAP2 expression in PC and CML cell lines, finding 
differences in mRNA transcription in these cell types (Doush et al., 2019). Interestingly, the preliminary experiments 
have shown a discrepancy in AGAP2 mRNA and protein levels and a potential of differential TSSs usage within the 
core promoter region of AGAP2 in PC and CML cell lines. If confirmed, the differential TSS selection could potentially 
modulate mRNA translatability by encoding regulatory features in the mRNA 5‘ UTR and contributing to the 
observed inconsistency. In the current PhD project, using AGAP2 gene as a model, the link between differential 
TSSs usage and inconsistency in mRNA translational output is further explored using PC and CML cell lines.  
This chapter aims to: 
• Examine the inconsistency in AGAP2 mRNA and protein levels and investigate the contribution of protein 
degradation through the Ubiquitin–Proteasome Pathway. 
• Characterise the distribution of TSSs within the AGAP2 core promoter region of PC and CML cell lines. 



















3.2 Method Optimisation  
Initially, 5’ RACE with homopolymeric tailing was attempted to characterise TSSs in PC and CML cell line using the 
method detailed in 2.2.5.1.2. In order to capture the 5’ end of mRNA sequences rich in GC base pairs (e.g. AGAP2), 
the conventional protocol was modified as per the manufacture’s guidelines to amplify full length 5’ cDNA ends rich 
in GC nucleotides. The use of standard poly dC-tailing with mRNA rich in G-C base pairs in 5‘ end could result in 
truncated products because the deoxyinosine-containing anchor primer would non-specifically anneal to the GC 
rich region. Instead, dA-tailing of cDNA was performed as per the modified protocol followed by second-strand 
cDNA synthesis using the oligo(dT)-containing abridged amplification primer site. The modified protocol was 
previously used to generate the preliminary TSS data (Figure 3.2C). 
However, in the current study, the suggested modifications and conditions were not able to produce any 5’ RACE 
products (Figure 3.3A). The control RNA template provided with the kit to check its performance was not suitable 
to use with the modified protocol as the control reaction was based on the standard poly dC-tailing.  
The conditions for the first-strand cDNA synthesis and nested amplification of dA-tailed cDNA were optimised to 
detect 5’ RACE products:  
3.2.1 Optimisation of first-strand cDNA synthesis conditions: 
The conversion of specific RNA sequences was carried by SuperScript II reverse transcriptase using a gene-specific 
primer 1 (Table 2.7). To optimise incubation timings and temperatures, four different conditions were selected: 
Incubation at 42°C for either 30 or 50 mins and incubating at 50°C for either 30 or 50 mins. We observed that longer 
incubation (50 mins) at a higher temperature (50°C) yielded a distinct cDNA product in the correct molecular weight 
range (~218 bp) (Figure 3.3B). 
3.2.2  Optimisation of nested amplification conditions: 
The PCR of the dA-tailed cDNA was performed using the provided AUAP primer and gene-specific primer 2 (Table 
2.7). However, no or faint bands were detected after the electrophoretic separation of the amplified products, even 
after increasing the amount of cDNA for the PCR (Figure 3.3C). To enable detection of products, a nested PCR was 
carried out using AUAP and gene-specific nested primers (Table 2.7) using the PCR conditions (annealing at 63°C) 
outlined in the manufacturer’s protocol with a hot-start step. However, unexpected products of incorrect molecular 
weights were observed (Figure 3.3D). The nested amplification PCR conditions were optimised using a touch-down 
PCR starting with a higher initial annealing temperature (67°C) followed by a 0.1°C decrease in temperature after 
each cycle. Although the use of touchdown-conditions facilitated detection of amplified products in the correct 
molecular weight range (between 200-300 bp), multiple products were observed in some samples (Figure 3.3E) and 
Sanger sequencing of these products yield non-specific 5’ RACE products that did not correspond to known AGAP2 






Figure 3.3: Optimisation of 5’ RACE with homopolymeric tailing. (A) 2% Agarose gel electrophoresis to detect 5’ 
RACE product following modified protocol and conditions used previously. Lane M:100 bp DNA ladder; Lane 1: 
KU812; Lane 2: DU145. (B) Reverse transcription of RNA using indicated incubation temperature and time and 
resolving the amplified first-strand cDNA product on the agarose gel. Lane M:100 bp DNA ladder; Lane 1: RT at 42°C 
for 30 mins; Lane2: RT at 42°C for 50 mins; Lane 3: RT at 50°C for 30 mins; Lane 4: RT at 50°C for 50 mins. The cDNA 
was amplified using AGAP2 forward primer (Table 2.4) and Gene-specific nested reverse primer (Table 2.7) using 
standard PCR condition (see 2.2.2.3). (C) Gel image showing PCR amplified products of dA-tailed cDNA using AUAP 
and gene-specific nested reverse primer (Table 2.7), different volumes of dA-tailed cDNA reaction mixture were 
tested. Lane M:100 bp DNA ladder; Lane 1: 2 µL dA-tailed reaction KU812; Lane 2: 2 µL dA-tailed reaction DU145; 
Lane 3: 5 µL dA-tailed reaction KU812; Lane 4: 5 µL dA-tailed reaction DU145; Lane 5: 7 µL dA-tailed reaction KU812; 
Lane 6: 7 µL dA-tailed reaction DU145; Lane 7: 10 µL dA tailed reaction mixture KU812. The concentrations of 
buffers, MgCl2, and dNTP were adjusted accordingly if >5 µL of tailing reaction was used. (D) Agarose gel showing 
nested PCR amplification with AUAP and nested gene-specific reverse primer by setting the annealing temperature 
to 63°C. Lane M:100 bp DNA ladder; Lane 1: KU812; Lane 2: DU145; Lane 3: negative RT control; Lane 4: NTC. (E) 
Nested amplification performed using a touch-down PCR starting at 67°C followed by a 0.1°C decrease with each 
cycle. Lane M:100 bp DNA ladder; Lane 1: KU812; Lane 2: TCCS; Lane 3: DU145; Lane 4: PC3; Lane 5: KCL-22. The 
red box indicates the region of the gel that was excised and sequenced (F) Representative Multalin alignment of a 
sequenced PCR product in (E) lane 1 [red box]. The product was aligned to AGAP2 5’ UTR region (chr12:57742057-
57742205). The highly aligned bases are represented by red and bases that are poorly aligned are shown by blue.  
 
3.2.3 Switching the approach to determine TSS:   
Despite several attempts to optimise the 5’ homopolymeric tailing kit, the genuine TSSs could not be captured. 
Additional optimisation experiments were also done including changing the amount of input RNA, increasing the 
incubation time for the tailing reaction, modifying the conditions for second-strand cDNA synthesis, adjusting MgCl2 
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concentration, and modifying the primer concentrations used. However, none of these optimisation steps were 
successful. Examples of additional optimisations that were performed to detect the authentic 5’ RACE product using 
this kit are shown in Figure 3.4A. As noted in the figure, changing recommended primer concentrations for nested 
amplification increased the formation of primer-dimers (Lane: 1-3), and increasing the time for tailing reaction 
resulted in smearing (Lane: 6-7). It is also evident from the figure that changing the incubation time for second-
strand cDNA synthesis did not detect specific 5’ RACE products (Lane: 4-5), the products amplified by both the 
conditions did not align to the AGAP2 5’ UTR sequence.  
An alternative approach was therefore adapted to capture the 5’ end of the mRNA. A method based on 5' RNA 
ligase-mediated rapid amplification of cDNA ends (see section 2.2.5.2) was employed following the manufacture’s 
protocol. Using this approach, the 5’ RACE products were successfully amplified in the control RNA template and a 
test sample (PC3 cell line), and the product also aligned specifically to AGAP2 5’ UTR, detecting one of the FANTOM 
CAGE-verified TSS (Figure 3.4B, 3.4C; Figure 3.12B). The kit based on RNA ligase-mediated RACE was thereafter used 
in the project to characterise TSSs. 
  
 
Figure 3.4: Alternative approach to characterise TSSs. (A) Additional optimisation of 5’ homopolymeric tailing kit 
without success. Lane M:100 bp DNA ladder; Lane 1: 5’ RACE produced amplified using the recommend 
concentration i.e. 400 nM AUAP and 400 nM GSP-2 without a hot start; Lane 2: PCR amplification using 400 nM 
AUAP and 400 nM GSP-2 with a hot start; Lane 3: PCR amplification using 600 nM AUAP and 600 nM GSP-2 with a 
hot start; Lane 4: Second-strand cDNA synthesis by incubating with the provided SuperScript II RT for 90 min at 
50°C, the amplified product was sequenced and found to be non-specific. Lane 5: Second-strand cDNA synthesis by 
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incubating with SuperScript II RT for 90 mins at 42°C; Lane 6: Tailing of first-strand cDNA by incubating cDNA with 
TdT for 15 mins, the product amplified was non-specific; Lane 7: Tailing reaction incubated for 30 mins showing 
smearing. (B) 5’ RLM-RACE using the manufacture’s guidelines showing specific amplification of 5’ RACE products. 
Lane M:100 bp DNA ladder; Lane 1: Total RNA of PC3 cell line processed by following manufacturer’s protocol and 
amplified using nested primers (Table 2.7), the product amplified is in the correct molecular weight range (~300 bp: 
30bp RNA oligo + 267 bp annotated AGAP2 5’ UTR); Lane 2: Control RNA template processed as above and the 
amplified using RLM-RACE 5’ forward primer and control primers B.1 and showed expected product (~872 bp), 
confirming optimal functioning of the kit. The red box indicates the region of the gel that was excised and cloned 
for sequencing (C) Alignment of the sequenced product from [B, Lane 1] showing specific alignment with AGAP2 5’ 













































3.3 Results and Discussion 
3.3.1 Negative correlation between AGAP2 mRNA and protein expression levels: 
To examine the discrepancy in AGAP2 mRNA and protein levels noted in the preliminary experiments, mRNA was 
extracted from PC cell lines (DU145, PC3 and LNCaP) and CML cell lines (KU812, TCCS, and KCL-22) and the AGAP2 
relative expression was analysed using qRT-PCR. The protein levels in these cell lines were measured by western 
blotting using isoform-specific AGAP2 antibody (Sigma-Aldrich). We noted a discrepancy in AGAP2 mRNA and 
protein levels in both groups of cell lines. In the CML cell lines, as noted previously, the relative mRNA expression 
was significantly higher compared to PC cell lines (P < 0.0001), however, the relative protein levels were significantly 
lower (P = 0.012). In contrast, the opposite occurred in PC cell lines (Figure 3.5A). The differences noted in the 
AGAP2 mRNA levels in these two groups of cell lines matched the corresponding RNA-seq data in the Cancer Cell 
Line Encyclopaedia (Barretina et al., 2012). 
The discrepancy between AGAP2 mRNA and protein levels were not limited to PC and CML cell lines but also 
observed in different cancer cell lines such as HepG2, HuH7, MCF-7, PA-1, SKOV-3, U-2OS, RAJI, KG-1, and Kasumi-
1. The pattern of inconsistent expression noticed in CML cell lines (high mRNA and low protein) was also observed 
in other cancer cell lines such as HepG2, PA-1, MCF-7, and Acute Myeloid Leukaemia cell lines (KG-1, KASUMI) 





Figure 3.5: Inconsistency in AGAP2 mRNA and protein.AGAP2 mRNA basal levels (top) were measured in Prostate 
cancer cell lines (DU-145, PC3, LNCaP) and Chronic Myeloid Leukaemia cell lines (KU812, TCCS, KCL-22) by qRT-PCR. 
The values presented are normalised against the levels of the housekeeping gene (HPRT) and shown relative to the 
PC cell line (DU145). Statistical analyses were carried out by one-way ANOVA [F (5, 12) = 21.23, P < 0.0001)] with 
post-hoc Sidak's multiple comparison tests, P-values shown. AGAP2 protein levels (middle) were detected by 
resolving 50 μg of protein using 10% SDS-PAGE followed by immunoblotting with PIKE-A isoform-specific antibody. 
β-Actin was used as a loading control. Densitometry values (below) for the relative protein expression are presented 
below the blots. Differences were analysed using a Kruskal-Wallis [H (5) = 14.71, P = 0.012] followed by uncorrected 
Dunn’s test, P-values shown. (B) AGAP2 relative mRNA levels in different cancer cell lines, normalised to HPRT and 
shown relative to DU145 (PC cell line). Statistical analyses for mRNA levels were carried out by one-way ANOVA [F 
(9, 20) = 41.30, P < 0.001)] with post-hoc Sidak's multiple comparison tests, P-values shown. AGAP2 protein levels 
are shown below with densitometry values for the relative protein expression. Differences between multiple 
samples were analysed using a Kruskal-Wallis test [H (9) = 20.85, P = 0.01]. All the data shown are the mean ± SD of 
three independent experiments (n=3), error bars represent S.D. (*P < 0.05; **P < 0.01). Full representative 




AGAP2 mRNA and protein levels showed an overall negative correlation. Combining AGAP2 mRNA and protein 
expression data from all the cell lines included in the study, we observed an anti-correlation between mRNA and 
protein levels (R=-0.64, P = 0.011) (Figure 3.6A). Restricting the data to PC and CML cell lines, a higher negative 
correlation was noted (R= -0.89, P = 0.016) (Figure 3.6B). As evident from Figure 3.6A, the leukaemia cell lines 
(KU812, TCCS, KCL-22, KG-1, RAJI, Kasumi-1), hepatocellular carcinoma cell line (HepG2), breast adenocarcinoma 
cell line (MCF-7), and ovary teratocarcinoma cell line (PA-1) predominately showed a discrepancy in AGAP2 
expression, having higher levels of mRNA that did not correlate with protein abundance.  
Other genes in the literature that followed the similar pattern of mRNA/protein discordance, as noted for AGAP2 
in CML cell lines, included MX2, NES, TMC8, WISP1, and HLA-G to name a few (Friedrich et al., 2020, Swindell et al., 
2015, Yan et al., 2018). In the case of WISP1, the discordant mRNA/protein expression in hepatocellular carcinoma 
cell lines was mediated by FAT10 (ubiquitin-like protein), tagging WISP1 for proteasomal degradation (Yan et al., 
2018). To evaluate the contribution of proteasomal degradation of AGAP2 in CML cell lines, we used proteasomal 
inhibitors and examined the levels of AGAP2 protein in these cell lines.   
 
 
Figure 3.6: Correlation between AGAP2 mRNA and protein. (A) Correlation between mRNA (x-axis) and protein 
expression levels (y-axis) for AGAP2 in different cell types included in the study. An overall negative correlation 
(Pearson’s R= -0.64, P = 0.011) is noted. (B) Correlation between AGAP2 mRNA and protein in PC and CML cell lines, 
a strong negative correlation (Pearson’s R= -0.89, P = 0.016) is observed. The data in (A) and (B) are presented 
relative to DU145 (PC cell line). 
 
3.3.2 Role of the proteasomal degradation in AGAP2 expression levels: 
Protein degradation plays an important role in maintaining steady-state protein abundance (Reviewed in Vogel and 
Marcotte, 2012). Ubiquitin (Ub)–proteasome pathway (UPP) is responsible for degrading the majority of 
intracellular proteins (Rock et al., 1994). The degradation of protein by UPP is carried out by covalently tagging 
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ubiquitin molecules to a protein substrate which is recognised by 26S proteasome complex, breaking down the 
protein into constituent amino acids with the release of reusable ubiquitin (Reviewed in Ciechanover and Schwartz, 
1998, Lecker et al., 2006). The catalytic core of the proteasome complex facilitates three distinct proteolytic 
activities namely chymotrypsin-like, trypsin-like, and caspase-like proteasomal activity (Dick et al., 1998, Kisselev et 
al., 2003, Nussbaum et al., 1998). The chymotrypsin-like proteolytic site has been shown to be the most important 
in protein breakdown (Heinemeyer et al., 1997) and could be target using specific inhibitors that modulate its 
proteolytic activity. The proteasomal inhibitors MG132 and Bortezomib have been shown to selectively inhibit the 
chymotrypsin-like activity of the catalytic core of the proteasome complex (Kisselev et al., 2006). 
The degradation of AGAP2 protein by the UPP is currently unknown. The role of UPP in AGAP2 protein regulation 
has not been reported yet in the literature. To evaluate the contribution of UPP in AGAP2 protein degradation and 
to account for the discrepancy in AGAP2 mRNA and protein levels noted in the CML cell lines, two proteasomal 
inhibitors (MG132 and Bortezomib) were used to evaluate AGAP2 protein in the CML cell lines. It is expected that 
the AGAP2 protein levels in the CML cell lines would increase if the proteins were ubiquitinated and degraded by 
UPP.  
3.3.2.1 Optimisation of MG132 and Bortezomib treatments:   
For MG132, the literature cited the use of 1-50 μM concentration with a treatment duration ranging from 2 to 24 
hours (Chui et al., 2019, Estève et al., 2009, Jung et al., 2019, Noels et al., 2009, Xu et al., 2009). The treatment 
period of 4 hours was frequently used by various studies (Ahuja et al., 2017, Chui et al., 2019, Jung et al., 2019, 
Noels et al., 2009). The following concentrations for a 4-hour MG132 treatment were selected: 5 μM for KU812 and 
TCCS, and 50 μM for KCL-22.  
For Bortezomib, treatments with a concentration range of 10 to 250 nM for 2-48 hours were reported in the 
literature (Alam et al., 2017, Fan and You, 2020, Pitcher et al., 2015, Van Herck et al., 2009). A study by Yang et al. 
(2016) has tested different bortezomib concentrations on CML cell lines (KU812, K562) for the treatment duration 
of 6 hours. The following bortezomib concentrations was selected for a 6-hour treatment in CML cell lines: 200 nM 
for KU812, 10 nM for TCCS, and 50 nM for KCL-22.   
The anti-ubiquitin antibody was used to optimise the selected proteasomal inhibitors concentrations. The relative 
levels of ubiquitinated proteins would increase under the optimal condition as the treatments would inhibit the 
proteolysis of the ubiquitin-tagged proteins, increasing their cellular levels compared to vehicle control. The 
selected treatment concentrations were evaluated using an anti-ubiquitin antibody (Table 2.6). As demonstrated 
in Figure 3.7, the treatment conditions for proteasomal inhibitors were optimal and resulted in an increase in the 
levels of ubiquitinated protein relative to the control. These concentrations were then used to analyse the 




Figure 3.7: Levels of ubiquitinated protein after treatment with proteasomal inhibitors. Immunoblotting with 
ubiquitin antibody after treatment (+) with proteasomal inhibitors: MG132 [KU812 (5μM), TCCS (5μM), KCL-22 
(50μM) for 4 hours] and Bortezomib [KU812 (200nM), TCCS (10nM), KCL-22 (50nM) for 6 hours] or untreated 
DMSO control (-). β-Actin was used as a loading control. 
 
3.3.2.2 Examining AGAP2 proteasomal degradation in CML cell lines: 
To evaluate the association between AGAP2 protein degradation by UPP and lower protein abundance noted in 
CML cell lines, the cells were treated with proteasomal inhibitors as optimised above. The analysis of western 
blotting data showed a limited role of UPP in modulating AGAP2 protein levels in CML cell lines, no statistically 
significant differences were observed in the cells treated with proteasomal inhibitors (MG132 or bortezomib) 
compared to untreated control (Figure 3.8). The data shows that ubiquitination has a limited contribution in AGAP2 
degradation and could not account for the inconsistency in the mRNA and protein levels noted in the CML cell lines.  
However, protein degradation is a highly elaborate and complex process that is influenced by many different 
factors. In addition to UPP, targeted protein degradation is also mediated by autophagy which is an important 
protein quality control mechanism in the context of misfolded and aggregated proteins (Kruse et al., 2006). Other 
protein degradation mechanisms could be also responsible for controlling AGAP2 abundance and needs further 






Figure 3.8: Inhibiting AGAP2 proteasomal degradation in CML cell lines. (A) Western blot analysis of AGAP2 in 
CML cell lines treated (+) with proteasomal inhibitors: MG132 [KU812 (5μM), TCCS (5μM), KCL-22 (50μM) for 4 
hours] and Bortezomib [KU812 (200nM), TCCS (10nM), KCL-22 (100nM) for 6 hours] or untreated DMSO control     
(-). Densitometry values are presented in (B). β-Actin was used as a loading control. The data shown are the 
mean ± SD of three independent experiments (n=3), Error bars represent S.D. Differences between the treated 
samples and untreated control were analysed by Mann–Whitney U test. BTZ: bortezomib.  
 
 
3.3.3 Role of translation initiation factors in AGAP2 expression discrepancies: 
The levels of intracellular translation initiation factors are critical in regulating protein abundance, particularly in 
response to environmental stressors (Reviewed in Crawford and Pavitt, 2019, Spriggs et al., 2010). A variety of 
eukaryotic initiation factors (eIFs) play an important role in facilitating cap-dependent translation initiation (section 
1.1.2.1). The activity of these eIFs could be controlled by their phosphorylation state and the phosphorylation of 
eIF4E, eIF4B, eIF4G has been shown to positively correlate with translation (Hershey et al., 2000).  
In the current study, we evaluated the relative cellular levels of key eIFs in PC and CML cell lines to determine their 
contribution in regulating AGAP2 protein abundance. Our results showed no statistically significant differences in 





Figure 3.9: Levels of selected translation initiation factors in PC and CML cell lines. Western blotting of selected rate-
limiting translation initiation factors (eIF4A, eIF4A1, eIF4B, eIF4E, eIF4G, eIF4H) detected by resolving 50 μg of protein 
using 4–20% precast protein gel followed by immunoblotting with specific antibodies. β-Actin was used as a 
loading control. All the proteins in the representative blot were detected by probing a single membrane. 
Densitometry values for the relative protein expression are represented below the blots. Differences were 
analysed using a Kruskal-Wallis followed by uncorrected Dunn’s test, no statistically significant difference 
observed (ns: not significant). All the data shown are the mean ± SD of three independent experiments (n=3), 
error bars represent S.D. 
 
 
We also analysed the phosphorylation state of selected eIFs such as eIF4E, eIF4G, eIF4B in different cell types 
included in our study (Figure 3.10). The analysis revealed no statistically significant differences in the 




Figure 3.10: Levels of selected phosphorylated translation initiation factors in PC and CML cell lines. Western blotting of 
selected phosphorylated translation initiation factors (phospho-eIF4B, phospho-eIF4E, phospho-eIF4G) detected by 
resolving 50 μg of protein using 4–20% precast protein gel followed by immunoblotting with specific antibodies. 
The proteins were normalised using corresponding total eIF levels. Densitometry values for the relative protein 
expression are presented to the right of blots. Differences were analysed using a Kruskal-Wallis followed by 
uncorrected Dunn’s test, P-values shown and is presented relative to DU145 (PC cell line). The data shown are the 
mean ± SD of three independent experiments (n=3), error bars represent S.D. (ns: not significant).  
 
 
The absence of any significant differences in the relative basal levels of eIFs do not rule out their role in modulating 
differential protein abundance. The process of translation requires a sophisticated interplay between various eIFs, 
cofactors, signalling cascades, and ncRNA (Reviewed in Sonenberg and Hinnebusch, 2009). The features in the 
mRNA 5’ and 3’ UTR such as secondary structures, RBP (RNA binding protein), and Poly(A)-binding protein (PABP) 
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are also involved in controlling translation activation and efficiency (Wilkie et al., 2003). Furthermore, the helicases 
activity of eIF4A and different DExH-Box protein members are required to scan mRNA with highly structured 5’ UTR 
and govern its translation (Pisareva et al., 2008). These complex and coordinated interactions shape mRNA-specific 
translational profile. Further studies are required to comprehensively understand the complex translation initiation 
regulation and dissect the possible contributions of different eIFs in mediating inconsistency in mRNA and protein 
levels.   
3.3.4 TSS usage for AGAP2 in PC and CML cell lines: 
During the transcription initiation, transcription factors bind to the specific sequences within the promoter region 
of the gene and recruit the RNA polymerase (RNAP) holoenzyme, followed by the unwinding of promoter DNA and 
selection of a TSS (section 1.1.1). The selection of the TSS by RNAP within the core promoter region is dynamic and 
variable in both prokaryotic and eukaryotic organisms (Qiu et al., 2020, Vvedenskaya et al., 2016). The diversity in 
TSS selection has been previously demonstrated for a large number of human cell lines and tissues. (Carninci et al., 
2006, Suzuki et al., 2001). Our preliminary work has identified a potential of differential TSS usage for AGAP2 in PC 
and CML cell lines (Figure 3.2C). In the current project, we have characterised the distribution of AGAP2 TSSs within 
the core promoter region of PC and CML cell lines. 
3.3.4.1  Characterising AGAP2 TSSs distribution: 
The AGAP2 TSSs in PC and CML cell lines were determined using 5’ RLM-RACE (section 2.2.5.2). Following the 
manufacturer’s instructions, the RNA was dephosphorylated, decapped, ligated with an RNA oligo, reverse 
transcribed using AGAP2 gene-specific primer 1, and amplified using nested primers (Table 2.7). The amplified 5’ 
RACE products were resolved using agarose gel electrophoresis showing the expected product (Figure 3.11A). The 
bands were excised, purified and cloned into a vector, transformed into chemically competent bacteria, and were 
grown in the presence of selecting medium. Single clones from each cell line were sequenced to provide a snapshot 
of AGAP2 TSS distribution patterns in PC and CML cell lines (Figure 3.11B). It could be noted from the figure that 
the cloned sequence consistently showed an upstream (>100 bp from ATG start codon) TSSs in CML cell lines 
relative to PC cell lines. To characterise the distribution of AGAP2 TSSs in detail, ten clones from KU812 (CML) and 
DU145 (PC) were sequenced, and the results are presented relative to the ATG start codon (Figure 3.11C). As 
evident from Figure 3.11C, the TSSs in DU145 were largely clustered around 90 bp upstream of the ATG start codon. 
On the contrary, the TSSs distribution in KU812 was relatively broad with prominent transcription starting around 
90 bp from ATG, similar to DU145. However, earlier TSSs (130 bp upstream of ATG start codon) were also noted in 
KU812. 
Our experiment showed that there is a population of TSSs which are differentially distributed in the core promoter 
region of AGAP2 in PC and CML cell lines. In contrast to one optimal TSS in PC and CML cell lines, there are multiple 
starting sites that are differentially selected in these cell lines and produce a heterogenous 5’ UTR population. The 
TSSs in the CML cell line (KU812) is broadly distributed compared to PC (DU145) cell line with several starting 
positions including earlier starting sites that encode a longer 5’ UTR containing the G4 forming consensus sequence 
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(Figure 3.11C, Figure 3.12B). Such different patterns of TSS distribution confirm the cell-specific expression of TSSs, 
as also noted by other studies (Kawaji et al., 2006, Ohmiya et al., 2014).   
 
 
Figure 3.11: Distribution of AGAP2 TSSs in PC and CML cell lines. (A) 5’ RACE products from PC and CML cell lines 
resolved on 2% agarose gel and showing expected bands at the correct molecular weight (~300 bp: 30bp RNA oligo 
+ 267 bp annotated AGAP2 5’ UTR). The red box indicates the region of the gel that was excised and cloned for 
sequencing. Lane M:100 bp DNA ladder; Lane 1-6: DU145, PC3, LNCaP, KU812, TCCS, KCL-22. (B) The position of the 
AGAP2 TSSs in PC and CML cell lines relative to ATG start codon, the TSSs were obtained by cloning the excised 
bands in (A) and sequencing a single purified clone (n=1) of the transformed bacteria cultured on selecting agar 
plate. The sequence was aligned to the AGAP2 5’ UTR region (chr12:57742057-57742205) and the position of 
starting nucleotide was considered as the transcription starting site. (C) The array of TSSs in DU145 (PC) and KU812 
(CML) cell line determined by 5’ RLM-RACE. The distribution frequency is plotted as the percentage at nucleotide 
position relative to ATG start codon (n=10). 
 
 
3.3.4.2 Validation of TSSs obtained by 5’ RLM-RACE: 
The TSSs obtained in the current study were validated by using the TSS data of the corresponding cell line in the 
FANTOM database. The FANTOM database is the largest collection of transcription initiation data, consisting of 
more than 1,000 human and mouse primary cells, tissues, and cancer cell lines (Lizio et al., 2015). The TSSs in the 
FANTOM database have been determined using HeliScope Cap Analysis of Gene Expression (CAGE) technology. It 
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uses a biotinylated cap-trapping approach to capture the 5' ends of the cDNAs, which are subsequently converted 
to short tags (20-27nt long) and directly sequenced using single-molecule sequencing (Kanamori-Katayama et al., 
2011). The CAGE tag starting sites represent the actual mRNA TSSs with base pair-level accuracy (Kawaji et al., 
2014).  
The TSS distribution characterised by 5’ RLM-RACE displayed a good concordance with the TSS distribution pattern 
defined in the FANTOM CAGE database (Figure 3.12A). As evident from the figure, there is a good overlap between 
TSSs identified in our study and TSSs detected by the high throughput HeliScopeCAGE sequencing approach. Our 
study also identified some novel TSSs that were not annotated in the FANTOM database. It is worth mentioning 
that the TSS distribution characterised by our study and in the FANTOM CAGE database are associated with a single 
core promoter region of AGAP2. These TSSs associated with the core promoter region were clustered together and 
separated from other clusters by a clear genomic space.  
The cumulative distribution profile of AGAP2 TSS in the FANTOM database is presented in Figure 3.12B. It could be 
noted that AGAP2 uses a variety of TSSs with prominent transcription initiating around 90 bp upstream of ATG start 
codon, as also noted in our study. The TSS with the highest frequency is usually categorised as the major TSS and is 
commonly used as the starting position of AGAP2 mRNA transcript in different RefSeq databases like NCBI 
(NM_014770.4) and Ensembl (ENST00000257897.7). As also highlighted in Figure 3.12B, earlier TSSs (~130 bp 
upstream of ATG start codon) were frequently used in KU812 and consequently increased the length of the 5’ UTR 
of AGAP2 mRNA.  We noticed that the extra nucleotides incorporated in the 5’ UTR by the earlier TSS selection had 
runs of guanine nucleic acid that followed the consensus for a G quadruplex structure (G3+N1-7G3+N1-7G3+N1-7G3+). 
This alternatively transcribed G quadruplex forming sequence could have a regulatory role and it is further explored 
in Chapter 4. 
Our study, for the first time, provided evidence that alternative TSS selection within a single cluster could encode a 
regulatory element in the 5’ UTR region. Previous studies have identified a variety of regulatory elements such as 
upstream open reading frame (uORF) and upstream start codon (uAUG), RNA secondary structures, RNA G 
quadruplexes, and internal ribosomal entry site (IRES) that are encoded in the mRNA 5’ UTR isoforms by alternative 
TSS selection (Blaschke et al., 2003, Hollerer et al., 2019, Pickering and Willis, 2005, Pozner et al., 2000). However, 
the alternative TSSs encoding these features belonged to different clusters and were separated by greater than 500 
bp. On the contrary, the alternative TSS selection in KU812 that yield a G quadruplex forming sequence in the longer 
5’ UTR isoform was only 36 bp upstream to the TSS in DU145 (Figure 3.12B). This novel layer of gene expression 




Figure 3.12: Overlay between TSSs obtained by RLM-RACE and FANTOM database. (A) TSSs for AGAP2 in KU812 
obtained by 5’ RLM-RACE is plotted alongside the TSSs reported by the HeliScopeCAGE technology used in the 
FANTOM database. The TSS distribution profiles determined in our study showed a good agreement with FANTOM 
CAGE TSSs. The relative frequencies are shown as a percentage at the nucleotide positions from the start codon. 
(B) Image derived from ZENBU genome browser, a data exploration tool for FANTOM database (Lizio et al., 2015), 
showing the distribution and usage of different AGAP2 TSSs within a core promoter region. The alternative TSSs 
mapped by 5’ RLM-RACE in KU812 (CML) cell line that encoded extra nucleotides in the 5’ UTR of KU812 containing 
the G quadruplex forming sequence is shown below. 
 
3.3.5 Expression of longer (G4-containing) 5’ UTR isoforms in PC and CML cell lines:   
We investigated the relative abundance of the longer 5’ UTR isoforms corresponding to the earlier TSSs in PC and 
CML cell lines. For this purpose, all the TSS isoforms encoding a G4 consensus sequence in the AGAP2 mRNA 5’ UTR 
were classified as longer 5’ UTR. We designed a nested PCR reaction to amplify the longer 5’ UTR, originating from 
upstream TSSs, in both the cell lines (Figure 3.13A). A nested PCR was used because the usage of upstream TSSs 
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were relatively lower compared to the major starting sites in both the cell lines (Figure 3.11C, 3.12B), and also the 
level of AGAP2 mRNA in PC cell lines was significantly lower and didn’t produce any amplification signals during the 
first PCR (data not shown). The levels of longer 5’ UTR isoforms obtained by the nested PCR amplification were 
normalised by the entire 5’ UTR population. The nested PCR product was verified using Sanger sequencing to 
confirm the expected amplicon. The results are presented in Figure 3.13B and reveal significantly higher levels of 
longer G4-containing 5’ UTR isoforms in CML cell lines relative to PC cell lines (P < 0.0001). For validation, the nested 
PCR was also performed on the 5’ RLM-RACE amplified cDNA which likewise displayed a significant increase in the 
level of longer 5’ UTR in the CML cell lines (P < 0.001) (Figure 3.13C).      
 
 
Figure 3.13: Levels of longer G4-containing AGAP2 5’ UTR isoforms in PC and CML cell lines. (A) Nested PCR 
amplification to detect longer AGAP2 5’ UTR isoform in PC and CML cell lines. The first PCR was performed using 
outer long AGAP2 primers. The PCR product was diluted 50 folds and amplified again using inner long AGAP2 
primers. To detect the entire UTR population, the forward primer was designed closer to the coding sequence. 
The sequences of the primers are listed in Table 2.4. The figure shows the first 373 nucleotides of AGAP2 mRNA 
transcribed from the furthest upstream TSS annotated in the FANTOM database. The coding sequence is 
presented in UPPERCASE (with ATG marked in bold) and the 5’ UTR is presented in the lowercase. The annotated 
TSS in NCBI and Ensembl is shown by the red arrow. Primer sequences are shown by respective coloured box and 
the AGAP2 primer in the overlapped region is shown by underline. (B) Relative levels of AGAP2 mRNA with longer 
5’ UTR in PC and CML cell lines. The levels are normalised by the entire 5’ UTR population and presented relative 
to DU145 (PC cell line). The data is the mean ± SD of three independent experiments (n=3). Statistical differences 
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were analysed by one-way ANOVA [F (5, 12) = 29.35, P < 0.0001)] with post-hoc Sidak's multiple comparison tests, 
P-values shown. (C) Validation of the levels of longer AGAP2 5’ UTR in PC and CML cell lines using RACE- amplified 
cDNA (n=2). The levels are normalised by the entire 5’ UTR population and presented relative to DU145. Statistical 
differences were analysed by one-way ANOVA [F (5, 6) = 73.65, P < 0.001)] with post-hoc Sidak's multiple 
comparison tests, P-values shown. (*P < 0.05; **P < 0.01; ***P < 0.001). 
 
The higher levels of longer 5’ UTR isoforms in the CML cell lines also confirm the relatively higher usage of upstream 
TSSs in these cell lines. However, these upstream, G4 encoding TSSs, represent a fraction of all the TSSs used in the 
cluster. The transcription in both the PC and CML cell line is predominately driven from the TSSs located around -
90 bp upstream of the ATG start codon, also termed as major TSS, that do not incorporate the G4 forming sequence 
in the 5’ UTR. Even though the G4 forming TSSs are not the major TSS, they could still render a large portion of the 
mRNA population susceptible to TSS-G4 mediated regulation.  
The distribution shape and usage of TSSs with the core promoter region defines the distinct group of promoters 
and promoter context: single dominated peak class of promoters are represented by concentrated transcription 
start positions with a single dominant TSS and are associated with TATA box; whereas the remaining classes are 
categories of broadly distributed TSSs with dominant or multimodal peak distributions and are shown to be 
associated with CpG islands (Carninci et al., 2006, Carninci et al., 2005). In our study, we noted comparable usage 
of AGAP2 minimal promoter region in PC and CML cell lines and also documented the relevance of SP1 and ATRA 
on AGAP2 transcription activation in both groups of cell lines (Figure 3.1). Taking these results into account, the 
alternative promoter usage in PC and CML cell lines is unlikely to explain the observed heterogeneity in the 5’ UTR.  
The selection of TSS within a cluster is a dynamic process dictated by a variety of factors including sequence 
features, ncRNA, various stimuli, and epigenetic factors (Javahery et al., 1994, Jiang and Pugh, 2009, Leenen et al., 
2016, Turowski and Tollervey, 2020), also see section 3.3.6. It is plausible that a TSS selection could switch under 
the influence of these factors and change the relative proportions of 5’ UTR isoforms. The work by Leenen et al. 
(2016) has verified this microvariability in the TSS location induced by different stimuli. In the case of AGAP2, the 
selection of earlier G4 forming TSSs could be also induced by different factors and require further evaluation. 
 
3.3.6 Differentially expressed TSSs in PC and CML cell lines: 
The TSS distribution within a core promoter region varies among different tissues and exhibits cell-specific 
distribution profiles (Kawaji et al., 2006, Ohmiya et al., 2014). We have noted a distinct TSS distribution profile in 
PC and CML cell lines using 5’ RLM-RACE (Figure 3.11C). The differential TSS distribution patterns produce 
heterogeneity in the 5’ UTR isoforms transcribed from the gene (Figure 3.12B). Differentially transcribed 5’ UTR 
isoforms could contain regulatory features that might impact mRNA translation potential. To identify other genes 
with differentially distributed TSSs, we tested a publicly available bioinformatics tool (SEASTAR) to generate a list 
of genes with a differential distribution pattern of TSSs in PC and CML cell lines.  
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3.3.6.1 Systematic Evaluation of Alternative Start site in RNA (SEASTAR) Algorithm: 
The SEASTAR is a computational pipeline developed by Qin et al. (2018) to identify alternative TSS and quantify 
their expression levels using the RNA sequencing data. The SEASTAR pipeline is implemented by initially producing 
a processed transcript assembly by annotating the aligned sequencing reads. Then, a non-redundant set of the first 
exon is generated, and a logistic regression model is applied to identify the bona fide first exon. The SEASTAR 
subsequently compares the usage of the alternative first exon (AFE) across the distinct biological conditions and 
applies rMATS statistical methods (Shen et al., 2014) to identify differential first exon usage. Using a DaPars change 
point statistical model (Xia et al., 2014), it also tests whether tandem TSSs exists within the first exon and detect 
TSSs that significantly differ between two sample groups. The technical overview of the algorithm is illustrated in 
Figure 3.14. 
The SEASTAR pipeline is written in Bash and R script and can be accessed using Github 
(https://github.com/Xinglab/SEASTAR). The transcription start sites identified by the SEASTAR package showed a 
good agreement with the FANTOM CAGE starting sites and also bears the hallmark of active promoters (Qin et al., 
2018). In the current project, the SEASTAR pipeline was employed to leverage the RNA sequencing data to gain 
insights into alternative TSSs usage and distribution profiles in PC and CML cell lines.  
 
 
Figure 3.14: Flowchart of SEASTAR algorithm. The SEASTAR computational pipeline to identify differentially 
expressed alternative transcription initiation sites. The algorithm input the aligned reads in the (.bam) format and 
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use the existing transcriptome annotation (.GTF) to construct a processed transcript assembly. The overlapping 
putative first exons are merged to generate a non-redundant set of first exons. The bona fide first exon is then 
determined using a logistic regression model and the differential usage of the alternative first exon is determined 
using the rMATS statistical method (Shen et al., 2014). The alternative tandem TSSs within the first exon is detected 
by the DaPars statistical model (adapted from Xia et al., 2014) and the relative proportions of significantly different 
TSSs are computed.  
 
 
3.3.6.1.1 Executing SEASTAR script: 
The aligned RNA sequencing data in the form of binary alignment matrix (.bam) format was used as an input for the 
SEASTAR package. The RNA-seq data of PC cell lines (DU145, PC3, LNCaP) was assigned to group A and that of CML 
cell lines (KU812, TCCS, KCL-22) was assigned to group B. The human gene annotation (GRCh38.p13, release 33) 
was used to annotate the aligned transcripts. The comprehensive gene annotation was downloaded from 
(https://www.gencodegenes.org/human/release_33.html) in the Gene Transfer Format (.GTF). The package was 
executed in Ubuntu 18.04 using the following command:  
 
The annotation of genes and transcripts was carried out in the reference mode (-G), skipping reference annotation-
based transcript assembly (RABT) to identify novel TSSs. The distance (-d) among the TSSs derived from the same 
promoter region was set to 100 bp (default values). The other parameters including the splicing difference cut off 
were also set to default values.  
3.3.6.1.2 SEASTAR Output: 
The output generated by the SEASTAR pipeline is comprised of two distinct tables analysing significantly different 
AFE (Table 3.1) and alternative tandem TSSs (Table 3.2) between PC and CML cell lines. The differentially expressed 
first exon was analysed by counting the RNA-seq reads that map to the first exon relative to the other exons in the 
gene. The differential usage of the first exon was then evaluated by rMATS statistical analysis. For analysis of 
alternative tandem TSS using DaPars statistical model, the length of the first exons were recorded in PC and CML 
cell lines and a switch point between the shortening and lengthening region was predicted, splitting the first exon 
into two regions. Using the rMATS statistical method as above, the significant differences in the relative usage of 
two split regions were computed.  
The following output columns were generated: 
• TSS ID: The ID of each TSS. Each ID represents one clustering of the raw TSSs with a distance less than 
100bp. 







-c 0.1 -p 1 -b U -d 100 -S U                                                                                                                                                                  
103 
 
• IC SAMPLE 1:  
o Table 1: counts of the first exons for Group A. 
o Table 2: counts of the RNA-seq reads in longer region of split exon for Group A, replicates are 
separated by a comma.  
• SC SAMPLE 1:  
o Table 1: counts of other first exons in the respective gene for Group A. 
o Table 2: counts of the RNA-seq reads in shorter region of split exon for Group A, replicates are 
separated by a comma. 
• IC SAMPLE 2:  
o Table 1: counts of the first exons for Group B. 
o Table 2: counts of the RNA-seq reads in longer region of split exon for Group B, replicates are 
separated by a comma. 
• SC SAMPLE 2:  
o Table 1: counts of other first exons in the respective gene for Group B. 
o Table 2: counts of the RNA-seq reads in shorter region of split exon for Group B, replicates are 
separated by a comma. 
• IncFormLen:  
o Table 1: length of the first exon understudy, used for normalization 
o Table 2: length of the longer region of split exon, used for normalization 
• SkipFormLen:  
o Table 1: average length of other first exons in the respective gene, used for normalization 
o Table 2: length of shorter region of split exon, used for normalization 
• IncLevel1: usage ratio for Group A replicates (comma separated), calculated from normalized counts using 
formula: (ICSAMPLE1/incformLen)/(ICSAMPLE1/IncformLen + SC_SAMPLE1/SkipformLen) 
• IncLevel2: usage ratio for Group B replicates (comma separated) calculated from normalized counts using 
formula: (ICSAMPLE2/incformLen)/(ICSAMPLE2/IncformLen + SC_SAMPLE2/SkipformLen) 
• IncLevelDifference: average difference between IncLevel1 and IncLevel2 
• FDR: adjusted P-value using the Benjamini-Hochberg method. 
 
3.3.6.1.3 Interpretation of the SEASTAR analysis and relevance to the current study:  
The analysis of differentially utilised first exons demonstrated 7 genes with significantly different AFE usage (Table 
3.1). Table 3.1 also presents the list of the top 30 gene transcripts showing heterogenous first exon in the PC group 
relative to the CML group. The list of top 15 tandem TSSs that showed differences in PC and CML cell are shown in 
Table 3.2. The analysis of differential tandem TSSs usage revealed no statistically significant differences between 
PC and CML cell lines. It could be attributed to combining the sequencing data from different related cell lines into 
two groups for analysis. The PC or CML group had sequencing data from three different but connected cell lines 
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instead of technical replicates, resulting in data variability and loss of any significant differences. The DaPars analysis 
was repeated using only DU145 cell line for the PC group and KU812 cell line for the CML group and the output 
generated a list of 4 tandem TSSs (TSS ID: TSS66290, TSS101970, TSS110127, TSS109986; Table 3.2) that showed 
significant differential distribution.  
However, the analysis of AFE and alternative tandem TSSs by the SEASTAR analysis pipeline had limited applicability 
in the current study. The type of TSSs examined by the SEASTAR pipeline does not fit the context of the current 
study. The alternative TSSs examined by the SEASTAR are in the form of alternative first exons and alternative 
tandem TSSs (Figure 3.15A). The TSSs generated by alternative first exon usage are separated by a large genomic 
space and would likely change the ORF (Figure 3.15A). On the contrary, the focus of the current project is to study 
the differential distribution of TSSs that change the length of 5’ UTR by a few nucleotides (< 100 bp) without 
changing the ORF.  
For tandem TSSs, the SEASTAR analyses the use of different TSSs within a given first exon that are separated by 
>100 bp and could also change the principal ORF in some instances (Figure 3.15A). This grouping of tandem TSSs 
that are within 100 bp of each other might overlook the contribution of TSS variants separated by just a few 
nucleotides. The SEASTAR analysis was also rerun by changing the default clustering of TSS to 50 bp, but it did not 
change the output generated possibly because of the sequencing depth in the 5’ UTR region. Although the RNA 
sequencing in the current project was carried out at a sufficient depth (48-53 million reads per sample), the 
coverage depth at the 5’ UTR region was lower (2-3X).  
Therefore, to analyse relevant TSSs that fit within the focus of the study, a customised in-house bioinformatics 
pipeline was designed that analysed the differential distribution of TSSs within the core promoter region that does 
not change the ORF (see below and Chapter 5).
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Table 3.1: List of differential alternative first exons between PC and CML cell lines curated by the SEASTAR pipeline. 






















IncLevel1 IncLevel2 IncLevel-Difference PValue FDR 




0 150,88,74 118 118 
0.321,0.432, 
0.452 0.007,0.0,0.0 0.399 0.00E+00 0.00 
TSS43024 ATP2C1 chr3:130893967-131003107 5067 1.31E+08 1.31E+08 22,14,15 0,0,4 
13,12, 
10 62,62,22 370 370 1.0,1.0,0.789 
0.173,0.162, 
0.313 0.714 8.91E-12 4.84E-08 












0.185 0.512 4.98E-11 1.80E-07 
TSS43023 ATP2C1 chr3:130850594-131003150 4888 1.31E+08 1.31E+08 0,0,4 20,13,14 
56,56, 
20 12,11,9 334 334 0.0,0.0,0.222 
0.824,0.836, 
0.69 -0.709 1.05E-10 2.84E-07 
TSS103723 TFDP2 chr3:141944427-142149521 9857 1.42E+08 1.42E+08 16,6,11 8,4,12 
4,6, 
3 32,190,25 362 362 0.667,0.6,0.478 
0.111,0.031, 
0.107 0.499 2.01E-09 4.36E-06 




0.067 0.304 2.55E-06 0.004617549 




0.274 0.317 5.11E-06 0.007928907 




0.505 -0.357 3.46E-05 0.046926539 
TSS52494 UTRN chr6:144344100-144426328 572 1.44E+08 1.44E+08 2,0,1 
27,48, 




0.696 -0.562 9.77E-05 0.117928509 
TSS3215 PDE4DIP chr1:148952340-148986477 8824 1.49E+08 1.49E+08 207,167,72 0,15,0 44,49,7 61,11,11 1565 1565 1.0,0.918,1.0 
0.419,0.817, 
0.389 0.431 1.11E-04 0.120431507 
TSS27278 SEPTIN9 chr17:77320312-77402415 553 77320313 77320348 10,11,1 15,41,8 33,20,17 13,7,5 36 36 0.4,0.212,0.111 
0.717,0.741, 
0.773 -0.503 1.40E-04 0.137794634 




0.774 -0.416 2.74E-04 0.247708893 
TSS121855 MLLT3 chr9:20341668-20622499 6724 20622245 20622518 9,1,12 0,0,3 5,8,5 38,23,5 274 274 1.0,1.0,0.8 0.116,0.258,0.5 0.642 5.41E-04 0.393269159 
TSS82787 NEDD4 chr15:55826921-55917131 7235 55915284 55917131 308,14,12 78,31,0 6,14,0 63,86,8 1848 1848 0.798,0.311,1.0 0.087,0.14,0.0 0.627 5.43E-04 0.393269159 
TSS87831 FAM117A chr17:49710994-49788592 1522 49788502 49788989 14,17,15 6,6,10 31,30,19 94,179,22 488 488 0.7,0.739,0.6 
0.248,0.144, 
0.463 0.395 4.96E-04 0.393269159 




0.081 0.424 8.74E-04 0.593341246 




0.488 0.375 1.07E-03 0.680241565 
TSS16948 ARHGAP5 chr14:32077303-32159728 9589 32077074 32077435 63,26,11 
145,40, 
33 4,7,9 0,3,0 362 362 
0.303,0.394, 
0.25 1.0,0.7,1.0 -0.584 1.32E-03 0.796244285 
TSS105386 SHISA5 chr3:48467797-48504050 2385 48504019 48504431 13,28,32 50,87,77 2,12,0 44,114,106 413 413 
0.206,0.243, 
0.294 0.043,0.095,0.0 0.202 1.62E-03 0.925194179 
TSS100031 FRG1CP chr20:28563849-
28602773 





Table 3.2: List of alternatively used tandem TSSs in PC and CML cell line generated by the SEASTAR pipeline. 
 
TSS ID IC SAMPLE 1 SC SAMPLE 1 IC SAMPLE 2 SC SAMPLE 2 IncFormLen SkipFormLen IncLevel1 IncLevel2 IncLevelDifference PValue FDR 
TSS66290.1 233,17,144 64,100,152 15,51,16 115,186,136 678 202 0.52,0.048,0.22 0.037,0.076,0.034 0.214 0.297 1 
TSS66290.2 64,100,152 233,17,144 115,186,136 15,51,16 202 678 0.48,0.952,0.78 0.963,0.924,0.966 -0.214 0.297 1 
TSS101970.1 375,361,326 148,139,125 461,373,152 188,172,75 337 203 0.604,0.61,0.611 0.596,0.566,0.55 0.038 1 1 
TSS101970.2 148,139,125 375,361,326 188,172,75 461,373,152 203 337 0.396,0.39,0.389 0.404,0.434,0.45 -0.038 1 1 
TSS104426.1 107,78,112 49,25,49 130,126,85 34,48,44 202 164 0.639,0.717,0.65 0.756,0.681,0.611 -0.014 1 1 
TSS104426.2 49,25,49 107,78,112 34,48,44 130,126,85 164 202 0.361,0.283,0.35 0.244,0.319,0.389 0.014 1 1 
TSS104755.1 8,526,261,987 476,327,882 154,032,072,050 7,651,544,849 466 417 0.616,0.631,0.668 0.643,0.65,0.684 -0.021 1 1 
TSS104755.2 476,327,882 8,526,261,987 7,651,544,849 154,032,072,050 417 466 0.384,0.369,0.332 0.357,0.35,0.316 0.021 1 1 
TSS104913.1 355,218,448 109,328,108 337,764,484 96,211,139 279 357 0.806,0.46,0.841 0.818,0.822,0.817 -0.117 1 1 
TSS104913.2 109,328,108 355,218,448 96,211,139 337,764,484 357 279 0.194,0.54,0.159 0.182,0.178,0.183 0.117 1 1 
TSS108247.1 214,260,214 57,58,54 300,205,449 81,66,120 202 82 0.604,0.645,0.617 0.601,0.558,0.603 0.035 1 1 
TSS108247.2 57,58,54 214,260,214 81,66,120 300,205,449 82 202 0.396,0.355,0.383 0.399,0.442,0.397 -0.035 1 1 
TSS109087.1 340,247,441 50,48,76 537,228,161 82,38,19 360 172 0.765,0.711,0.735 0.758,0.741,0.802 -0.03 1 1 
TSS109087.2 50,48,76 340,247,441 82,38,19 537,228,161 172 360 0.235,0.289,0.265 0.242,0.259,0.198 0.03 1 1 
TSS109986.1 8,291,091,218 8,591,189,184 214,138,201 236,128,211 202 407 0.66,0.649,0.705 0.646,0.685,0.657 0.009 1 1 
TSS109986.2 8,591,189,184 8,291,091,218 236,128,211 214,138,201 407 202 0.34,0.351,0.295 0.354,0.315,0.343 -0.009 1 1 
TSS110127.1 109,198,117 28,69,39 89,102,77 29,39,29 202 159 0.754,0.693,0.703 0.707,0.673,0.676 0.031 1 1 
TSS110127.2 28,69,39 109,198,117 29,39,29 89,102,77 159 202 0.246,0.307,0.297 0.293,0.327,0.324 -0.031 1 1 
TSS115354.1 128,188,198 20,20,23 337,519,335 40,63,43 299 232 0.832,0.879,0.87 0.867,0.865,0.858 -0.003 1 1 
TSS115354.2 20,20,23 128,188,198 40,63,43 337,519,335 232 299 0.168,0.121,0.13 0.133,0.135,0.142 0.003 1 1 
TSS118917.1 173,514,021,552 627,596,098,385,549 167,815,351,811 553,687,237,884,617 202 721 0.09,0.076,0.061 0.098,0.07,0.071 -0.004 1 1 
TSS118917.2 627,596,098,385,549 173,514,021,552 553,687,237,884,617 167,815,351,811 721 202 0.91,0.924,0.939 0.902,0.93,0.929 0.004 1 1 
TSS118918.1 173,314,021,546 629,246,112,985,759 167,415,271,810 555,557,252,084,781 202 721 0.09,0.076,0.06 0.097,0.07,0.071 -0.004 1 1 
TSS118918.2 629,246,112,985,759 173,314,021,546 555,557,252,084,781 167,415,271,810 721 202 0.91,0.924,0.94 0.903,0.93,0.929 0.004 1 1 
TSS118919.1 405,034,163,925 128,591,017,313,271 409,737,504,521 126,601,309,616,907 660 263 0.112,0.118,0.105 0.114,0.102,0.096 0.008 1 1 
TSS118919.2 128,591,017,313,271 405,034,163,925 126,601,309,616,907 409,737,504,521 263 660 0.888,0.882,0.895 0.886,0.898,0.904 -0.008 1 1 
TSS118920.1 172,714,011,540 630,616,144,785,878 167,015,191,808 559,287,263,684,980 202 721 0.089,0.075,0.06 0.096,0.069,0.071 -0.004 1 1 
TSS118920.2 630,616,144,785,878 172,714,011,540 559,287,263,684,980 167,015,191,808 721 202 0.911,0.925,0.94 0.904,0.931,0.929 0.004 1 1 
TSS118968.1 123,124,108 15,16,9 239,162,91 38,17,16 312 148 0.795,0.786,0.851 0.749,0.819,0.73 0.045 1 1 
TSS118968.2 15,16,9 123,124,108 38,17,16 239,162,91 148 312 0.205,0.214,0.149 0.251,0.181,0.27 -0.045 1 1 
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3.3.6.2 In-house bioinformatics pipeline to analyse differential TSS distribution:  
A custom-made bioinformatics pipeline was developed that combined different packages to analyse the differential 
distribution of TSSs within a region of interest in the 5’ UTR (Figure 3.15B). Our pipeline utilised the TSS data from 
the FANTOM CAGE database and mapped the TSSs within the gene’s 5’ UTR. An area of interest in the 5’ UTR was 
selected and the number of TSSs within that region were subsequently counted, normalised and the differences 
between different samples were calculated using linear modelling and the empirical Bayes approach. The details 
on the development of the bioinformatics pipeline, its technical aspects, and the results related to differential TSS 
distribution is presented in chapter 5. 
 
 
Figure 3.15: Relevance of the SEASTAR analysis in the current project. The SEASTAR examines alternative TSSs that 
in the form of alternative first exons and alternative tandem TSSs. The TSSs interrogated by the SEASTAR pipeline 
would likely change the ORF and are spread across a larger genomic region (A). The bioinformatics pipeline designed 
in the current PhD project evaluated TSSs within the area of interest that does not change the ORF and the distance 
among the alternative TSS is less than 100 bp (B). 
 
 
3.3.7 Nucleotide sequence around the TSS in PC and CML cell lines:  
The selection of TSS by the RNA Pol II is a complex process dictated by transcription factors, DNA sequence 
elements, ncRNA, and other epigenetic factors (Javahery et al., 1994, Jiang and Pugh, 2009, Kugel and Goodrich, 
2017, Pardee et al., 1998, Turowski and Tollervey, 2020). Studies have shown that about 50% of human core 
promoters contain an initiator (Inr) element that encompasses the TSS (Gershenzon and Ioshikhes, 2005, Yang et 
al., 2007). The consensus sequence flanking the TSS, as shown by mutagenesis studies, was found to be Y-Y-A(+1)-
N-W-Y-Y from −2 to +5 [where, Y = pyrimidine (C/T), W = (A/T), N = (A/C/G/T), and +1 is the TSS] (Kadonaga, 2012) 
and consensus of B-B-C-A(+1)-B-W for focused TSSs [where, B = (C/G/T), W = (A/T)] (Vo Ngoc et al., 2017). 
Conversely, the analysis of the FANTOM CAGE database has identified a considerably shorter mammalian initiator 
consensus with transcription starting preferentially with a purine at +1 and pyrimidine at -1 position: YR (+1) [where, 
R = Purine (A/G) and Y = pyrimidine (C/T)] (Carninci et al., 2006). The majority of AGAP2 TSS obtained by 5’ RLM-
RACE in the current project followed the YR consensus as reported by Carninci et al. (2006) for the FANTOM CAGE 
dataset (Figure 3.12B).          
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A study by Neininger et al. (2019) has demonstrated significant enrichment of SNPs (single nucleotide 
polymorphisms) and indels (insertion–deletion mutations) in the +/-200 bp area around the TSS. The authors have 
also assessed the SNP pattern in the direct vicinity (−15 to +12) of TSSs and found a significant SNP density peak at 
position -1 relative to TSS.  Mutations in the Inr sequence have shown to modulate the TSS usage and the 
transcriptional levels (Kugel and Goodrich, 2017, Vo Ngoc et al., 2017).  
In the current study, we analysed the 5’ UTR genomic sequence of AGAP2 in the PC and CML cell lines to detect any 
relative mutations (SNP and indels) in the vicinity of the TSSs that could explain differential TSS usage of AGAP2 in 
PC and CML cell lines. Genomic DNA from DU145 (PC) and KU812 (CML) was extracted and a +/-200 bp region 
around the annotated TSS was amplified using AGAP2 genomic forward and outer long AGAP2 reverse primer (Table 
2.4, Figure 3.16A). The amplified product was resolved on a gel and cloned for sequencing. The alignment of 
sequences displayed no differences in the sequences in the TSS region of PC and CML and ruled out the role of DNA 
sequence features in mediating differential TSS selection in these cell lines (Figure 3.16B). The genomic sequence 
corresponding to the AGAP2 5’ UTR region in PC and CML cell line was similar to the AGAP2 sequence in the RefSeq 
database (Appendix 2).   
However, other epigenetic factors such as CpG methylation, histone modifications, and chromatin organisation 
could also potentially influence TSS selection by modulating the accessibility of a particular TSS and the recruitment 
of trans-acting factors that shield or advocate a specific TSS. The role of these epigenetic factors has been 
extensively studied in regulating gene expression in physiological and pathological conditions including cancers 
(Cholewa-Waclaw et al., 2016, Kagohara et al., 2017). Moreover, different studies have highlighted their 
enrichment/activity in the region around the TSS (Ando et al., 2019, Luo et al., 2018), making them relevant as a 






Figure 3.16: Analysis of flanking DNA sequence around annotated TSS of PC and CML cell lines. (A) The genomic 
DNA was extracted using the DNeasy Blood & Tissue Kit (Qiagen) following the manufacturer’s guidelines. The +/- 
200 bp region around the annotated TSS was amplified using forward primer (AGAP2 genomic) and reverse primer 
(outer long reverse) (Table 2.4) and sequenced using Sanger sequencing. Figure not drawn to scale. (B) Multalin 




























3.4 Summary of findings (Chapter 3)   
In summary, the results presented in this chapter indicated a discrepancy in AGAP2 mRNA and protein levels 
primarily in PC and CML cell lines, also noted in other cell types, with higher mRNA expression and lower protein 
abundance found in the CML cell lines. The reduced AGAP2 protein yield observed in CML cell lines was not 
associated with protein degradation by UPP. No differences were also observed in the basal level of selected rate-
limiting translational initiation factors, limiting their relevance in mediating discordant mRNA and protein levels. 
This chapter also characterised the TSS usage for AGAP2 in PC and CML cell lines by 5’ RLM-RACE and demonstrated 
distinct patterns of TSSs distribution in both the cell group. The TSSs identified in our study were in agreement with 
the TSSs obtained by the highly sophisticated deep CAGE technology in the FANTOM database and highlighted the 
efficacy of the 5’ RLM-RACE technique in detecting genuine TSSs. Additionally, a SEASTAR computational pipeline 
to classify differentially distributed TSSs using RNA-seq data was described in this chapter, interrogating its 
applicability to the current study, and also emphasizing the gaps in the SEASTAR tool that forms the basis for 
developing our bioinformatic pipeline. Furthermore, the evidence in this chapter also ruled out any mutations in 




















4 Chapter 4:                       
Alternative transcription of 
G quadruplex structures 










4.1 Introduction  
In the previous chapter, we have discovered unique TSS distribution profiles in PC vs. CML cell lines. We also 
evidenced that the differential TSS selection in these cell groups produces heterogeneity in the 5’ UTR isoforms and 
add extra nucleotides in the 5’ UTR of AGAP2 mRNA in KU812 (CML cell line) due to the upstream TSS selection. 
The earlier TSS selection increases the length of 5’ UTR and could incorporate regulatory features that might affect 
the mRNA translation efficiency and could possibly explain the observed inconsistency in AGAP2 mRNA and protein 
expression (Figure 4.1). As indicated in chapter 3, we have noted an upstream TSS (-130 bp relative to ATG start 
codon) in the KU812 cell line that would transcribe 36 extra base pairs in the 5’ UTR relative to the major TSS. 
Interestingly, these extra nucleotides contained a G quadruplex (G4) forming sequence which is not present in the 
5’ UTR isoform derived from other downstream starting sites and also the major TSS (Figure 4.1). As pointed out in 
the earlier chapter, the TSSs examined in the current PhD project belong to the same TSS cluster and are within 50 
bp of each other. In this chapter, we have explored the significance of the G4 consensus sequence in the 
alternatively transcribed longer TSS isoform and its impact on mRNA translation.   
 
 
Figure 4.1: TSS selection and 5’ UTR heterogeneity. The TSS selection within the core promoter region generates 
diverse 5’ UTR isoforms with the length of the 5’ UTR depending on transcript starting position. The selection of 
earlier TSS increases the length of 5’ UTR and incorporate additional nucleotides that could have a regulatory role. 
In the previous chapter, we noted that the selection of earlier TSS selection encoded a G quadruplex forming 




G-quadruplexes are non-canonical, four-stranded, secondary structures which are formed by sequences rich in 
guanine nucleic acid (section 1.4). The consensus sequence capable of forming a G4 could be described as GX-N1-7-
GX-N1-7-GX-N1-7-GX, where x is 3–6 and N corresponds to any nucleotide (A, G, T, C, or U) (Reviewed in Fay et al., 
2017). However, the existence of imperfect G4s that do not follow the canonical consensus sequence has been also 
reported (Reviewed in Puig Lombardi and Londoño-Vallejo, 2020). The G4 motifs are often enriched in the 5’ UTR 
of mRNA, suggesting an important role in regulating mRNA translation (Huppert et al., 2008). Numerous studies 
have highlighted the association of G4 structures in the 5’ UTR with translational suppression (Arora et al., 2008, 
Reviewed in Beaudoin and Perreault, 2010). However, in some instances, an activating role for G4 has also been 
noted (Agarwala et al., 2013).  
The effect of G4 motifs on mRNA translation is complex and depends on the location of G4 structures, G4-binding 
proteins, and G4-resolving helicases. A study by Kumari et al. (2008) has reported that the G4 motif significantly 
represses translation when they are located within the first 50 bp of the mRNA 5’ UTR. The steric effects of these 
motifs likely interfere with serial translation processes including the formation of PIC, scanning, and elongation 
(Reviewed in Bugaut and Balasubramanian, 2012). Moreover, the formation of G4s by the 5΄ UTR (CGG)n repeat 
has been implicated in reduced polysome formation and stalled ribosomes on FMR1 mRNA, resulting in decreased 
translational efficiency (Feng et al., 1995, Primerano et al., 2002). Furthermore, a range of proteins interacts with 
the G4 structure through specialised RNA recognition motifs, facilitating the formation of specialised eIF4A-
dependent translational processes (Masuzawa and Oyoshi, 2020, Wolfe et al., 2014). In spite of a body of literature 
on G4 and its translational effects, little is known about the significance and consequences of alternatively 
transcribed G4 motifs by TSS selection within a single cluster.  
The formation of G4 structures has been extensively studied in vitro using circular dichroism (CD) spectroscopy. 
These G4s exhibit unique CD spectral signatures depending on G4 particular topology (Reviewed in Del Villar-Guerra 
et al., 2018). Previously, we employed CD spectroscopy to analyse the formation of G4 by the extra nucleotides 
encoded in the longer 5’ UTR of AGAP2 mRNA (Doush, 2015). We showed that the longer UTR extra sequence folds 
into a parallel G quadruplex in vitro (Figure 4.2A) and the characteristic CD spectrum disappeared by mutating the 






Figure 4.2: CD spectroscopy of G4 forming sequence in the longer 5’ UTR of AGAP2 mRNA (Doush, 2015). (A) The 
Circular dichroism (CD) experiments were performed on 10 µM of RNA oligos in Tris–HCl (pH 7.5) buffer containing 
either 100 mM of NaCl or KCl or no salts. The measurements were performed using a JASCO J-715 
Spectropolarimeter (JASCO). Quartz cell cuvettes of 0.1 cm path length were used, and wavelengths were recorded 
between 220 - 320 nm at a scan speed of 50 nm/min with a response time of 2 sec. All CD spectra were generated 
at 25°C. (A) The CD spectra RNA oligo of extra nucleotides in the longer AGAP2 mRNA 5’ UTR folded in presence of 
100 mM NaCl, 100 mM KCl, or no salts. The characteristics formation of parallel G4 is noted, exhibiting a positive 
peak at ~260 nm and a negative peak at ~240nm in the presence of salts. (B) Loss of the characteristic G4 formation 
in RNA oligo with mutations (GA). The sequences of RNA oligos are presented below the CD spectra with the 
mutations shown in RED.  Note: The experiment for CD spectroscopy was performed by Dr Christoph Ufer from 
Charité University, Berlin. 
 
 
Despite the possibility of determining the formation of G4 structures in vitro, the techniques to demonstrate their 
formation inside the cell are still under development. Different approaches have been used to detect the RNA G4 
structures inside the cell including the use of G4-stabilising ligands/ions (Biffi et al., 2014, Kwok et al., 2016), small 
molecule probes (Yang et al., 2018), RNA structural mapping (Guo and Bartel, 2016), reverse transcription stalling 
(Kwok and Balasubramanian, 2015), RNA G4-protein interactions (Herdy et al., 2018), ligands with fluorescence 
activity (Chen et al., 2018), self-biotinylation methodology (Einarson and Sen, 2017), and G4-structure specific 
antibody (Biffi et al., 2013). However, most of the methodologies described above used specific ligands and/or 
reactive small molecules that could shift the equilibrium in the favour of G quadruplex formation and might not be 
representative of actual RNA G4 conformations in the living cells. Further studies are required to explore novel 
techniques to capture these motifs in their native state which would provide direct evidence linking functional 





4.1.1 Aims of chapter 4: 
The upstream AGAP2 TSS selected in KU812 (CML cell line) produces a longer mRNA 5’ UTR containing the G4 
sequences. Our previous CD spectroscopy experiment confirmed the additional nucleotides incorporated in the 
longer 5’ UTR formed a G4 in vitro. This G4 motif could potentially contribute to the discordant mRNA and protein 
expression profile observed in the CML cell group by affecting the mRNA translation efficiency.  
This chapter aims to: 
• Validate the in cellula formation of the G4 structure in the longer 5’ UTR isoforms of AGAP2 mRNA using an 
in-house developed immunoprecipitation technique.  
• Study the relative presence of G4-containing 5’ UTR isoforms in PC and CML cell lines. 





















4.2 Method Development (G4-RNA-Immunoprecipitation) 
Currently, most studies analysing the G4-containing mRNA population within a cellular system utilise 
transcriptome-wide sequencing approaches based on either reverse transcriptase stalling or the use of small 
molecules (Reviewed in Kamura et al., 2020, Yang et al., 2018). However, the ligands and/or small molecules used 
in these techniques could induce the formation of G4 structures and might not be representative of actual RNA G 
quadruplex folding in the living cells. As part of the current PhD project, we have developed an in-house 
immunoprecipitation technique termed GRIP (G4-RNA-Immunoprecipitation) to selectively enrich and pulldown 
RNA containing G quadruplex structures that could be quantitively analysed by real-time PCR. Compared to the 
current approaches, our technique is capable to capture these structures in their native states and selectively enrich 
mRNA containing them. 
4.2.1 Principle: 
This protocol is used to enrich RNA with G4 structure using a structure-specific antibody. The antibody (BG4) was 
generated by Biffi et al. (2013) to selectively bind DNA G4. The antibody was selected from the Sanger phage display 
library using a panel of intramolecular DNA G quadruplex structures (Biffi et al., 2013). The BG4 antibody was also 
used by the same group to visualise the RNA with G4 motifs (Biffi et al., 2014). To achieve this, the authors 
selectively stabilised RNA G4 using a ligand (carboxypyridostatin) and then fixed the cells using formaldehyde 
followed by detection with the BG4 antibody and a secondary fluorescently tagged antibody against the BG4 to 
detect the RNA G4. However, the use of a stabilising ligand in the study could influence RNA structure, metabolism, 
and impact native G quadruplex conformations. The stabilising small-molecule ligand (BioTASQ) has been also 
shown to prefer specific RNA topology (Yang et al., 2018). Moreover, BG4 antibody binds with stronger affinity to 
DNA G4 (Kd: 1.1-2.0 nM) compared to RNA G4 (Kd 5.5-18.0 nM) (Biffi et al., 2014, Biffi et al., 2013) and, therefore, 
would require an optimised method to facilitate their use to detect only RNA G4 within the cellular environment.     
To overcome these limitations and to exploit the potential of the BG4 antibody to selectively bind RNA G4 structure, 
a method was designed to enrich the cytosolic RNA, remove contaminating genomic DNA, and capture the G4 
structure in the mRNA in their native conformation without the use of a fixative or stabilising ligand. To specifically 
isolate cytosolic RNA, cells were permeabilised with the weak non-ionic detergent ‘digitonin’ which at lower 
concentration selectively permeabilises the plasma membrane, leaving the nuclear envelope and other major 
membrane-bound organelles intact (Adam et al., 1990). The preferential permeabilization of the plasma membrane 
is due to its higher cholesterol content which forms complexes with digitonin, creating pores in the membrane 
(Schulz, 1990, Colbeau et al., 1971).  
The cytosolic RNA is extracted in a buffer containing K+ ions at a concentration similar to intracellular K+ levels (150 
mM). These potassium ions are required for stabilising G4 structures (Wang and Liu, 2017), enabling their detection 
with the structure-specific BG4 antibody. To specifically promote the detection of RNA G4, the protocol 
incorporates a DNase treatment step to remove any contaminating genomic DNA. Moreover, the method 
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integrates steps to decrease non-specific background signals by repeated washing and releasing the bound RNA 
from the antibody-beads complex by incubating at a higher temperature which unfolds these structures.   
4.2.2 Protocol: 
In the GRIP protocol, the longer G4-containing 5’ UTR isoforms of AGAP2 mRNA were pull down using the TCCS 
cell line. The TCCS cell line were specifically selected as it exhibited higher levels of G4-containing longer AGAP2 5’ 
UTR isoform compared to other CML cell lines used in the study (Figure 3.13B, 3.13C).  
The GRIP was performed with a structure-specific G quadruplex (BG4) antibody (Absolute Antibody). TCCS cells (15 
X 106) were collected, washed with ice-cold PBS, and resuspended in ice-cold lysis buffer (150 mM KCL, 50 mM 
HEPES, 25 µg/mL Digitonin, 100 U/mL RNase inhibitor). The cells were incubated with lysis buffer for 10 minutes at 
4°C using end over end rotation and centrifuged at 2,000 x g for 5 minutes at 4°C. The supernatant (cytosolic 
fraction) was saved and 10 % was removed to be used as input control. When transfections were required, 1 x 106 
DU145 cells were seeded in a 100 mm dish, transfected using JetPRIME transfection reagent (Polyplus), trypsinised 
after 48 hours, and processed as above.  
The lysate was precleared by incubating with 100 µL protein G magnetic beads for 1 hour at 4°C in an end over end 
rotator to remove non-specific binding to the empty beads. The protein G magnetic beads were prepared for pre-
clearing and antibody binding by thoroughly washing the beads thrice with PBS-T. In case of antibody binding, the 
beads were incubated with either 3 µg of BG4 antibody or an equivalent isotype-matched negative antibody 
control. The negative antibody is an isotype-matched antibody from the same species that maintain the similar 
property to the primary (target) antibody but lacks specific target binding and is used to measure the level of non-
specific background signals. The precleared lysate was incubated overnight with BG4/control antibody bound to 
protein G magnetic beads (Biorad). After incubation, the beads were magnetised, washed thrice with the lysis 
buffer, and incubated at 65°C for 15 minutes to release the bound nucleic acids. The eluent was treated with 2U of 
RNase-free DNase I (ThermoFisher) for 15 minutes at 37°C to remove contaminating DNA. The RNAs from input and 
IP fractions were then isolated through TRIzol (ThermoFisher) extraction followed by isopropanol precipitation.  
For RNA extraction, 1 mL or 500 µL TRIzol reagent was added to the DNase treated sample or the input controls, 
respectively, followed by the addition of 200 µL of chloroform per 1 mL of TRIzol. The tubes were shaken vigorously 
for 15 seconds, incubated at room temperature for 5 minutes, and subsequently centrifuged at 12,000 x g for 15 
minutes at 4°C to separate the solution into 3 layers: clear aqueous layer containing RNA, middle interphase layer 
containing mostly the DNA and lower pink organic phase containing protein. The top aqueous phase (60% of the 
volume of TRIZOL Reagent used) was removed and 20 µg glycogen and 500 µL of 100% room temperature 
isopropanol per 1 mL TRIzol reagent was added to the aqueous phase. The mixture was then incubated at room 
temperature for 10-15 minutes followed by centrifugation at 12,000 x g for 30 minutes at 4°C to precipitate the 
RNA. The RNA pellet was washed by 1 mL 75% ice-cold ethanol per 1 mL TRIzol reagent and centrifuged twice at 
7,500 x g for 5 minutes at 4°C to remove ethanol. The washed pellet was air-dried for 2-3 minutes at room 
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temperature and resuspend in 15 µL of nuclease-free water. The RNA was then converted to cDNA (section 2.2.2.2) 
and amplified using qRT-PCR (section 2.2.2.3). 





Figure 4.3: Schematics of GRIP protocol. Overview of G quadruplex RNA immunoprecipitation (GRIP). The cells are 
treated with 25 µg/mL digitonin, and the extracted cytoplasmic fraction is precleared and incubated overnight with 
structure-specific G quadruplex (BG4) antibody bound to protein G magnetic beads. After incubation, the complex 
is washed, and the bound RNA is eluted by unfolding the G4 by heating at 65 °C for 15 minutes. The eluent is treated 
with DNase I treatment followed by qRT-PCR. The time required for each step is shown in (parenthesis). 
 
 
4.2.3 Optimisation of GRIP method: 
The rationale for including different steps along with optimisation of a key step is presented below: 
4.2.3.1 Optimisation of digitonin concentration: 
The final concentration of digitonin in the GRIP lysis buffer needs to be optimised for different cell types. The lowest 
concentration of digitonin yielding satisfactory levels of mRNA of interest and lower levels of genomic 
contamination should be selected. For TCCS, different concentrations (25 µg/mL, 50 µg/mL, and 100 µg/mL) were 
tested relative to lysis buffer without digitonin (0 µg/mL). The levels of AGAP2 mRNA were detected using AGAP2 
forward and reverse primers (Table 2.4). The genomic contamination was analysed using primers designed to 
amplify the promoter region using AGAP2 genomic (-425) forward and AGAP2 genomic (-218) primers (Table 2.4) 
(Figure 4.4A). The results indicated that 25 µg/mL digitonin concentration yield sufficient mRNA levels with the 
lowest genomic contamination and was selected as the final concentration of digitonin in the GRIP lysis buffer 





Figure 4.4: Optimisation of digitonin concentration. (A) Primer designing consideration for the target mRNA 
(AGAP2) and genomic DNA. Figure not drawn to scale. (B) TCCS cells were lysed with GRIP lysis buffer containing 
varying concentration of digitonin (x-axis). After lysis and extraction of cytosolic fraction, the RNA was isolated, and 
the expression was analysed using qRT-PCR. The expression level of the AGAP2 mRNA and genomic DNA (primer 
amplifying the promoter region) were normalised using housekeeping gene HPRT and presented relative to 0 
µg/mL. The data shown are the mean ± SD of two independent experiments (n=2).   
 
 
4.2.3.2 Rationale for including preclearing and DNase treatment step: 
The preclearing step was included to decrease the background associated with non-specific binding of RNA to the 
beads. To examine the relevance of preclearing, GRIP was performed for a positive control mRNA (NRAS) with or 
without the preclearing step. The formation of the G4 motif in the 5’ UTR of NRAS mRNA has been already 
established in the literature (Kumari et al., 2007). The enrichment was evaluated relative to the negative isotype 
antibody control. As shown in Figure 4.5A, the GRIP without the preclearing step showed lower differences in the 
NRAS enrichment between BG4 and negative antibody compared to the GRIP with the preclearing step. It could be 
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attributed to the increase in the background signals in GRIP without the preclearing step owing to nonspecific RNA 
binding to the beads. 
The DNase treatment step was added to prevent amplification of signals resulting from the binding of BG4 antibody 
to G4 motifs in the DNA. The G4 consensus in the non-template (+) DNA strand could also theoretically form a G4 
structure if the DNA is in single-stranded conformation. Since the BG4 antibody binds with a stronger affinity to the 
DNA compared to RNA G4 (Biffi et al., 2014, Biffi et al., 2013), the detection of G4 motifs in the target of interest 
could be amplified from both the mRNA and DNA. To avoid this bias, a DNase step was performed to remove any 
contaminating genomic DNA. The relevance of incorporating the DNase treatment is depicted in Figure 4.5B. As 
shown in the figure, the GRIP performed without the DNase treatment showed a significantly higher amplification 
of the genomic DNA compared to the GRIP with DNase added (P < 0.01) (Figure 4.5B). Alternatively, a negative RT 
control could be also used to highlight the genomic contamination of the GRIP eluent.   
     
 
Figure 4.5: Relevance of the preclearing and DNase treatment steps in the GRIP method. (A) The levels of NRAS 
mRNA after GRIP enrichment with or without the preclearing step. The levels are normalised by the input control 
and presented relative to the negative control antibody. A lower difference between the BG4 and negative antibody 
enrichment is noted compared to the GRIP with the preclearing step (n=1). (B) Levels of AGAP2 genomic region in 
the eluant after BG4 enrichment. The -DNase samples are processed identically except for the DNase treatment 
step. The levels are normalised by the input control and presented relative to -DNase condition. The data shown 
are the mean ± SD of two independent experiments (n=2) and differences are analysed by unpaired t-test [t(2) = 


















4.3 Results and Discussion 
4.3.1 Demonstration of G4 formation inside the cell using GRIP method: 
We used our GRIP method to pulldown G4 structures in the AGAP2 mRNA. Briefly, the CML TCCS cells were lysed 
using digitonin treatment to isolate the cytoplasmic cellular fraction which was precleared and incubated with BG4 
or negative isotype control antibody followed by washing, elution, DNase treatment, and amplified using qRT-PCR 
(Figure 4.6A). Employing GRIP, we noted a significant enrichment of AGAP2 in the BG4 antibody fraction relative to 
the negative isotype control (P < 0.001) (Figure 4.6B). Significant enrichment was also noted for NRAS (P < 0.01) and 
MM16 (P < 0.001) (Figure 4.6B). The formation of the G4 motif in NRAS and MM16 has already been established in 
the literature and were used as a positive control in the GRIP experiment (Kumari et al., 2007, Morris and Basu, 
2009). The TBP was used as a negative control since it lacks a G4 consensus sequence in its entire mRNA as 
determined computationally using the pqsfinder web application (Labudová et al., 2019). No statistically significant 
differences were noted for TBP (P = 0.419), confirming the specificity of our technique to pulldown only mRNA 
containing-G4.  
   
 
Figure 4.6: In cellula formation of G4 motif in AGAP2 mRNA using GRIP. (A) A brief overview of the GRIP method. 
(B) GRIP performed in the TCCS and the immunoprecipitated samples were normalised by their input controls. 
NRAS and MM16 mRNAs were used as a positive control for the presence of G4 structures, as documented in the 
literature. TBP mRNA (NM_003194.5) was used as a negative control as it lacks G4 consensus sequences in its full-
length mRNA. Data shown correspond to three independent immunoprecipitations (n=3) and the error bars denote 
standard deviation. Differences between samples were analysed with unpaired t-test, P-values shown (***P < 
0.001, **P < 0.01, ns: not significant). 
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However, AGAP2 mRNA contains several putative G4 forming sequences along its entire length (Figure 4.7A). The 
analysis of AGAP2 transcript (NM_014770.4) using the pqsfinder web application (https://pqsfinder.fi.muni.cz/) 
(Labudová et al., 2019) exhibited 14 G4 consensuses in the AGAP2 mRNA transcript. To specifically detect the G4 
formation in the longer 5’ UTR of AGAP2 mRNA, we transfected either an empty vector or a plasmid vector 
containing the longer 5’ UTR (Table 2.8) cloned proximal to Renilla luciferase (2.2.6.1). The presence of G4 
consensus in the Renilla luciferase mRNA was ruled out using the pqsfinder package that showed no putative G4 
sequences in either sense or antisense strand. The results showed significant enrichment of Renilla luciferase mRNA 
in the lysate of cells transfected with the cloned 5’ UTR compared to the empty vector, or the pull down performed 
with the negative isotype control (P = 0.0117), indicating the formation of G4 in the longer 5’ UTR of AGAP2 mRNA 
(Figure 4.7B). The shorter UTR cloned to the Renilla luciferase mRNA was not used as a control because the shorter 
UTR also contained a putative G4 consensus (Figure 4.7A) that is present in both the longer and shorter 5’ UTR 
isoforms and could be potentially enriched following GRIP. Instead, empty luciferase mRNA that did not have any 





Figure 4.7: Enrichment of G4 motif in the 5’ UTR of AGAP2 mRNA using GRIP. (A) Image derived from the pqsfinder 
browser (https://pqsfinder.fi.muni.cz/) showing the position of 13 G4 consensus sequences along the entire length 
of AGAP2 mRNA transcript. The G4 forming sequences are depicted by pink box and displayed according to their 
sequence positions in AGAP2 mRNA transcript, the width of the box indicates the length of the G4 consensus. (B) 
GRIP performed in DU145 cells transfected with either an empty vector (No 5’ UTR) or the same vector with AGAP2 
longer 5’ UTR in front of the Renilla luciferase gene. The levels of Renilla mRNA in the immunoprecipitated samples 
are normalised by their input controls. A nonspecific isotype antibody (IgG) was used as a negative control. 
Differences between samples were analysed by unpaired two-tailed t-tests, P-values shown. All the data shown 
correspond to three independent immunoprecipitations (n=3) and the error bars denote standard deviation. 
(*P < 0.05; ns: not significant). 
 
 
The results highlighted the effectiveness of our GRIP technique to pulldown mRNAs with G4 motifs and also 
confirmed the formation of a G4 structure in the 5’ UTR of AGAP2 mRNA. Recently, Maltby et al. (2020) attempted 
RNA immunoprecipitation using the BG4 antibody and demonstrated enrichment of G4 motifs in the 5’ UTR of 
Task3 mRNA. The authors used a sonicated homogenate for immunoprecipitation and the RNA was incubated at a 
higher temperature (70°C) for a longer duration (1 hour) to elute the bound nucleic acid. However, these steps 
(homogenisation and longer incubation at high temperature) could enhance the detection of DNA G4 instead of 
RNA G4. To address these caveats and successfully immunoprecipitate G4 in RNA only, our GRIP method employed 
digitonin to selectively enrich cytosolic RNA and utilised RNase-free DNase I to degrade any trace amount of 
genomic DNA. We also adopted a unique elution and RNA precipitation strategy that would facilitate selective 
detection of G4-containing RNA.  
Despite the effectiveness of our GRIP method to successfully enrich G4-containing mRNA population, the dynamic 
of G4 formation and its folding and unfolding patterns are still a matter of debate. The formation of intracellular 
G4 structures is dependent on different factors including binding of RBP, levels of helicases, and ion concentrations 
(Reviewed in Cammas and Millevoi, 2017). The complex interplay between these factors determines the formation 
of the RNA G4 motif inside the cell. A study by Guo and Bartel (2016) using complementary approaches (Dimethyl 
sulphate treatment and selective 2′-hydroxyl acylation analysed by primer extension) revealed that a large number 
of predicted RNA G4 are overwhelmingly unfolded in the cells. Moreover, a study by Chen et al. (2018) reported 
that a rapid dynamic transition occurs between folding and unfolding states for some RNA G4s. The transient nature 
of RNA G4 folding is also exhibited by Yang et al. (2018), who used crosslinking in their study to capture these 
structures. Taking these findings together, the RNA G4 exist in an equilibrium between transiently folded and 
unfolded state and are influenced by a variety of competing factors. Unlike other studies that use formaldehyde 
and G4 stabilising ligands to ‘fix’ these structures (Yang et al., 2020, Yang et al., 2018), our GRIP method captures 
these structures in their native state. Our GRIP method has proven to be an effective technique to enrich mRNA 




4.3.2 Translational consequences of 5’ UTR G4 motif in AGAP2: 
5’ UTR G4 structures have been previously shown to suppress mRNA translation in most cases by disrupting key 
processes including the formation of PIC and ribosome scanning and translocation (Bugaut and Balasubramanian, 
2012, Beaudoin and Perreault, 2010). In our study, we utilised two different approaches to examine the translation 
consequences: dual-luciferase reporter assays and polysome profiling. These distinct techniques would facilitate a 
broader understanding of the impact of 5’ UTR G4 on mRNA translation efficiency and output.   
4.3.2.1 Reporter assay to evaluate the impact on translational output mediated by 5’ UTR G4: 
The effects of 5’ UTR G4 structures on mRNA translation were evaluated using a dual-luciferase reporter assay with 
a bicistronic plasmid. The plasmid expresses Renilla and Firefly luciferase reporter with the translation of Renilla 
cistron mediated by an upstream cloned fragment. The Firefly cistron undergoes cap-independent translation 
through the poliovirus IRES and serves as an internal control. We generated dual-luciferase reporter constructs 
comprising either shorter 5’ UTR without G quadruplex forming sequences (as noted in PC cell lines), longer 5’ UTR 
containing G quadruplex forming sequences (observed in CML cell lines) and mutated longer 5’ UTR with mutations 
in G quadruplex consensus (section 2.2.6.1; Table 2.8; Figure 2.4A, 2.4B). These 5’ UTR variants were fused to Renilla 
luciferase ORF. Since only one unique restriction site (NheI) was used in the plasmid to insert the fragment proximal 
to the Renilla luciferase, several attempts were made to correctly insert the fragment into the reporter vector. The 





Figure 4.8: Alignment of sequenced clones to verify insertion of 5’ UTR fragment. The 5’ UTR fragments (Table 
2.8) were inserted at the unique NheI restriction site (section 2.2.6.1). The constructs were transformed into DH5α 
competent cells, cultured in selecting LB medium, and positive clones were sequenced using Sanger sequencing. 
The alignment of sequenced clones shows correct insertion of shorter 5’ UTR (A), longer 5’ UTR (B), and mutated 
longer 5’ UTR fragment (C). The (G A) mutations in the mutated longer 5’ UTR is highlighted using a black box.    
 
 
These inserted fragments influence the translation of Renilla luciferase mRNA. The impact on the mRNA translation 
was examined by measuring the levels of Renilla luciferase protein using the DLR assay, which estimate the levels 
of protein by analysing the luciferase enzymatic activity (section 2.2.6.3). Using the in vitro transcription and 
translation system, we observed that the longer 5’ UTR isoform containing the G4 forming sequence induced a 
significant decrease in the normalised reporter activity relative to the shorter 5’ UTR. This effect was reversed by 
mutating the G quadruplex consensus that prevented the formation of these secondary structures (Figure 4.9A). 
We also transfected these reporter constructs into DU145 (PC) and KU812 (CML) cell lines and observed similar 
shifts in relative reporter activity (Figure 4.9B, 4.9C). Together, these results suggested that the G4-containing 
longer 5’ UTR decreases the translation potential of mRNA which could be rescued by mutating the G4 consensus. 
  
 
Figure 4.9: Impact of 5’ UTR G4 on the translational output using the dual-luciferase reporter assay. (A) The dual-
luciferase reporter activity of the reporter constructs using the in vitro transcription and translation system. The 
graph is the mean +/- SD of 4 independent experiments (n =4) and expressed as relative Rluc/Fluc ratio. Differences 
were analysed using a Kruskal-Wallis [H (2) = 47.13, P =< 0.001] followed by uncorrected Dunn’s test, P-values 
shown. (B) Reporter activity after transfecting the plasmids in DU145 (PC cell line) using JetPRIME transfection 
reagent (section 2.2.6.2.1) and analysing the luciferase activity 48 hours post-transfection. The graph represents 
the mean of 3 independent experiments (n=3) and expressed as relative Rluc/Fluc ratio. Differences were analysed 
using a Kruskal-Wallis [H (2) = 23.79, P =< 0.001] followed by uncorrected Dunn’s test, P-values shown. (C) Reporter 
activity measured in KU812 (CML cell line) after 6 hours of electroporation (section 2.2.6.2.2). The graph represents 
the mean of 3 independent experiments (n=3) and is expressed as relative Rluc/Fluc ratio. Differences were 
analysed using a Kruskal-Wallis [H (2) = 40.49, P =< 0.001] followed by uncorrected Dunn’s test, P-values shown. 
(*P < 0.05; **P < 0.01; ***P < 0.001; ns: not significant). The Firefly luciferase was used as an internal control. The 
Rluc/Fluc ratio of the shorter 5’ UTR for in vitro transcription and translation assay (A) and for the transfected cells 
in (B) and (C) were 18.84, 2.01 and 3.27, respectively, and this was equalled to 100). 
 
 
Our reporter assay results from the in vitro transcription and translation system showed about ~ 45% decrease in 
the relative luciferase activity compared to shorter 5’ UTR due to the presence of G4 motif in the longer AGAP2 5’ 
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UTR isoform. Other studies evaluating the effect of 5’ UTR G4 on the luciferase activity using the cell-free system 
reported ~70% decrease for NRAS (Kumari et al., 2007) and ADAM10 (Lammich et al., 2011), and ~85% for ERS1 
(Balkwill et al., 2009). In our study, the transfection of the reporter constructs into DU145 and KU812 cell lines 
exhibited ~35% and ~21% decrease, respectively. Other comparable studies reported ~80% decrease for ZIC1 (Arora 
et al., 2008), ~55% for MMP16 (Morris and Basu, 2009), ~45% for EBAG9 (Beaudoin and Perreault, 2010), ~50% for 
BCL-2 (Shahid et al., 2010), ~60% for FZD2 (Beaudoin and Perreault, 2010), ~70% for TRF2 (Gomez et al., 2010), and 
~35% for NCAM2 and THRA (Beaudoin and Perreault, 2010). The studies cited above used different cell lines for the 
transfection of reporter constructs. The HELA cells were used by Arora et al. (2008) and Morris and Basu (2009). 
The HEK 293 cells were used by Beaudoin and Perreault (2010) and Gomez et al. (2010). All the studies cited above 
used a chemical-based transfection method (Lipofectamine). In our study, we used PC cell line (DU145) and CML 
cell line (KU812) for transfection using chemical method and electroporation, respectively.   
We also noted a significant increase in the relative luciferase level of the mutated longer 5’ UTR compared to the 
shorter 5’ UTR isoform in the cell-free system and after transfecting the plasmids into the KU812 cell line (Figure 
4.9A, 4.9C). The increase in the relative translation could result from certain sequence features that are introduced 
while mutating the runs of guanine to destroy the G4 consensus and requires further evaluation. Nonetheless, our 
reporter experiments underlined the relevance of the AGAP2 5’ UTR G4 motif in suppressing translation. In contrast 
to other studies above which examined the 5’ UTR G4 in different gene transcripts, our study emphasised the 
relevance of the G4 motif in alternatively transcribed 5’ UTR isoforms that are less than 50 bp apart and uncovered 
this novel layer of gene expression regulation.  
In our reporter experiments, we noted that the impact of 5’ UTR G4 was less profound in KU812 (~21% decrease) 
compared to DU145 (~35% decrease), even though, the patterns of relative luciferase activity were similar. This 
could be explained by the differences in the method of transfection (see Appendix 3). Due to the differences in the 
transfection method (chemical-based method vs. electroporation), the post-transfection timings for the collection 
of the cells were selected accordingly. For cells transfected using electroporation, an earlier timepoint was selected 
as the electro-permeabilization of the membrane results in the direct and rapid transfer of the foreign DNA and 
hence the earlier expression compared to chemical-based methods (Kim and Eberwine, 2010).    
4.3.2.2 Polysome association profile of longer and shorter 5’ UTR isoforms: 
The polysome profiling provides valuable information about the translational status of specific mRNA by 
determining the ribosome density on the given mRNA (Chassé et al., 2016). The polysome loading and occupancy 
have been frequently used as a proxy for translational efficiency in the literature and have been previously used to 
examine the effects of different mRNA structural features including G4s on protein translation (Faye et al., 2013, 
Murat et al., 2018, Thandapani et al., 2015). A variety of studies have also used polysome profiling to study the 
translational potential of TSS isoforms derived from alternative promoters (Li et al., 2019, Wang et al., 2016). In our 
study, we performed polysome profiling to evaluate the association of poly-ribosome with mRNA transcripts having 
shorter or longer versions of the 5’ UTR. For the purpose of this experiment, the 5’ UTR isoform containing the full 
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G4 consensus sequence were classified as longer 5’ UTR whereas the remaining others that do not contain any part 
of the consensus were grouped as shorter 5’ UTR isoforms. 
The longer and shorter AGAP2 5’ UTR isoforms were detected using the nested PCR amplification (Figure 4.10A) 
and normalised using luciferase RNA spike to control for differences in recovery. The PCR data were processed as 
described in section 2.2.8.2.4. A representative example of calculation for longer and shorter AGAP2 5’ UTRs in 
different fractions of TCCS cell line is displayed in Figure 4.10B. 
 
 
Figure 4.10: Primer designing and representative analysis of polysome profiling data. (A) Primers for nested PCR 
amplification to detect longer and shorter AGAP2 5’ UTR isoform. For longer 5’ UTR, the first PCR was performed 
using outer long AGAP2 primers. The PCR product was diluted 50 folds and amplified again using inner long primers. 
To amplify shorter 5’ UTR, the PCR was carried out with outer short primers and the diluted PCR product was 
reamplified using AGAP2 primers. The sequences of the primers are listed in Table 2.4. The figure shows the first 
373 nucleotides of AGAP2 mRNA transcribed from the furthest upstream TSS annotated in the FANTOM database. 
The coding sequence is presented in UPPERCASE (with ATG marked in bold) and the 5’ UTR is presented in 
lowercase. Primer sequences are shown by respective coloured box and the inner short forward primer in the 
overlapped region is shown by underline. (B) Example calculation for polysome profiling data of TCCS (replicate 1) 
using qRT-PCR with luciferase (luc) spike in. The calculations are shown for longer and shorter UTR isoforms 
amplified using nested PCR in (A). The values of proportions were used to plot the graphs.  
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Interestingly, we noted a decreased polysome association of AGAP2 mRNA with the longer 5’ UTR compared to 
shorter 5’ UTRs (Figure 4.11C, 4.11D). The polysome profiling was performed with two CML cell lines (KU812 and 
TCCS) in which the higher relative levels of longer 5’ UTR have been established (Figure 3.13B, 3.13C). As evident in 
Figure 4.11C and 4.11D, the longer UTR was primarily enriched in the non-polysomal ribonucleoprotein (RNP) 
fraction (Fraction 1-3). On the other hand, the shorter UTR was mainly enriched in the polysome fraction (6-10). 
We also did not observe any changes in the global RNA polysome profiles in these cell lines (Figure 4.11A, 4.11B). 
By pooling the data of non-polysomal (fraction 1-5) and polysomal (fraction 6-10) from both the cell lines, we noted 
significantly increased levels of longer 5’ UTR in the non-polysomal fraction compared to mRNA with a shorter 5’ 
UTR length (P < 0.001) (Figure 4.11E). It implies inefficient translation of mRNA population with longer 5’ UTRs. The 
polysomal profiling was not performed in the PC cell lines because the primary objective of the experiment was to 
compare polysome association between the longer vs. shorter 5’ UTR isoforms; since the levels of longer 5’ UTR 
were very low in PC cell lines, these were not ideal for comparing longer and shorter 5’ UTR isoforms levels.   
However, the primers designed for the polysomal profiling experiment could specifically amplify the longer 5’ UTR 
isoforms only. The sequences amplified in the shorter 5’ UTR isoforms are also shared by the longer version (Figure 
4.10A). Therefore, the nested PCR for the shorter isoforms would in effect amplify the entire 5’ UTR population 
including the longer isoforms. Since most of the shorter transcript isoforms are derived from the annotated major 
TSS that does not contain the G4 consensus (Figure 3.12B), the amplified product would mostly contain the 
transcripts generated from the major TSS and would have lower levels of longer transcript variants. This would not 
affect the interpretation of our results as the primers for the shorter UTR would amplify products representative of 
the major TSS. Even excluding shorter UTR isoforms from the analysis, the result of the polysome fractionation 
would still remain valid, i.e., the longer version of the transcript poorly associated with polysome and are enriched 





Figure 4.11: Polysome association of longer and shorter 5’ UTR isoforms of AGAP2 mRNA. Lysates for polysome 
profiling were prepared from KU812 and TCCS (CML cell lines) and fractionated through a sucrose gradient. The 
profiles were monitored by measuring the absorbance at 254 nm (A254nm). The representative polysome profiles are 
shown for KU812 (A) and TCCS (B). The relative distribution of AGAP2 mRNA with longer and shorter 5’ UTR are 
shown in polysome fractions 1-10 of KU812 (C) and TCCS (D). The RNA distribution is presented as the fraction of 
the total RNA recovered. The mRNA levels were normalised to the exogenous spike-in luciferase control mRNA. The 
graphs above represent the means ± SEM of 2 independent experiments (n=2). (E) Relative levels of AGAP2 mRNA 
with longer and shorter 5’ UTR in non-polysomal (Fraction 1 – 5) and polysomal (Fraction 6 –10) segments pooled 
from both the cell lines. The data represent the means ± SD of the fraction of the total RNA recovered and P-values 
were calculated by an unpaired students t-test, ***P < 0.001. Note: the polysome profiles [A, B] were generated 




Other studies in the literature have also pointed out the poor translational efficiency of the longer 5’ UTR (Arrick et 
al., 1991, Davuluri et al., 2000, Sobczak and Krzyzosiak, 2002, Wang et al., 2016).  A study by Wang et al. (2016) has 
conducted a systematic analysis of isoform-specific translation and have identified different cis-regulatory features 
in the longer 5’ UTR that contributed to poor translation capability. The authors also conducted a non-linear 
regression modelling, integrating a variety of regulatory 5’ UTR features which together explain 57% of the variance 
in the observed translation efficiency differences between TSS isoforms. The two single best predictors of 
translation efficiency differences, as identified by the authors, were uORFs and 5’ UTR length. The authors did not 
analyse the contribution of 5’ UTR G4 motifs which could account for some of the remaining unexplained variations. 
An earlier study by Rojas-Duran and Gilbert (2012) has also demonstrated large differences in the translational 
efficiency for mRNA transcribed from alternative starting sites in multiple promoters. The alternate TSS selection 
within a core promoter could also potentially mediate divergent translational profiles due to alternatively 
transcribed G4 structures which, as evidenced through our study, could significantly impact mRNA translational 
output (Figure 4.9).  
The longer UTR provides a favourable platform to harbour a variety of regulatory elements and structural features 
that could modulate mRNA translation (Reviewed in Leppek et al., 2018). Most of the longer UTR isoforms reported 
in the literature above were derived from alternative promoters and are usually > 500 bp longer compared to their 
shorter counterpart (Landry et al., 2003, Kimura et al., 2006). However, a recent study by Palavecino et al. (2020) 
has reported the inhibitory effects of a longer 5’ UTR, encoded by alternative TSS selection, which contained an 
uAUG in the extra ~100 bps incorporated in the longer 5’ UTR. Similarly, in our study, we have identified a G4 
structure in the alternative longer 5’ UTR that differs from the shorter isoform by only 36 additional nucleotides. 
To our knowledge, ours is the first study that has determined physiologically small changes in the length of the 5’ 
UTR isoform that significantly impact on polysome seeding.  
G4 motifs in the 5’ UTR have been reported to associate poorly with the ribosome. Reduced ribosomal occupancy 
has been noted for G4-containing mRNAs by a variety of studies (Cammas et al., 2015, Murat et al., 2014, Yang et 
al., 2020). In a study by Murat et al. (2014), the authors noticed a reduced abundance of VEGF mRNA in the 
polysomal fractions after treating the HeLa cells with a G4 stabilising ligand. A review of the literature has shown 
that the 5’ UTR G4, like other secondary structures, does not interact directly with the polysome but exerts its 
effects indirectly by impairing assembly of the translation initiation machinery and perturbation of ribosome 
scanning toward the start codon (Babendure et al., 2006, Bugaut and Balasubramanian, 2012, Jenkins et al., 2010, 
Koromilas et al., 1992, Kozak, 1989, Kozak, 1986). In our study, we also found a decreased association of the 
polysomes with G4-containing longer 5’ UTR isoforms which resulted in poor mRNA translation exhibited by the 
enrichment of the longer isoforms in the non-polysomal fraction. This form of regulation in which the mRNA 
translational potential could change drastically by the incorporation of a few extra nucleotides (<50 bp) that form 
a stable G4 motif has not been defined before.  
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4.4 Summary of findings (Chapter 4) 
In summary, this chapter builds upon the findings from the previous chapter and confirmed the formation of G4 
structures by the alternatively transcribed G4 consensus sequences encoded in the longer 5’ UTR of AGAP2 mRNA 
by an upstream TSS selection, as noted in the CML cell lines. Using an in-house developed immunoprecipitation 
technique (GRIP), we demonstrated the in cellula formation of the G4 motif in the 5’ UTR of AGAP2 mRNA. 
Combining the GRIP results with our earlier in vitro CD spectroscopy experiments, we provided conclusive evidence 
for the formation of an alternatively transcribed G4 structure in the longer 5’ UTR of AGAP2 mRNA. We have also 
exhibited differential expression of the longer G4-containing AGAP2 5’ UTR isoform with higher levels noted in the 
CML cell lines and validated it using 5’ RLM-RACE amplified cDNA. This chapter also highlighted the functional 
consequences of the 5’ UTR G4 motif using reporter assays and polysome profiling. Our dual-luciferase reporter 
assay data showed a significant reduction in the luciferase activity exhibited by the G4-containing longer UTR which 
was reversed by destroying the G4 structure by mutating the consensus sequence. These G4-containing isoforms 
were also enriched in the non-polysomal fraction indicating inefficient translation. Together, these results suggest 
that earlier TSSs are frequently selected in CML relative to PC cell lines resulting in mRNA with longer 5’ UTR 
containing G4 forming sequences. These sequences fold into a stable G4 and influence the translation ability of 
AGAP2 mRNA, contributing to the observed discrepancy between mRNA and protein expression.  
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5.1 Introduction  
Based on our work presented in the previous chapters, we have elucidated a novel mechanism that contributed to 
AGAP2 regulation in the CML cell lines. The results presented in chapter 3 described the discrepancy in AGAP2 
mRNA and protein levels in PC and CML cell lines, with higher mRNA and lower protein output noted in the CML 
cell lines. We also noted the differential distribution of TSSs in these cell lines with earlier TSSs found in the CML 
cell lines that incorporated a G4 forming sequence in the resulting longer 5’ UTR isoforms. Our experiments in 
Chapter 4 confirmed the formation of a stable G4 structure by these extra nucleotides. We also validated the 
increased levels of these G4-containing AGAP2 5’ UTR isoforms in the CML cell lines using qRT-PCR. Moreover, in 
chapter 4, we highlighted the translational impact of these alternatively transcribed 5’ UTR G4 and observed a 
substantial decrease in the translation efficiency mediated by these structures. Figure 5.1 summarises the 
understanding acquired through the experiments conducted in the previous chapters. Together, these findings 
reveal a novel mechanism that controls AGAP2 expression in the CML cell lines and could contribute to the observed 
mismatch in mRNA and protein levels. 
The discrepancy in the RNA and protein expression has been frequently reported in the literature and previous 
studies linking differential TSS selection to the impaired translational output usually analysed TSSs originating from 
alternative promoters (section 1.3.1, section 3.1.2). Previous studies have reported that a gene displays a distinct 
distribution of TSSs within a core promoter region in different cell lines (Carninci et al., 2005, Ohmiya et al., 2014) 
which could contribute to the cell-specific gene regulation. In our study, using AGAP2 as a model, we evidenced the 
impact of alternate TSSs on controlling the translational efficiency of the mRNA isoforms. To our knowledge, the 
consequences of alternative TSS selection, which are separated by only a few nucleotides, have not been studied 
before.  
Earlier studies have demonstrated significant enrichment of G4 forming sequences in the 5’ UTR with 2,034 putative 
G quadruplex sequences found in annotated major 5’ UTR of protein-coding genes (Bedrat et al., 2016, Huppert et 
al., 2008). However, the presence of G4s in the alternatively transcribed 5’ UTR isoforms have not been studied 
before. The differential TSS selection generates a heterogeneous mRNA 5’ UTR population that could contain 
different regulatory features influencing mRNA translation potential. Considering only the major TSS isoforms for 
discovering 5’ UTR regulatory elements would not provide a complete picture and would miss key regulatory 
elements. The transcript isoform derived from the major TSSs have been the focus of attention and minor TSSs 
were largely considered as nonadaptive and products of molecular errors (Xu et al., 2019). However, as documented 
through our work using AGAP2, alternatively transcribed G4 motifs by upstream TSS selection significantly affect 
mRNA translation potential. We believe that the TSS-G4 mediated mechanism which we discovered for AGAP2 
might be also implicated in regulating the expression profile of other genes. 
Given the potential of alternatively transcribed G4 motifs in influencing mRNA translation, it could lead to the 
discrepancy in mRNA and protein level, where higher levels of mRNA do not translate into protein. Finding the 
genes with alternatively transcribed G4 and analysing their translational impact would produce new knowledge 
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regarding the contribution of the TSS-G4 mechanism in mediating divergent translation profiles. It would also 
delineate the relevance of this novel mechanism in regulating the expression of other genes in addition to AGAP2.   
 
 
Figure 5.1: Summary of the results generated in the previous chapters. Brief overview of the data produced in 
chapter 3 (top) and chapter 4 (bottom). Through our work in the previous chapters, we noted differential TSS 
distribution in PC and CML cell lines that produced a heterogeneous mRNA population with varying length of 5’ 
UTRs. The longer 5’ UTR contain the G4 consensus that folds into stable G4 and decreased the polysome association, 
resulting in reduced translation efficiency. 
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5.1.1 Aims of chapter 5: 
To address the gaps in the literature and identify alternatively transcribed G4 forming sequences in the human 
genome, we designed a bioinformatics pipeline to generate a list of genes that encode a G4 consensus in the 
divergent TSS isoforms by the selection of upstream TSSs. It would facilitate the identification of other genes that 
are susceptible to TSS-G4 mediated regulation, as noted for AGAP2. For these genes, we also analysed the 
differential expression of G4-containing transcript variants in PC and CML cell lines. To find relevant genes for 
validating this novel mechanism, we used different datasets to identify genes that demonstrated inconsistency in 
mRNA and protein expression and showed higher usage of G4 forming TSS. 
This chapter aims to: 
• Identify other genes in the human genome with alternatively transcribed G4 forming sequence in the 
variant 5’ UTR isoforms, derived from an upstream TSS selection within the same TSS cluster.  
• For the genes with alternatively transcribed G4, map the differential distribution of G4 forming TSSs in PC 
and CML cell lines, that will encode the G4 consensus sequences in the longer 5’ UTR isoforms.  
• Identify other genes in PC and CML cell lines that display a discordant mRNA and protein profile with higher 
relative mRNA level and lower protein abundance, as reported for AGAP2.  
• Generate a list of genes for validation that display a higher level of mRNA, lower protein abundance, and 
higher relative expression of G4 forming transcript variants.  















5.2 Designing the Bioinformatics pipeline 
A bioinformatics pipeline was designed to meet the aims outlined above. The pipeline was designed combining 
various packages and was executed in different platforms including R, Python, and Microsoft Excel. The pipeline is 
principally divided into three steps as depicted in Figure 5.2. Briefly, in step 1, the TSS data was downloaded from 
the FANTOM database followed by converting the data to a relevant format for analysis. The converted TSS data 
were subsequently mapped to the +/- 50 bp region around the genes annotated 5’ UTR regions. In step 2, the 
sequences between alternative TSSs were extracted and analysed for the presence of G4 forming sequences using 
the pqsfinder package. The list of genes with alternatively transcribed G4 was curated and put into pathway maps 
using Metacore to identify enriched pathways, network, and processes. In step 3, the differential distributions of 
these G4 encoding TSSs were determined in PC and CML cell lines that would incorporate the G4 consensus in the 
differential 5’ UTR isoforms. The NCI-60 microarray and SWATH-MS data were also processed to identify genes in 
PC and CML cell lines that displayed higher mRNA expression and lower protein abundance. The genes with 
discordant mRNA and protein levels were then combined with genes showing the differential expression of G4 TSS 
to generate a list of genes in PC and CML cell lines that had higher mRNA and lower protein levels and increased 
relative expression of G4 forming TSS. This gene list was then used to validate the TSS-G4 mechanism. 
 
5.2.1 STEP 1: Downloading and annotating FANTOM TSSs: 
5.2.1.1 Downloading FANTOM database: 
The TSS data was downloaded from the FANTOM (Functional Annotation of the Mammalian Genome) database. 
The FANTOM database (version 5) is the largest collection of human TSS profiles and contain a diverse range of cells 
and tissues, sequenced using a single platform, to provide a comprehensive map of all the TSSs used in the human 
(Forrest et al., 2014, Lizio et al., 2015). The FANTOM TSS database for human contains the TSS profiles for 573 
primary cell lines, 152 human post-mortem tissues and 250 different cancer cell lines covering distinct cancer 
subtypes.     
The 5’ end of the mapped CAGE reads (tags) were counted at a single bp resolution, and the counts were normalised 
as tags per million (TPM) after scaling by normalization factors calculated by Relative Log Expression (RLE) – an 
expression of 5 TPM means that out of a million transcripts, 5 transcripts corresponded to the TSS in question. The 
normalised counts were downloaded from the ZENBU browser, a data exploration and mining tool that displays the 
TSS data from all the CAGE experiments in the FANTOM database (Severin et al., 2014). The data was download in 
the browser extensible data (.bed) format which presents the genomic coordinates (chromosome location - start 
and end positions) of the normalised collective count of tag-starting sites. The raw (.bed) data was processed and 
the TSSs with less than 2 TPM were removed to select robust starting sites. The data was split up into plus (+) and 
minus (-) strands for easier handling and analysis. The data were processed and analysed using a high-power 





Figure 5.2: Overview of the bioinformatics pipeline. Bioinformatics pipeline to identify a list of genes in PC and 
CML cell lines that exhibit inconsistencies in mRNA and protein expression levels with higher levels of G quadruplex 
forming TSSs which encode alternatively transcribed G4 motifs in the 5’ UTR isoforms. G4: G quadruplex; TSS: 
Transcription Start Site; UTR: Untranslated region; PC: Prostate cancer; CML: Chronic Myeloid Leukaemia.  
139 
 
5.2.1.2 Mapping the TSSs to gene 5’ UTR: 
The processed TSSs were mapped within the +/- 50 bp region around the annotated transcription starting site. The 
gene TSS annotations were downloaded from Ensembl biomart based on GRCh38.p13 (release 98) (Yates et al., 
2019). The annotated TSS usually correspond to the major transcription starting position and a 50 bp region on 
either side was selected to identify all the alternative starting sites within this area. The mapping was performed 
using the LOOKUP function in Excel that matches the TSSs to a gene 5’ UTR region based on genomic coordinates. 
The genes on plus (+) and minus (-) strands were mapped separately. The gene transcripts having a common starting 
position were grouped and overlapping transcripts from different genes were omitted from the analysis. The 
overlapping transcripts from different genes were removed to specifically associate a TSS to a single gene 
transcript/s.  For mapping purposes, the genomic coordinates that were considered included chromosome strand, 
chromosome number, the starting and ending positions of gene 5’ UTR and TSS position (if it is within the defined 
range).  
 
5.2.2 STEP 2: Detecting G4 forming sequences between alternative starting sites: 
5.2.2.1 Extracting sequence between major and upstream TSSs: 
All the TSSs mapped within the defined region with overlapping CAGE tags were included for downstream analysis. 
The overlapping tags were considered because they would form part of the single TSS cluster. The TSS with the 
highest TPM in the cluster was considered as the major starting site. The major TSSs were identified for all the gene 
transcripts and in most of the cases, they were within +/-10 bp of the annotated transcript starting sites. 
The upstream TSS relative to the major TSS in the cluster was then identified. For our bioinformatics analysis, the 
upstream TSSs was defined as the earliest CAGE tag starting site in the defined +/- 50 bp region around the 
annotated TSS that is more than 15 bp upstream to the major TSS. The 50 bp region around the annotated (major) 
TSS was selected to identify nearby TSSs that would encode for alternate 5’ UTR isoforms containing extra G4 
forming consensus sequence.  The 15 nucleotides distance between the major and upstream TSSs was selected 
because the minimum length of the G4 reported in the literature is 12 bp (Bakalar et al., 2019). The sequences 
between the two alternative starting positions (major TSS and upstream minor TSS) were extracted using Bio. Entrez 
module in Biopython (Cock et al., 2009). The following script was written to output sequences between major and 
upstream TSSs for all the genes included for analysis. The script was executed in the PyCharm community edition 






import Entrez, SeqIO 
import pandas as pd 
 
data = pd.read_csv("C:/Users/suran/Desktop/Bioinformatics Analysis Revised Jan 2020/TSS 
Negative/Seq analysis/Combine final for analysis neg textfile.txt", header ="infer", 
delimiter="\t") 
 
def get_dna_sequence(startCoordinate, stopCoordinate, chromosome): 
    Entrez.email = "A.N.Other@example.com" 
    Start = (startCoordinate) 
    Stop = (stopCoordinate) 
    Chr = (chromosome) 
    handle = Entrez.efetch(db="nucleotide", 
                           id=Chr, 
                           rettype="fasta", 
                           strand=2, 
                           seq_start=Start, 
                           seq_stop=Stop) 
    record = SeqIO.read(handle, "fasta") 
    handle.close() 
    return record.seq 
 
def get_coordinates(data): 
    coordinates = [] 
    textFile = (data) 
    for line in textFile: 
        coordinates.append(line) 
    return coordinates 
 
startCoordinates = get_coordinates(data["Start"]) 
stopCoordinates = get_coordinates(data["Stop"]) 
chromosome = get_coordinates(data["Chrom"]) 
transcript_id = get_coordinates (data["Transcript_id"]) 
strand= get_coordinates(data["Strand"]) 
sequenceTextFile = open("C:/Users/suran/Desktop/Bioinformatics Analysis Revised Jan 
2020/TSS Negative/Seq analysis/TSSnegativeseq.txt", "w") 
sequenceFastaFile= open("C:/Users/suran/Desktop/Bioinformatics Analysis Revised Jan 
2020/TSS Negative/Seq analysis/TSSnegativeseqFASTA.txt", "w") 
 
for i in range(len(startCoordinates)): 
    sequenceText = "" 
    sequence = get_dna_sequence(startCoordinates[i], stopCoordinates[i], chromosome[i]) 
    sequenceTextFile.write(str(startCoordinates[i]).rstrip('\n')) 
    sequenceTextFile.write(" " + str(stopCoordinates[i]).rstrip('\n')) 
    sequenceTextFile.write(" " + str(sequence).rstrip('\n')) 
    sequenceTextFile.write(" " + str(chromosome[i]).rstrip('\n')) 
    sequenceTextFile.write(" " + str(transcript_id[i]).rstrip('\n')) 
    sequenceTextFile.write(" " + str(strand[i]).rstrip('\n')) 
    sequenceTextFile.write("\n") 
    sequenceFastaFile.write(">" + str(transcript_id[i]).rstrip('\n')) 
    sequenceFastaFile.write("\t" + str(sequence).rstrip('\n')) 




5.2.2.2 Identifying G4 consensus in the extracted sequence: 
The extracted sequences were analysed for the presence of a G quadruplex consensus using the pqsfinder package 
in R (Hon et al., 2017). The pqsfinder is an intensive and imperfection-tolerant computational tool to detect 
potential G4 forming sequences. It is trained using the currently known and experimentally existing G4 structures 
and accommodates possible divergences (mismatches, bulges, loop length) from the ideal G4 consensus sequence. 
It also computes a score based on the G-tetrad stacking and the presence of mismatches and bulges. The score 
generated has shown to be closely related to the G4 stability (Hon et al., 2017). The authors have reported that the 
package algorithm has superior accuracy compared to other existing tools. Moreover, this package could be 
adapted for batch analysis which was suitable for analysing all the extracted sequences generated in the above 
step. The following script was executed in R using the pqsfinder package: 
 
In the script above, the G4 was detected in the sense sequence only and the G4 score threshold to label a sequence 
as G4 forming sequence was set to the default value of 52, as it exhibited a balanced accuracy on the human G4 
sequencing data (Hon et al., 2017). The score assignment by the package has been shown to positively correlate 
with the propensity of G4 formation. The maximum score generated by the pqsfinder package is 395 and is 
produced by a sequence input only comprising of runs of Gs. The default values to label a putative G4 sequence 




dna <- readDNAStringSet(file="sequences.fa") 
 
pqs <- lapply(dna,pqsfinder, strand = "+") 
 
pqsdf1 <- list_df2df(lapply(lapply(pqs,ranges),as.data.frame)) 
pqsdf2 <- list_df2df(lapply(lapply(pqs,score),as.data.frame)) 
pqsdf3 <- list_df2df(lapply(lapply(pqs,strand),as.data.frame)) 
pqsdf4 <- list_df2df(lapply(lapply(pqs,DNAStringSet),as.data.frame)) 
pqsdfcombine <- cbind (pqsdf1, pqsdf2$`X[[i]]`, pqsdf3$X[[i]], pqsdf4$x) 
 
colnames(pqsdfcombine)[1] <- "Transcript_id" 
colnames(pqsdfcombine)[5] <- "G-Score" 
colnames(pqsdfcombine)[6] <- "Strand" 
colnames(pqsdfcombine)[7] <- "G4 Seq" 
 
colnames(pqsdfcombine) 
write.table(pqsdfcombine,file="Gqaudtable.txt", sep = "\t", row.names = FALSE, col.names 
= TRUE) 
 
#generate output to text file 








with alternatively transcribed G4 were characterised according to their biotype using the attributes defined in the 
Ensembl biomart based on GRCh38.p13 (release 98) (Yates et al., 2019).    
 
5.2.2.3 Pathway maps of genes with alternatively transcribed G4: 
Functional pathway maps of genes that contain alternatively transcribed G4 were created using Metacore, version 
21.1 (Clarivate Analytics) [https://portal.genego.com/]. The ranked hypergeometric test was used to determine the 
enriched pathways maps and GO (gene ontology) processes. The GO processes were presented as a histogram and 
pathway maps were presented as dot plot generated using ggplot2 package in R using the following script.  
 
 
5.2.3 STEP 3: Identifying genes for validation: 
The objective of this step of the bioinformatics pipeline was to integrate the matched TSS and mRNA and protein 
expression data to determine the genes which showed higher mRNA expression, lower protein abundance and 
significantly increased level of G4 forming TSS isoforms, as also reported for AGAP2 gene. The list would be used to 
validate the TSS-G4 mechanism in which the selection of G4 forming TSSs reduce the mRNA translational output, 
producing mismatched mRNA and protein expression profiles.    
5.2.3.1 Determining the differential distribution of G4 TSSs in PC and CML cell line: 
To determine the differential distribution of G4 forming TSSs in PC and CML cell lines, the TSS count data for PC cell 
lines [DU145 (10490-107B4), PC3 (10439-106E7)] and CML cell lines [replicates for K562 (10454-106G4, 10824-
111C5)] were downloaded from the FANTOM database. The TSS data, available in the format of (.bam) file, were 
downloaded from the link: 
https://fantom.gsc.riken.jp/5/datafiles/reprocessed/hg38_latest/basic/human.cell_line.hCAGE/. 
The (.bam) files were converted to (.bed) format to construct the TSS information according to the genomic 
coordinates (chromosome location - start and end position). The conversion was done following the guidelines 
provided by the authors (Lizio et al., 2015). Briefly, the (.bam) files were processed by samtool package (Li et al., 
2009), and the high quality reads corresponding to an accuracy of 99% (Phred Quality Score 20) were retained. The 
library(ggplot2) 
data <- read.csv("Enrichment_analysis truncated.txt", sep ="\t", header = TRUE,  
 stringsAsFactors = FALSE) 
S1<- ggplot(data, aes(x=GeneRatio, y=reorder(Maps, as.numeric(-p.adjust)),   
     color=p.adjust, size=Count)) + geom_point(alpha = 0.8) + theme_classic() +  
     ylab(NULL) + guides(color = guide_colourbar(order=1),size = guide_legend(order=2)) 
S1 = S1+scale_color_gradient(low = "red2",  high = "mediumblue", guide = "colourbar",  
     space = "Lab") + xlab("Gene Ratio") + theme(axis.title.x = element_text(face="bold",  
     size = 10)) +theme(axis.text.y = element_text(size = 8, face = "bold"))                                                                                                                                                         
ggsave("Outpout.tiff", width = 8, height = 5, device='tiff', dpi=700) 
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bam files were then converted to bed coordinates, strand-selected, and sorted. The 5’ ends of the mapped CAGE 
tags were then aggregated by groupBy command in the bedtool package (Quinlan and Hall, 2010). The command-
line codes are shown below and executed separately for the plus (+) and minus (-) strand. 
 
 
The command generates a (.bed) file containing the raw TSS count data in the standard chromosomal coordinates. 
For the analysis of G4 forming TSSs, the gene list generated in section 5.2.2.2 was used and the proportions of G4 
forming TSSs were estimated by dividing the numbers of cumulative TSS tags within a 21 bp subregion upstream of 
the G4 starting position and the total tags in the selected TSS cluster (G4 + non G4 TSSs) (Figure 5.3). The 21 bp 
subregion was selected to maintain uniformity and also because the CAGE tags are about 21 bp long and any 
upstream overlapping tags within this region would belong to the same cluster (Takahashi et al., 2012). The 
differential proportions were analysed by linear modelling and empirical Bayes approach using the Limma package 
in R (Ritchie et al., 2015). The genes with significantly higher proportions of G4 forming TSSs were selected in PC 




# For Plus (+) Strand: 
samtools view -uq 20 BAMfile \ 
| bamToBed -i stdin \ 
| awk 'BEGIN{OFS="\t"}{if($6=="+"){print $1,$2,$5}}' \ 
| sort -k1,1 -k2,2n \                                                                                                              
| groupBy -i stdin -grp 1,2 -opCols 3 -ops count \ 
| awk 'BEGIN{OFS="\t"}{print $1,$2,$2+1,  $1":"$2".."$2+1",+"  ,$3,"+"}'                                                                   
 
#For minus (-) Strand: 
samtools view -uq 20 BAMfile \ 
| bamToBed -i stdin \                                                                                                                                        
| awk 'BEGIN{OFS="\t"}{if($6=="-"){print $1,$3,$5}}' \ 
| sort -k1,1 -k2,2n \ 
| groupBy -i stdin -grp 1,2 -opCols 3 -ops count \ 
| awk 'BEGIN{OFS="\t"}{print $1,$2-1,$2,  $1":"$2-1".."$2",-"  ,$3,"-"}' 
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Figure 5.3: Diagrammatic representation of estimating differential G4 TSS distribution. Overlapping CAGE tag 
starting sites within the defined TSS cluster. The proportion of G4 forming TSSs, that would encode a G4 forming 
sequence in the corresponding 5’ UTR, is calculated by counting CAGE tag starting sites within the 21 bp region 
upstream of the G4 start site and divided by the total number of starting sites within the TSS cluster. The proportions 
were computed for PC and CML cell lines and the significantly different proportions were determined using linear 
modelling and empirical Bayes approach. As an example, the number of G4 forming (10) and non G4 (34) TSSs in 
the cluster are shown at the top and were used to calculate proportions.  
 
 
The script for processing (.bed) file, mapping to 21 bp region upstream of G4 start sites, counting the TSSs within 
the region, merging the TSSs from different cell lines, and performing Limma analysis to determine differential 





# Read table positive 
Gene <- 
read.table("chronic%20myelogenous%20leukemia%20cell%20line%3aK562%20ENCODE%2c%20biol_rep1 
    .CNhs12334.10824-111C5.hg38.nobarcode.ctss.bed", header = FALSE, sep = "\t", 
stringsAsFactors = FALSE) 
colnames(Gene) <- c("chrom","V", "position", "chrom-loc", "TPM", "Strand") 
Gene$V = NULL  
plus <- read.table("Pos coordinates G4 -20 to major.txt", header = TRUE, sep = "\t",  
 stringsAsFactors = FALSE) 
pos <- Gene[Gene$Strand == "+",] 
# True false argument positive 
 
pos$found <- ifelse(sapply(seq_along(pos$position), function(i) {inds <-plus$Start <= 
      pos$position[i] & plus$Stop >= pos$position[i] & pos$chrom[i]==   
      plus$Chromosome any(inds)}), "YES", "NO") 
table(pos$found)["YES"] 
posfound <- pos[pos$found == "YES",] 
write.table(posfound,"K562rep1posall.txt",sep ="\t",col.names=T, row.names = F) 
 
# Load back gene table positive 
posgene <- read.table("K562rep1posall.txt", header = TRUE, sep = "\t", stringsAsFactors =  
    FALSE) 
poslist <- aggregate(posgene$TPM, by=list(Category=posgene$Gene), FUN=sum) 






# Read table negative 
neg <- read.table("Neg coordinates G4 +20 to major.txt", header = TRUE, sep = "\t",  
       stringsAsFactors = FALSE) 
KUneg<- Gene[Gene$Strand == "-",] 
 
# True false argument negative 
KUneg$found <- ifelse(sapply(seq_along(KUneg$position), function(i) {inds <-neg$Start >=  
        KUneg$position[i] & neg$Stop <= KUneg$position[i] & KUneg$chrom[i]==  
        neg$Chromosome any(inds)}), "YES", "NO") 
table(KUneg$found)["YES"] 
KUnegfound <- KUneg[KUneg$found == "YES",] 
write.table(KUnegfound,"K562rep1negall.txt",sep = "\t",col.names=T, row.names = F) 
 
#Load back gene table negative 
KUneggene <- read.table("K562rep1negall.txt", header = TRUE, sep = "\t", stringsAsFactors  
      = FALSE) 
KUneglist <- aggregate(KUneggene$TPM, by=list(Category=KUneggene$Gene), FUN=sum) 
colnames(KUneglist) <- c("Gene","TPMsum") 
#Merge both table  
KUgene <- rbind(poslist, KUneglist)  
write.table(KUgene,"K562rep1all.txt",sep = "\t",quote = F,col.names=T, row.names = F) 
datag4 <- read.table("K562rep1G4.txt", header = TRUE, sep = "\t") 
dataall <- read.table("K562rep1all.txt", header = TRUE, sep = "\t") 
Mergedgene <- merge(x=datag4, y=dataall, by="Gene", all= TRUE) 
Mergedgene[is.na(Mergedgene)] <- 0 
colnames(Mergedgene) <- c("Gene","G4", "ALL") 
write.table(Mergedgene,"K562rep1GeneMerged.txt",sep = "\t",col.names=T, row.names = F) 
 
#Merge Cell lines 
Mergedallcelline <- merge(x=MergedPC, y=MergedCML, by="Gene", all= TRUE) 
Mergedallcelline[is.na(Mergedallcelline)] <- 0 
colnames(Mergedallcelline) <- c("Gene","DU145","PC3", "K562","K562.rep1") 
write.table(Mergedallcelline,"DUPCK562andrep1Merged.txt",sep = "\t",quote = 
F,col.names=T, row.names = F) 




counts <- read.delim("DUPCK562andrep1Merged.txt", sep = "\t", row.names = 1, header = T)         
d1 <- DGEList(counts = counts[,1:4], group = c("PC", "PC", "CML", "CML")) 
design1 <- model.matrix(~group, data = d1$samples) 
fit1 <- lmFit(d1$counts, design1) 
fit1 <- eBayes(fit1) 
output1 <- topTable(fit1, sort.by = "p", n = Inf) 
output1$Significant <- ifelse(sapply(seq_along(output1$adj.P.Val), function(i) {inds <-
output1$adj.P.Val[i] <= 0.05 any(inds)}), "Significant", "NS") 
length(which(output1$adj.P.Val< 0.05)) 
write.table(output1,"Output DUPCK562rep1.txt",sep = "\t",col.names=T, row.names = T) 
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5.2.3.2 Characterising genes with a discrepancy in mRNA and protein levels in PC and CML cell lines: 
To identify gene showing inconsistency in mRNA and protein level as noted for AGAP2, the NCI-60 microarray 
(GSE32474) and NCI-60 SWATH-MS databases were used (Guo et al., 2019, Reinhold et al., 2015). The required data 
was downloaded using the CellMinerCDB website (https://discover.nci.nih.gov/cellminercdb/) (Rajapakse et al., 
2018). The differentially expressed RNAs in PC (DU145, PC3) and CML (K562) cell lines were analysed by GEO2R 
(NCBI) and verified in R using the Limma package (Ritchie et al., 2015). The significant differences in protein mass 
spectral intensity values were evaluated by linear modelling and empirical Bayes statistics using Limma. The genes 
with a differential RNA expression of 2-folds or greater (RNA logFC >=1) and no statistically significant differences 
in protein levels and/or significantly lower protein levels were considered to have a discrepancy in mRNA and 
protein levels. The significance was defined at an adjusted P-value threshold < 0.05. The discordant genes were 
determined separately for PC and CML cell lines. 
The script to identify differentially expressed RNA and protein using R is exhibited below: 
 






# load series and platform data from GEO 
gset <- getGEO("GSE32474", GSEMatrix =TRUE, AnnotGPL=TRUE)                                       
if (length(gset) > 1) idx <- grep("GPL570", attr(gset, "names")) else idx <- 1 
gset <- gset[[idx]] 
 
# log2 transformation 
ex <- exprs(gset) 
qx <- as.numeric(quantile(ex, c(0., 0.25, 0.5, 0.75, 0.99, 1.0), na.rm=T)) 
LogC <- (qx[5] > 100) || (qx[6]-qx[1] > 50 && qx[2] > 0) 
if (LogC) { ex[which(ex <= 0)] <- NaN 
  exprs(gset) <- log2(ex) } 
 
# assign samples to groups and set up design matrix 
gs <- factor(sml) 
groups <- make.names(c("PC","CML")) 
levels(gs) <- groups 
gset$group <- gs 
design <- model.matrix(~group + 0, gset) 
colnames(design) <- levels(gs) 
 
# fit linear model 
fit <- lmFit(gset, design)   
cts <- paste(groups[1], groups[2], sep="-") 
cont.matrix <- makeContrasts(contrasts=cts, levels=design) 
fit2 <- contrasts.fit(fit, cont.matrix) 
 
# compute statistics and table of top significant genes 
fit2 <- eBayes(fit2, 0.01) 
tT <- topTable(fit2, adjust="fdr", sort.by="B", number=250) 
tT <- subset(tT, 
select=c("ID","adj.P.Val","P.Value","t","B","logFC","Gene.symbol","Gene.title")) 





5.2.3.3 Integrating the data to find the genes for validation in PC and CML cell lines: 
The genes with significantly higher levels of G4 forming TSSs, higher mRNA expression and lower protein abundance 
were found using InteractiVenn (Heberle et al., 2015). It is a web-based tool to find and illustrate the relationship 
between different sets. Using this tool, the common genes between three analysed datasets (FANTOM, NCI-60 



















counts <- read.delim("Proteinlog2normalised.txt", sep = "\t", row.names = 1, header = T) 
d1 <- DGEList(counts = counts[,c(1,2,3,4,7,8)],  
      group = c("PC","PC","PC","PC","CML","CML")) 
design1 <- model.matrix(~group, data = d1$samples) 
fit1 <- lmFit(d1$counts, design1) 
fit1 <- eBayes(fit1) 
output1 <- topTable(fit1, sort.by = "p", n = Inf) 
output1$Significant <- ifelse(sapply(seq_along(output1$adj.P.Val), function(i) {inds <- 
                       output1$adj.P.Val[i] <= 0.05 
any(inds)}), "Significant", "NS") 
length(which(output1$adj.P.Val< 0.05)) 
write.table(output1,"DEprotein.txt",sep = "\t",col.names=T,row.names = T) 
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5.3 Results and Discussion 
5.3.1 Alternatively transcribed G4 consensus sequences in the FANTOM database: 
To identify genes with alternatively transcribed G4 forming sequence, we performed a bioinformatics analysis to 
find G4 consensus between alternative TSS isoforms within a defined region of the cluster (section 5.2.2). The 
analysis was performed using all the available human samples (~1,000) in the FANTOM database. The 
bioinformatics pipeline was designed to detect genes with putative G4 sequences between the major and upstream 
TSSs within the same TSS cluster. Our analysis identified 4,920 transcripts associated with 3,888 genes that contain 
G4 forming sequences between the two transcription start positions in the TSS cluster, upstream of major TSS. 
The average length of the TSS cluster between the major and earliest TSSs in the cluster was 58.72 (+/-19.46) bp. 
The mean length of the G4 consensus was found to be 27.67 (+/-8.17) bp. The average distance between the earliest 
TSSs in the cluster and the G4 start position was 16.66 (+/-15.84) bp. In most cases, a single G4 was noted between 
the alternative TSSs and multiple G4 were only noted for 107 transcripts (2.1%). Interestingly, a large majority of 
the transcripts identified by our analysis were protein-coding genes (91.1%) followed by lncRNA (7.2%). The 
biotypes of the genes containing alternatively transcribed 5’ UTR G4 forming sequences are presented in Figure 5.4. 
The selective enrichment of alternatively transcribed G4 in the protein-coding genes indicates a potential regulatory 
role of these structures, making the genes susceptible to regulation by the TSS-G4 mechanism. 
  
 
Figure 5.4: Biotypes of the genes with alternatively transcribed G4. (A) Biotypes of the genes that contain the G4 
consensus sequence between the two transcription start positions. lncRNA: long noncoding RNA; miRNA: 
microRNA; PPG: Processed pseudogene; TUP: Transcribed unprocessed pseudogene; TP: Transcribed unitary 
pseudogene; TEC: To be experimentally confirmed; TPP: Transcribed processed pseudogene; TR-J: Joining chain T 





To identify important regulatory pathways that could be modulated by alternatively transcribed G4 motifs, we 
assigned the above genes to the pathway maps and GO processes using Metacore (section 5.2.2.3). The top three 
significantly enriched pathways included cytoskeleton remodelling, development, and apoptosis and survival 
(Figure 5.5A). To explore the functional processes involved, we performed a gene ontology analysis using Metacore 
as described above and found that these genes were frequently involved in regulating cellular and metabolic 
processes and the organisation of cellular components (Figure 5.5B).  
Our study, for the first time, reported the incorporation of alternatively transcribed G4 forming sequences by the 
selection of nearby upstream TSSs within the cluster. Other studies on 5’ UTR have reported the G4 structures in 
the annotated 5’ UTR (Huppert et al., 2008) and alternative UTR of protein-coding transcripts (splice variants) (Lee 
et al., 2020). The number of protein-coding genes with alternatively transcribed G4 forming sequences within a 
core promoter region, as noted in our study, was 3491 genes. The results obtained by our study is in alignment with 
another study that analysed G4 forming sequences between splice variants and reported 2967 unique protein-
coding genes that encoded for at least one transcript isoform containing a G4 sequence within the 5′ UTR Lee et 
al., 2020). The bioinformatics analysis carried out by Huppert et al. (2008) on 5’ UTR G4s has reported a higher 
incidence of putative G4 sequences near the 5’ end of the UTR. Likewise, our study also showed the presence of 
these sequences within the first 30 nucleotides from the 5’ end. The enriched pathways and process identified by 
our studies were also noted by other studies on 5’ UTR G4s (Huppert et al., 2008, Lee et al., 2020). Some of the 
common enriched pathway and processes included signal transduction, transcription regulation, and regulation of 
cell metabolism. It highlights that the G4 formation in 5’ UTR regulate specific biological pathways and processes 
and could have functional implications in the cell. Since the TSS selection is dynamic, as defined in the earlier 
chapters, the production of alternative 5’ UTRs with or without these structures could act as an additional layer of 
regulation for the cells to respond to different stimuli and extrinsic and intrinsic factors.  
In the current study, we restricted the alternatively G4 analysis to a smaller (max 100 bp) region between the 
upstream and the major TSSs in the cluster. Kawaji et al. (2006), using the FANTOM database, found the mean 
length of the TSS tag cluster to be more than 130 bp with the majority of reported tag cluster having less than 250 
bp. Taking this into consideration, our restrictive analysis might overlook other potential G4 forming sequence 
between different alternative sites separated by more than 100 bp. However, in the current study, we aimed to 
analyse the translation impact induced by minor shifts in the TSS selection and designed our bioinformatics pipeline 
to specifically detect alternative G4 encoded by TSSs separated by only a few nucleotides. In-depth bioinformatic 
analysis to detect all the possible (overlapping/non-overlapping) G4 consensus sequences in the entire TSS cluster 
would characterise the G4 landscape of the cluster and generate novel insights.  
In the current study, the G4 forming sequence was determined between the major and upstream TSSs in the cluster. 
The major TSS in the cluster was identified by the tag with the highest TPM. However, this method of determining 
a major TSS would not be valid in the case of bi or multimodal TSS peak distribution profiles, where multiple major 
TSSs exists (Carninci et al., 2006). For a small number of cases in our studies (bi or multi-modal peak), the G4 
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consensus might not be upstream to the major TSS and may be between two major TSS or downstream to major 
starting sites. An advanced bioinformatics analysis would be required to tailor the analysis according to the TSS 
distribution context. Nonetheless, our bioinformatics analysis has robustly identified a G4 forming sequence 




Figure 5.5: Pathway maps and Go processes of the genes with alternatively transcribed G4. (A) Metacore pathway 
enrichment analysis of transcripts containing alternatively transcribed 5’ UTR G4. The dot plot shows the top 15 
enriched pathways with the largest gene ratio, the size of the dots represents the number of genes in each pathway 
and the colour of the dots represents the adjusted p values (BH). (B) GO-process enrichment was performed using 
Metacore and enrichment was determined by meeting a BH adjusted P-value cutoff of 0.05. The histogram showing 
the top 10 GO processes enriched, the results are ranked by -log(P-values). 
 
5.3.2 Genes with discordant mRNA and protein expression and significantly higher levels 
of G4 forming TSSs:  
We analysed the proportions of G4 forming TSSs in PC and CML cell lines to determine differential expression of 
G4-containing 5’ UTR isoforms (section 5.2.3). Using linear modelling and the empirical Bayes approach, we 
identified 1,007 genes out of 3,888 that showed differential cell line-specific expression of G4 TSSs. Next, we 
determined differential mRNA and protein expression in the matched PC and CML cell lines using the NCI-60 
microarray data and NCI-60 SWATH-MS data, respectively. We found that 6,585 genes displayed differential relative 
RNA expression profiles in PC and CML cell lines and also noted that 605 proteins were significantly different in 
these cell line groups.  
We were interested in identifying genes that had discrepancies in mRNA and protein expression with higher mRNA 
and lower protein expression, as observed for AGAP2 in the CML cell line. To find mismatched genes, we examine 
their mRNA and protein levels and selected those genes that had 2-folds or greater relative RNA expression (RNA 
logFC >=1) and no statistically significant differences in protein levels and/or significantly lower proteins levels. We 
then merged the discordant expression data with differential G4 TSS data to identify genes having discordant mRNA 
and protein expression with higher levels of G4 forming TSSs. Our analysis identified 2 genes (HK1 and TMEM263) 
in the CML cell lines and 35 genes in the PC cell lines (ALDH7A1, ARHGAP29, BAG5, CASK, CAV1, CD9, CDKN2A, 
CKAP4, CNN3, COL4A1, DUSP3, ERMP1, FAM114A1, FARP1, FERMT2, IFT27, ITGA3, ITGB4, ITGB5, LMO7, LRRC1, 
LRRFIP1, MEST, MLKL, NDRG1, NT5C2, PGM2L1, PODXL, PXDN, RRBP1, SDC1, SYNCRIP, TBL1XR1, TPD52, and WASL) 
(Figure 5.6). Surprisingly, the bioinformatics pipeline did not identify AGAP2 as a gene displaying discrepancy in 
mRNA and protein levels in the CML cell line (K562). It could be explained by the use of K562 cell lines in the CML 
group which in contrast to other CML cell lines included in the project do not exhibit relatively higher levels of 
AGAP2 mRNA. No statistically significant differences were noted in AGAP2 mRNA expression levels between the PC 





Figure 5.6: Genes displaying inconsistency in mRNA and protein level and higher levels of G4 forming TSS. Venn 
diagrams illustrating the overlapping genes in FANTOM and NCI-60 database that show differential levels of G4 TSS, 
differentially expressed mRNA (>=1 log FC), and no statistically significant differences in protein levels and/or 
significantly lower proteins levels in CML cell lines (left) and PC cell lines (right). The differential expressions were 




Our analysis identified genes that demonstrated an inconsistency in mRNA and protein levels that could be 
mediated by alternatively transcribed G4. These structures, as shown by our study, could modulate the translational 
efficiency of their respective mRNA transcript, leading to inconsistent RNA and protein profiles. However, the 
criteria used in our study to define the discordant mRNA and protein would detect only those genes with larger 
significant differences in translation efficiency. The alternative 5’ UTR G4 might not always mediate such larger 
differences in the mRNA translation output. As a result, our approach could possibly miss many other relevant 
genes that do not display such larger relative differences in the protein output. Moreover, our defined criteria only 
select genes that display a 2-fold or greater relative increase in mRNA, consequently, it would ignore the genes with 
similar mRNA level but differences in protein abundance. Furthermore, the protein expression data for the PC and 
CML cell lines used for the analysis was inadequate. The NCI-60 SWATH-MS dataset had protein expression levels 
for only about 3,100 genes that were common to all the cell lines in the NCI-60 database. The lack of protein data 
for a large number of genes in PC and CML cell lines resulted in a lower than expected numbers of genes detected 
for validation.  
The NCI-60 mRNA and protein expression database had the data for only one of the CML cell lines (K562). The K562 
is one of the commonly used CML cell lines but was not part of the CML cell line group in the current study. Instead, 
the CML group included other related cell lines such as KU812, TCCS, and KCL-22. Although these cell lines would 
be grossly similar, the RNA and protein expression and the TSS distribution profiles might not be representative of 
the CML cell lines included in our study. To our knowledge, there were no other datasets, except NCI-60, that 
analysed the RNA and protein levels in PC and CML cell lines using the same platform. Despite some evident 
limitations, our analysis was able to detect relevant genes which could be used to demonstrate the relevance of 
the TSS-G4 mechanism in controlling the expression of gene output.        
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5.3.3 RNA sequencing of the cell lines included in our study: 
To make the bioinformatics analysis relevant to the cell lines included in our study, we performed RNA sequencing 
of the PC (DU145, PC3, LNCaP) and CML (KU812, TCCS, KCL-22) cell lines used in the current project (section 2.2.9). 
A single sequencing reaction was performed for each cell line and the expression profiles of the PC and CML cell 
lines were grouped together and considered as biological replicates. The principal component analysis (PCA) was 
performed to cluster the samples based on the patterns of gene expression and evaluate the level of 
similarity/dissimilarity between the two groups. The PCA analysis showed clear differences between the two cell 
line groups. The first two principal components (PC1 and PC2) explained more than 70% of the variability among 
the samples with distinct clustering of the PC and CML groups (Figure 5.7A). 
The differential expression analysis of the RNA-seq data identified 2,350 genes that had significantly different 
relative levels in PC and CML cell lines. The heatmap of the top 1,500 differentially expressed genes is presented in 
Figure 5.7B. As depicted in the heatmap, the PC and CML cell lines samples have clustered into distinct cell line 
groups using hierarchical clustering analysis and validate discrete clustering of the biological replicates used for 
each group. We then examined the differential RNA expression of the genes selected for validation (section 5.3.2) 
and noted that 8 out of 37 genes selected for validation in PC and CML cell lines showed similar differential 
expression patterns as reported in NCI-60 microarray data. The relative profiles of the genes showing higher relative 





Figure 5.7: Expression profile of differentially expressed genes. (A) PCA of RNA sequencing data. The analysis was 
performed using the top 500 differentially expressed genes in PC and CML cell lines. The percentages on each axis 
represent the % variation explained by the respective principal component. (B) Heatmap showing the z-scores 
based on FPKM values of the top 1,500 differentially expressed genes. Each row in the heatmap represents a gene 
and the column represents a sample. The green colour indicates highly expressed genes and red shows genes with 
low expression. The dendrogram representing hierarchical clustering based on Euclidean distance is presented 
above the heatmap. (C) Volcano plot highlighting differentially expressed (DE) genes in PC and CML cell lines with 
log2 fold change >1 and log10 adjusted P-value < 0.01. The expression profiles of the genes that showed similar 
patterns of expression in the NCI-60 database and our study are shown in the box. The differential expression of 
AGAP2 is also shown. The red and blue indicates genes with higher relative expression in CML and PC cell lines used 
in our study, respectively.     
 
 
The expression pattern of most of the genes that were selected for validation using the NCI-60 microarray database 
did not match the expression profiles of the PC and CML cell lines included in our study. Out of 37 genes selected 
for validation, only 8 showed similar expression profiles. It is attributed to differences in the cell lines used for 
analysis that led to contrasting expression pattern. The LNCaP from the PC group and all the CML cell lines used in 
the study were not present in the NCI-60 database. Moreover, the available CML cell line (K562) in the NCI-60 
155 
 
database was not part of the current study. Although being part of the same cell line group, these cell lines are 
established from different patients, sites, and disease levels and could demonstrate variable expression for some 
genes. (Jiang et al., 2016) 
Moreover, grouping RNA sequencing data of different related cell line into either PC or CML group could also create 
biological noise and variation, as noted for LNCaP and TCCS in PCA analysis (Figure 5.7A).  The use of technical 
replicates, instead of biological replicates, for one of the PC or CML cell lines, preferably a cell line whose TSS data 
is available in the FANTOM database (CML: KU812, KCL-22; PC: DU145, PC3) and performing both RNA sequencing 
and mass spectrometry analysis on these cell lines could precisely identify relevant genes for validation that could 
be used to examine the relevance of TSS-G4 mechanism.    
 
5.3.4 Validation of the TSS-G4 mechanism using another gene: 
Thus far, our study has established the contribution of the TSS-G4 mechanism in regulating AGAP2 expression. To 
demonstrate the universality of this mechanism, we performed a bioinformatics analysis of NCI-60 and FANTOM 
databse to generate a list of genes that exhibited a discrepancy in RNA and protein expression and had a 
significantly higher level of G4-containing TSSs. We selected some of these genes and analysed their mRNA and 
protein expression profiles in the PC and CML cell lines included in our study to identify genes that displayed a 
similar level of mismatches as noted for AGAP2 (high mRNA and lower protein). 
We analysed the RNA and protein expression profiles of HK1 genes from the CML cell line group as it demonstrated 
higher proportions of G4 forming TSSs (Figure 5.8). We also selected other genes (PON2 and CAV-1) from the PC 
cell line group that were identified using an earlier bioinformatics analysis without linear modelling and empirical 
Bayes (Appendix 4). However, we didn’t note a discrepancy in mRNA and protein levels in these cell lines (Figure 
8.4) possibly due to no statistically significant differences in TSS distribution, which was not accounted for in the 
earlier bioinformatics analysis.  
The analysis of the HK1 RNA and protein levels revealed a similar pattern of inconsistency as observed for the 
AGAP2 gene. Figure 5.8A and 5.8B show the relative RNA and protein expression for HK1 in PC and CML cell lines 
included in our study and highlight significantly higher relative level of the mRNA in two CML cell lines (KU812 and 
TCCS) with relatively lower protein expression in these cell lines (Figure 5.8B). The KCL-22, unlike other CML cell 
lines, did not show inconsistency in mRNA and protein expression. Hence, we decided to evaluate the contribution 





Figure 5.8: RNA and protein expression profiles of HK1 and CDKN2A. (A) The relative mRNA and protein expression 
profiles of HK1 in PC (DU145, PC3, LNCaP) and CML cell lines (KU812, TCCS, KCL-22). The mRNA measured by qRT-
PCR, normalised using the HPRT housekeeping gene and shown relative to DU145. The difference in RNA expression 
was analysed using one-way ANOVA [F (5, 12) = 22.25, P < 0.001)] with post-hoc Sidak's multiple comparison tests, 
P-values shown. (B) HK1 protein levels were detected by resolving 50 μg of protein using 10% SDS-PAGE followed 
by immunoblotting with HK1 isoform-specific antibody. The representative blot is shown and normalised for protein 
loading using β-tubulin. Densitometry values for the relative protein expression are presented below the blots and 
displayed relative to DU145. Full immunoblot for HK1 is presented in Appendix 5. 
 
Hexokinase 1 (HK1) gene is located on chromosome 10 and is one of the key genes in glucose metabolism and 
implicated in neurodevelopmental abnormalities (Okur et al., 2019). The distribution of TSSs for the HK1 transcript 
(NM_033496.3) in the FANTOM database is shown in Figure 5.9. As depicted in the figure, the alternative TSS 
selection encodes 45 extra nucleotides in the longer 5’ UTR of the HK1 gene which contained the consensus 
sequence for a G4. As observed for AGAP2, the upstream G4 forming starting site is a minor TSS and the majority 
of transcription in the FANTOM database is initiated from the downstream position, mainly at -130 bp from the 
ATG start codon. Our bioinformatics analysis (section 5.3.1) revealed that the G4 forming upstream TSS was 





Figure 5.9: TSS distribution profile of HK1 gene transcript (NM_033496.3). Image derived from ZENBU genome 
browser showing the distribution and usage of different HK1 TSSs. The alternative TSS in the CML cell line that 




The formation of the G4 motif by the extra nucleotide in the longer 5’ UTR of HK1 was verified using the GRIP 
method in the TCCS cell line (Figure 5.10A, also section 4.2). We have noted statistically significant enrichment of 
HK1 in the BG4 fraction which signifies the formation of G4 structures within the HK1 mRNA (P < 0.001). In the 
current GRIP experiment, the pulldown of longer G4-containing 5‘ UTR of HK1 mRNA was analysed using samples 
generated previously to examine AGAP2 G4 pulldown (section 4.3.1). It will be relevant to use a PC cell line in the 
current experiment as a control to analyse differences in the relative pulldown between CML and PC cell lines. 
Unlike AGAP2, the PC cell lines have detectable levels of longer G4-containing 5’ UTR of HK1 (Figure 5.10B) and 
could serve as a control in this experiment. An experiment with a PC GRIP control would be required in future to 
further validate the G4 formation by the longer 5’ UTR of HK1.  
We have also analysed the levels of longer G4-containing 5’ UTR of HK1 mRNA using a qRT-PCR and exhibited a 
significant increase in the relative levels of G4 forming 5’ UTR population in the KU812 and TCCS cell lines, consistent 
with relatively higher usage of G4 forming TSSs in these cell lines (Figure 5.10B).  As shown in Figure 5.10B, about 
2-3 folds relative increase was noted in KU812 and TCCS compared to other cell lines. No significant increase was 
noted for the third CML cell line (KCL-22) which also did not display a mismatched RNA and protein expression 
profile. It indicates that a lower usage of upstream G4 TSSs in these cell lines could explain the higher protein 





Figure 5.10: GRIP to detect G4 in the HK1 gene and relative levels of the HK1 longer 5’ UTR isoforms in PC and 
CML cell lines. (A) GRIP for HK1 normalised by input control, the data correspond to three independent 
immunoprecipitations (n=3) in TCCS cell line, and the error bars denote standard deviation. Differences between 
samples were analysed by unpaired two-tailed t-tests [t(2) = 10.99, P = 0.0082], P-values shown. (B) Relative levels 
of HK1 mRNA with longer 5’ UTR containing the G quadruplex forming sequence in PC and CML cell lines determined 
using qRT-PCR. The data is the mean ± SD of three independent experiments (n=3). The longer UTR levels were 
normalised by the levels by the entire 5’ UTR population and presented relative to DU145. Statistical differences 
were analysed by one-way ANOVA [F (5, 12) = 8.6, P < 0.001)] with post-hoc Sidak's multiple comparison tests, P-
values shown. (*P < 0.05; **P < 0.01). 
 
We also noted that the longer 5’ UTR isoforms of HK1 that contained the G4 forming sequence poorly associate 
with polysomes and were enriched in the non-polysomal fraction (Figure 5.11).  As noted in Figure 5.11A, the longer 
5’ UTR isoforms were mainly amplified in the RNP fraction, while the shorter 5’ UTRs without the G4 were enriched 
in the polysomal fraction, signifying efficient translation of the shorter 5’ UTR. Pooling the data from replicates of 
KU812 and TCCS cell lines into non-polysomal (fraction 1-5) and polysomal (fraction 6-10) showed a significant 






Figure 5.11: Polysome association of the longer and shorter 5’ UTR isoforms of HK1 mRNA. (A) The relative 
distribution of HK1 mRNA with shorter and longer 5’ UTR are shown in polysome fractions 1-10 of KU812 (top) and 
TCCS (bottom) cell line. The RNA distribution is presented as the fraction of the total RNA recovered. The mRNA 
levels were normalised to the exogenous spike-in luciferase control mRNA. The graphs above represent the means 
± SEM of 2 independent experiments (n=2).  (B) Relative levels of HK1 mRNA with longer and shorter 5’ UTR in non-
polysomal (Fraction 1 – 5) and polysomal (Fraction 6 –10) segments pooled from both the cell lines. The data 
represent the means ± SD of the fraction of the total RNA recovered and P-values were calculated by an unpaired 
students t-test, ***P < 0.001. 
 
 
Our validation experiments with HK1 demonstrated that the TSS-G4 mediated gene regulation mechanism 
contribute to the inconsistency observed for HK1 in PC and CML cell lines. It also highlights the widespread existence 
of this mechanism and is not just limited to the AGAP2 but is also relevant in controlling the expression of other 
genes. In the current study, PC and CML cell lines were used to study this mechanism using the AGAP2 gene as a 
model. However, this mechanism could be also implicated in other cell lines as noted by the discrepancy in AGAP2 
mRNA and protein levels in other cell lines (Figure 3.5B). Further studies are required to understand the relevance 
of this mechanism in other cell lines and primary cells.  
The selection of earlier TSSs that encode regulatory elements and results in a translationally inefficient mRNA has 
been previously reported for many different genes including BRCA1, SHOX, and RUNX1 (Blaschke et al., 2003, 
Pozner et al., 2000, Sobczak and Krzyzosiak, 2002). However, the alternative 5’ UTRs in these studies are separated 
by a large genomic space and originate from multiple promoters. On the contrary, in our study, the alternative 5’ 
UTRs are derived from TSSs that are less than 50 bp apart that incorporate a G4 forming sequence by the selection 
of TSSs separated by only a few nucleotides. In addition to an alternatively transcribed G4 sequence by the selection 
of variant TSSs in the same cluster, other shorter regulatory elements such as uORFs, uAUGs, and hairpins could be 
also alternatively transcribed in a similar fashion and modulate mRNA translation potential. 
Previous studies have shown a significant translation impact by uORF and uAUG (Reviewed in Chatterjee and Pal, 
2009, Leppek et al., 2018), and it will be interesting to analyse the impact of these elements when they are 
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incorporated as a result of minor changes in the TSS selection. Recently, Palavecino et al. (2020) had reported the 
impact of alternatively transcribed uAUG by the selection of ~100 bp upstream TSSs. These alternatively transcribed 
motifs by selecting nearby TSSs in the core promoter could encompass a novel untapped layer of gene regulation. 
Further studies analysing these extra nucleotides sequences incorporated by upstream TSSs would enable the 
identification of different alternatively transcribed regulatory features that could modulate mRNA translation 
potential based on transcript starting position in the cluster.  
The relevance of the TSS-G4 mediated mechanism in regulating genes other than AGAP2 adds a novel layer of gene 
expression control, which in the case of AGAP2 and HK1 also contributed to discrepant mRNA and protein 
expression profile. Other regulatory features in the 5‘ UTR, 3’ UTR, ncRNA landscape and cell-specific factors need 
further evaluation to understand their contribution in mediating mRNA and protein discrepancies. In addition to 
identifying factors that impair mRNA translational efficiency, further studies are also required to examine the 
factors responsible for promoting mRNA translation. In our study, we have noted increased translation of AGAP2 
mRNA in the PC cell line in spite of the significantly lower relative mRNA level compared to the CML cell line. 
Likewise, we also noted a similar pattern for HK1 in KCL-22 which also showed higher protein abundance, albeit 
significantly lower mRNA expression. Understanding these factors would create new insights into the dynamic 
modulation of mRNA translation and would facilitate the discovery of novel elements that increase translation 
efficiency.  















5.4 Summary of findings (Chapter 5) 
In summary, this chapter presented the development of the bioinformatics pipeline to identify alternatively 
transcribed G4 forming sequence in the human genome using the FANTOM database. Our analysis identified 4,920 
transcripts associated with 3,888 genes that contained alternatively transcribed G4 consensus by the selection of 
upstream TSSs within the defined cluster. These G4-containing genes were enriched in key pathway maps including 
cytoskeleton remodelling, apoptosis, and cell adhesion. This chapter also described the bioinformatics analysis to 
identify genes with differential distribution of G4 forming TSSs. Additionally, we performed analysis on the NCI-60 
microarray and SWATH-MS database and curated a list of genes that displayed discrepancies in RNA and protein 
expression. We integrated the data with the G4 TSS data to identify genes that had higher mRNA expression, lower 
protein abundance, and a significantly higher level of G4 forming TSS. We then examined the gene list to find a 
suitable target for validation and identified the HK1 gene for further evaluation as it showed higher relative 
proportions of G4 TSSs and demonstrated a similar pattern of RNA/protein inconsistency as noted for AGAP2. Two 
CML cell line (KU812, TCCS) with discordant RNA/protein profile exhibited higher relative levels of G4-containing 
longer 5’ UTR isoforms with the formation of G4 structure verified using our GRIP method. We also showed that 
these alternatively transcribed G4 in HK1, like AGAP2, decrease the translation efficiency as shown by decreased 
polysome association. This indicated that the TSS-G4 mediated mechanism we discovered for AGAP2 regulation is 
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6.1 General Discussion 
Our study has discovered a novel TSS-G4 mediated mechanism that modulates mRNA translation by incorporating 
a G4 forming sequence through alternative TSS selection, decreasing mRNA translation efficiency (Figure 6.1). These 
alternative TSSs are selected within a single core promoter region and are separated by only a few nucleotides (< 
50 bp). The drastic change in the mRNA translational potential mediated by alternatively transcribed G4 structures 
has not been reported before in the literature. Our study exhibited the relevance of this mechanism in the AGAP2 
gene and using a variety of approaches have demonstrated the formation and functional consequences of these 
structures on translation. Our bioinformatics analysis has identified many potential genes that encode a G4 
consensus sequence in the alternative 5’ UTR isoforms and are susceptible to regulation by TSS-G4 mediated 
mechanism. We also validated this mechanism using the HK1 gene, indicating that it is not just implicated in 
controlling AGAP2 expression but is more universal and involved in regulating the expression of other genes. 
 
 
Figure 6.1: TSS-G4 mediated mechanism. The selection of alternative TSSs in the cluster incorporates G4 regulatory 
elements in the 5’ mRNA UTR. (A) The selection of earlier TSS results in a longer 5’ UTR that contain a G4 forming 
sequence. The formation of G4 structure by the extra nucleotides decreases the translational efficiency, possibly 
by impeding ribosome scanning and decreasing the association with polysomes and result in reduced translational 
output. (B) The selection of downstream TSS yields a shorter 5’ UTR without the G4 forming sequence and 




Alternative transcription initiation (ATI) contributes to the transcriptomic diversity of eukaryotic organisms. It 
produces a multitude of transcript isoforms from a single gene that qualitatively and quantitatively differs in their 
ability to produce proteins (Davuluri et al., 2008, Landry et al., 2003). The usage of a TSS determines the nature of 
the 5’ UTR and the regulatory elements it encompasses. The selection of earlier, upstream TSSs yield a longer 5’ 
UTR region, harbouring regulatory elements which modulate mRNA translation potential (Reviewed in Hinnebusch 
et al., 2016). It is reasonable to assume that the longer the length of 5’ UTR, the more regulatory features it could 
incorporate. A previous study that modelled the isoform-specific translation efficiency differences identified 5’ UTR 
length as one of the two single best predictors in the model (Wang et al., 2016). These and a variety of other studies 
have exhibited and characterised the cis-acting elements in the longer version of transcript isoform and their impact 
on mRNA translation potential (Arrick et al., 1991, Davuluri et al., 2000, Sobczak and Krzyzosiak, 2002, Wang et al., 
2016). So far, studies investigating the regulatory role of ATI have focused on the transcript isoforms that are 
derived from alternative promoters and are separated by a clear genomic space. In our study, we have elucidated 
the impact on translational output mediated by the selection of nearby TSSs in the cluster and showed that the 
longer 5’ UTR isoforms derived from earlier TSSs in the cluster demonstrated a significant difference in the amount 
of protein produced. Unlike previous studies, our study has shown that even a smaller difference (< 50 bp) between 
alternative TSSs could lead to a large difference in translation efficiency. 
A study by Xu et al. (2019) proposed that there is only one optimal TSS per gene and alternative TSS are nonadaptive 
and largely reflect molecular errors in transcription initiation. However, these assumptions are only relevant in the 
context of conservation genetics and underestimate the presence and contribution of divergent TSSs on gene 
output (Karlsson et al., 2017, Rojas-Duran and Gilbert, 2012). Contrary to the finding reported by Xu et al. (2019), 
a study by Karlsson et al. (2017), measuring the TSS usage in a single cell, showed that the expression of major and 
minor TSSs are coregulated and these TSSs are not stochastically expressed. Additionally, it has been shown that 
polysomes associate differentially with distinct 5’ UTR isoforms (Dieudonné et al., 2015, Wang et al., 2016), 
supporting the regulatory role of divergent TSS isoforms. A dominant (major) TSSs is usually considered by different 
RefSeq databases (NCBI and Ensembl) to annotate the 5’ UTR boundary. This approach identifies the representative 
5’ UTR region of the transcript but provides limited information about the TSS diversity which generates a 
heterogenous 5’ UTR population. The selection of upstream minor TSSs in the cluster could result in a relatively 
longer UTR and could encode regulatory features. At the outset, the contribution of minor TSSs to the mRNA 5’ UTR 
diversity is seemingly low as the majority of transcription are derived from the major TSS. However, given the 
dynamic nature of TSS selection which could be influenced by a variety of factors detailed in section 3.3.6, the minor 
TSSs are equally important and could incorporate cis-acting features by switching the starting sites. 
The analysis of TSS profiles using the FANTOM database, which is the largest repository of human TSS data, has 
revealed that gene transcription is spread across a region of multiple start sites in discrete clusters, with the 
distribution profiles depending on the promoter context (Kawaji et al., 2006). Some of the distribution profiles, 
particularly those that are associated with the CpG based promoters display broad, bi or multi-modal TSSs peak 
distribution profiles. The presence of multi-dominant TSSs also subverts the claims made by Xu et al. (2019) about 
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the existence of only one optimal TSS per gene. In addition to dominant TSSs, the minor TSSs are equally important, 
notably, the upstream TSSs as these produce TSS isoforms with variant 5’ UTR containing additional nucleotides 
that could have a regulatory role. In our study, the selection of an upstream TSS encoded a stable G4 structure in 
the 5’ UTR of AGAP2 mRNA. Although that G4 forming TSSs was minor starting sites, the collective impact of all the 
G4 yielding TSSs could be substantial. In the case of AGAP2, we noted that any TSSs located 120 nucleotides 
upstream of the start codon in exon 1 would yield a G quadruplex consensus sequence in the 5’ UTR isoforms. 
Taking together with dynamic changes in TSS, the selection of upstream TSSs could significantly impact the overall 
gene output and result in a discrepancy in mRNA expression and protein abundance.   
The distribution profiles of TSS are found to be tissue specific (Kawaji et al., 2006, Ohmiya et al., 2014). Kawaji et 
al. (2006) analysed the TSS clusters in the FANTOM database and showed a positional (median TSS) and regional 
(within 21 bp subregion) bias in the TSS distribution depending on the tissue types. These varying distribution 
profiles produce cell-specific TSS diversity and generate a heterogenous 5’ UTR population for the same gene 
transcript in different cells that only varies by a small number of nucleotides in the 5’ UTR. Our study also showed 
distinct distribution profiles of AGAP2 TSSs in PC and CML cell lines with upstream (G4 forming) TSSs frequently 
noted in the CML cell lines. It could be argued that lower TSS diversity in PC cell lines could be due to reduced 
relative mRNA levels. However, the expression level of a gene was found to have an inverse correlation with the 
TSS diversity (Xu et al., 2019). The distinct distribution profiles of TSS have been previously associated with 
promoter context (Carninci et al., 2006, Carninci et al., 2005). However, in our previous study, we have noted a 
comparable minimal promoter region for AGAP2 in both the cell lines with a prominent role of SP1 and ATRA in 
transcriptional activation of AGAP2 in these cell lines (Doush et al., 2019) (section 3.1.1). Thus, ruling out the role 
of differential promoter usage in the observed TSS distribution pattern. A variety of cell-specific factor as 
highlighted in Chapter 3 (section 3.3.6) could also influence TSS selection and could lead to distinct distribution 
profiles in these cell lines. Further studies are required to expand our understanding of the determinants for TSS 
selection.  
Our bioinformatics analysis has identified many genes in the human genome (3,888) that are susceptible to 
regulation by the TSS-G4 mechanism (section 5.3.1). These genes contained a G4 forming sequence in the 5’ UTR 
isoforms derived from alternative TSSs between major and upstream starting sites that are less than 100 bp apart. 
Analysing the TSS distribution profiles of these genes in PC and CML cell lines revealed significantly different 
distribution for more than 1,000 genes for G4 forming TSSs (section 5.3.2). Our bioinformatics analysis not only 
supports the finding reported by earlier studies on the cell-specific distribution of TSSs but also highlighted the 
potentially consequential distribution of TSSs that would encode a G4 motif in the alternative 5’ UTR and 
significantly impact the mRNA translation output. The pathway maps of these genes indicated enrichment of 
pathways and processes that are implicated in key regulatory mechanisms affecting the cellular phenotype and 
fate. We believe that the G4 forming sequences between alternative starting sites are non-random and are enriched 
in genes that have a regulatory role. Our analysis also showed that most of the genes (91.1%) that contained the 
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alternative G4 sequence were protein-coding, confirming their non-random distribution and emphasizing their 
potential role in controlling gene output.  
The 5‘ UTR G4 has been previously shown to modulate mRNA translation efficiency (Agarwala et al., 2013, Arora et 
al., 2008, Beaudoin and Perreault, 2010). These structures like other secondary structures produce a steric 
hindrance, disrupting serial translational processes including the formation of PIC and ribosome scanning and 
translocation (Bugaut and Balasubramanian, 2012, Beaudoin and Perreault, 2010). However, the previous studies 
on RNA G4s have reported their formation in the annotated 5’ UTR (major TSS) or the alternative splice isoform 
(Huppert et al., 2008, Lee et al., 2020). Our study, for the first time, reported the formation of a stable G4 motif in 
the alternative 5’ UTR isoforms by the selection of earlier TSSs in the cluster. It forms a distinct layer of regulation 
in which the transcript isoforms of a gene only differ by the presence of an additional G4 putative sequence in the 
5’ UTR region that directs their translatability. The alternatively transcribed G4 creates variability in translational 
efficiency of different transcript isoforms and results in a mismatched profile where higher mRNA levels do not 
correlate with protein abundance. A study by Wang et al. (2016) performed quantitative modelling integrating 
various features in the differential 5’ UTR isoforms that together explained 57% of the variance in the isoform-
specific translation differences. Integrating alternatively transcribed G4 could improve the predictive performance 
of the model and could account for more variances.  
Different computational tools are available to detect potential G4 forming sequences and are based on different 
algorithms (section 1.5.1). In the current study, the pqsfinder tool was used due to its ability to process a batch of 
sequences and superior accuracy compared to G4Hunter and QGRS Mapper (Hon et al., 2017). However, the 
presence of a G4 forming sequence in the alternative 5’ UTRs does not guarantee their formation in vivo. A study 
by Guo and Bartel (2016) demonstrated that a large number of predicted G4 consensus sequences are unfolded in 
the cells. It implies that the mere presence of these sequences is not always associated with the formation of the 
G4 structure. The intracellular formation of G4 structures is dependent on different factors including monovalent 
ion concentration, RBP, and levels of helicases (Reviewed in Cammas and Millevoi, 2017) and the interaction of 
these factors determine the likelihood of G4 folding by the consensus sequences. It is, therefore, important to verify 
G4 formation inside the cell. The in vitro techniques including CD spectroscopy are useful and could provide some 
idea about the folding pattern of these structures (Kejnovská et al., 2019). But CD spectroscopy analyses only a 
short isolated sequence and it is important to analyse the G4 formation in the context of the entire mRNA folding 
(Weldon et al., 2016). Taking this into consideration, there is a need for a technique to established formation of the 
G4 motif by putative quadruplex sequences inside the living cell. In our study, we have addressed this gap by 
designing in-house an immunoprecipitation technique that has successfully detected G4 structure in the selected 
mRNA. 
Different approaches have been used to validate the formation of G4 structures inside the cell (section 4.1). Due to 
the inherent limitations with some of these techniques, the equilibrium may shift in the favour of G4 formation. 
The use of fixative in some of these techniques may influence the RNA structure and detect G4 conformations which 
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might not be representative of the native RNA G4. To overcome these limitations and to capture the RNA G4 motifs 
in their native state, our method uses the structure-specific BG4 antibody (section 4.2). Our GRIP method has 
demonstrated successful enrichment of these structures using the BG4 antibody (section 4.3.1). Recently, Maltby 
et al. (2020) described an immunoprecipitation of RNA with G4s using BG4 antibody. However, their technique does 
not ensure removal of the contaminating DNA and it is possible that their signal could originate from DNA instead 
of RNA G4. Conversely, in our method, we have employed digitonin to selectively enrich cytosolic RNA and remove 
the contaminating DNA using RNase-free DNase I. Our elution strategy also decreased the background signal and 
facilitated selective detection of G4-containing RNA. Using our GRIP method, we have not only demonstrated the 
presence of the G4 motif in AGAP2 mRNA but also specifically showed the formation of G4 in the longer 5’ UTR 
region using plasmid transfection. Currently, our GRIP method is based on PCR amplification to detect the relative 
enrichment of RNA G4 in selected genes and could be optimised to use with sequencing-based platforms.  
Previously it has been shown that the alternative longer 5’ UTR tends to weakly associate with the polysomes (Li et 
al., 2019, Wang et al., 2016). These longer UTR contained regulatory features that decrease the polysome 
occupancy and consequently the translational efficiency. Different studies have also reported reduced ribosomal 
association for the G4-containing mRNAs (Cammas et al., 2015, Murat et al., 2014, Yang et al., 2020). A review of 
literature has shown that the 5’ UTR G4, like other secondary structures, does not interact directly with the 
polysome but exerts its effects indirectly by impairing assembly of the translation initiation machinery and 
perturbation of ribosome scanning toward the start codon (Babendure et al., 2006, Bugaut and Balasubramanian, 
2012, Jenkins et al., 2010, Koromilas et al., 1992, Kozak, 1989, Kozak, 1986). In our study, we have also noted 
decreased polysome association of longer G4-containing 5’ UTR of AGAP2 and HK1 (section 4.3.3.2, section 5.3.4). 
Together with the luciferase reporter assay in our study (section 4.4.3.1), it evidenced that the G4 in the 5’ UTR 
decreased the mRNA translation efficiency. Such small changes in the length of 5’ UTR isoforms that significantly 
impact polysome seeding and translation efficiency have not been previously described. It validates that the 
alternatively transcribed G4 motifs are functionally relevant and decreased the translational output of their mRNA 
transcript.  
Our study noted a discrepancy in AGAP2 mRNA and protein expression level and attempted to elucidate the 
contribution of the TSS-G4 mechanism in mediating the observed discordant profile. Our dual-luciferase reporter 
assay demonstrated a significant decrease in the luciferase activity of longer G4-containing 5’ UTR relative to the 
shorter UTR without the G4 and indicated about ~45% decrease using in vitro transcription and translation system 
and ~35% decrease after transfecting the reporter constructs into DU145 cell line (section 4.3.3.1). The extent of 
translation suppression, however, may not completely explain the magnitude of AGAP2 RNA/protein discrepancy 
observed in our study. Other regulatory features in the 5‘ UTR, 3’ UTR, ncRNA landscape, and cell-specific factors 
needs further evaluation to elaborate their contribution in mediating mRNA and protein inconsistency. Our study 
also showed a mismatched profile for the HK1 gene similar to that of AGAP2 and confirmed a role of the TSS-G4 
mechanism in mediating such profile. However, we did not perform the reporter assay to analyse the extent of the 
translational suppression caused by the alternative 5’ G4 structure in the case of the HK1. It is likely that the TSS-
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G4 mechanism might have a contributing role instead of a leading role in generating a discordant profile and further 
studies are required to define the effect of the TSS-G4 mediated mechanism on translation output. Additionally, 
the different regulatory features might also interact with each other to shape the gene output. 
In our study, we have also performed bioinformatics analysis to identify genes with higher mRNA expression, lower 
protein abundance, and a higher level of G4 forming TSS. The criteria used in our study to classify discrepancy in 
mRNA and protein level would detect only those genes with large significant differences in translation efficiency. 
The alternative 5’ UTR G4 might not always mediate such large differences in the mRNA translation output. As a 
result, our approach could miss many other relevant genes that do not display larger relative differences in the 
protein output. Even though the TSS-G4 mechanism impacts the gene translation output in our study, the G4 
forming starting sites are not the major TSS and would not always mediate very large differences in mRNA and 
protein levels as anticipated in our bioinformatics analysis. There is room for improvement in our bioinformatics 
pipeline to account for subtle differences in the mRNA and protein levels mediated by alternatively transcribed G4. 
Additionally, advanced bioinformatics modelling integrating different mRNA features would provide a system to 
predict mRNA translation potential based on alternatively transcribed features. It would also provide insights into 
the contribution of different regulatory elements that are incorporated into the 5’ UTR by upstream TSS selection 
and their impact in dictating mRNA translation. 
Furthermore, the available CML cell line (K562) used in the bioinformatics analysis of the NCI-60 database was not 
part of the current study. Although it is one of the established CML cell lines, the results produced might not be 
fully applicable for use with the CML cell lines used in our study. For the same reasons, some of the genes selected 
from the validation list did not show the mRNA and protein expression profiles as noted in the NCI-60 database 
(section 5.3.4). Further studies that analyse the complete set (mRNA, protein and TSS distribution profile) using the 
same cell lines would identify pertinent genes that could be used for validation.        
Our study analysed the differences in mRNA and protein level using AGAP2 as a model and elucidated the 
contribution of the TSS-G4 mechanism in mediating discordant profiles in PC and CML cell lines. In our study, we 
have also evaluated the discrepancy in AGAP2 mRNA/protein levels in other cancer cell lines. However, differential 
selection of G4 TSSs that affect the translatability of mRNA isoforms is also relevant in normal cells and tissues. 
Additionally, the TSS-G4 mechanism is important during development where the tissue-specific and temporal-
specific usage of TSSs has been previously defined (Zhang et al., 2017). Further studies are required to examine the 
significance of the TSS-G4 mechanism in different physiological and pathological conditions. In this regard, an omics 
wide approach incorporating the TSS information would provide a broader understanding of how the minor shifts 
in TSS could encode regulatory elements, including G4, and affect translation efficiency. It is also important to see 
how the TSS-G4 fits in with other gene regulatory mechanisms and its interaction with other cell-specific factors 
that influence the selection of TSS. Identifying factors that significantly shift a gene TSS and encode regulatory 
elements in the 5’ UTR could be used as a therapeutic strategy to modulate the translational output of a gene. This 
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strategy would be meaningful in cancer management to modulate the translation of oncogenes by increasing 
transcription of the transcript with inefficient translation potential. 
In the case of HK1, one of the CML cell line (KCL-22) did not exhibit a discordant profile like other CML cell lines and 
had comparable levels as other PC cell lines (section 5.3.4). Additionally, like other PC cell lines, KCL-22 had lower 
levels of G4 forming TSSs. It highlights that all the CML cell line might not demonstrate similar TSS distribution 
profiles and due to subtle differences in cell-specific factors, the distribution of TSS and/or gene expression profiles 
could be significantly different compared to other cell lines in the group. Likewise, the cell line-specific expression 
and TSS distribution profiles might not be similar to the corresponding primary cell. A cell-specific rather than cell-
group specific approach would be required to examine a relationship between TSS distribution profiles and gene 
expression in future studies. Moreover, further studies are also required to explore the basis for differential 
distribution of HK1 TSSs in KCL-22 cell lines. Nonetheless, our study showed that HK1 demonstrated a discrepancy 
in mRNA and protein expression, as also observed for AGAP2, and is regulated by the novel TSS-G4 mediated 


















6.2 Future Work  
To extend the current body of work, the following recommendations are made for future work: 
It will be an interesting avenue to identify factors that influences the selection of start sites within the TSS cluster 
and explain the tissue-specific TSS distribution profiles. Previous studies have identified different factors that could 
influence the selection of TSS including transcription factors, DNA sequence elements, ncRNA, and other epigenetic 
factors (Javahery et al., 1994, Jiang and Pugh, 2009, Kugel and Goodrich, 2017, Pardee et al., 1998, Turowski and 
Tollervey, 2020). The epigenetic modifications could potentially have an impact on tissue-specific TSS distribution 
profiles as these epigenetic changes are important in driving tissue-specific gene expression programs. Additionally, 
a recent study by Mao et al. (2018) has exhibited that the G4 sites in the promoter region are enriched for DNA 
methyltransferase 1 (DNMT1) occupancy and the G4 structures formed at these sites inhibit DNMT1 enzymatic 
activity leading to hypomethylation at CpG islands in the promoter region. In this regard, our group has performed 
BS-Seq (bisulphite sequencing) to identify differential methylation patterns in the TSS region and we are currently 
analysing the sequencing data. It will be appropriate to explore the contribution of CpG methylation in influencing 
the selection of TSS. In this regard, our group is also planning to explore the impact of differential methylation 
pattern using methylation (DNMT) inhibitors (5-aza-2′-deoxycytidine) and methylation induction through the 
CRISPR-Cas9 system. Likewise, other epigenetic factors including histone modifications and chromatin organisation 
could be also studied using nucleosome-scanning assay and ATAC-seq (Assay for Transposase-Accessible Chromatin 
using sequencing), respectively (Buenrostro et al., 2015, Infante et al., 2012). It will elucidate the role of these 
factors in shaping the TSS landscape.  
Other cell-specific components might be also implicated in regulating AGAP2 expression in PC and CML cell lines. 
To this end, we have previously noted an antisense lncRNA AGAP2-AS1 near the 3’ end of the gene and observed 
an increase in the levels of AGAP2-AS1 in the PC cell lines (Doush, 2015). The antisense lncRNAs have been 
previously shown to regulate the gene expression of their cognate sense transcripts (Csorba et al., 2014, Deforges 
et al., 2019). It is plausible that there is a link between the higher relative levels of AGAP2-AS1 and a lower AGAP2 
mRNA expression in PC cell lines. Further studies would provide interesting insights into the regulation of sense 
mRNA translation by cis-antisense lncRNA. We are currently performing experiments to evaluate the contribution 
of the antisense transcript in controlling AGAP2 expression. Other ncRNAs including miRNA could also impact 
AGAP2 expression and we are also currently analysing the differential expression of miRNA in our RNA-Seq data. It 
would be also interesting to examine the role of 3’ UTR and poly-A tail length to explain the involvement of these 
post-transcriptional factors in regulating AGAP2 discordant profiles.    
Another area of interest would be to optimise the GRIP method for use with a sequencing platform. It would 
generate a transcriptome-wide map of G4-containing mRNA. Currently, two RNA-G4 seq data are available which 
were produced using reverse transcription stalling (Kwok and Balasubramanian, 2015) and G4-RNA-specific 
precipitation using small-molecule ligand (BioTASQ) (Yang et al., 2018). However, as mentioned previously, these 
methodologies use G4 stabilising ligands and/or fixation which could also induce G4 formation and may not be 
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representative of native RNA G4 conformations. Optimising the GRIP method for use with a sequencing platform 
would facilitate the identification of RNA G4 folding in their native state without the use of stabilising ligands and 
would supplement the existing sequencing data on RNA G4. Additionally, it is relevant to confirm the formation of 
AGAP2 5’ UTR G4 in its long functional RNA. The 5’ UTR G4 formation in the full-length mRNA could be in 
competition with other secondary structures, making the G4 unstable and non-functional (Weldon et al., 2016). 
Further experiments analysing the formation of 5’ UTR G4 using 7-deazaguanine substituted nucleotides in the full-
length AGAP2 RNA followed by RNA footprinting, as suggested by Weldon et al. (2017), could further validate the 
relevance of 5’ UTR G4 in the context of the entire mRNA molecule. It will be also relevant to use well established 
RNA G4 stabilising ligands such as carboxypyridostatin (Di Antonio et al., 2012), BRACO-19 (Moore et al., 2006), and 
RHPS4 (Salvati et al., 2007) to further confirm the formation of G4 structure in the alternative 5’ UTR. The use of a 
G4 stabilising ligand could further strengthen the authenticity of the DLR and polysome profiling results. 
Furthermore, it will be interesting to analyse the luciferase activity of the longer G4 containing 5’ UTR isoforms 
after treatment with a G4 stabilising ligand.  
Future studies are also required to validate the TSS-G4 mechanism using other cell lines. In our study, we have also 
noted a discrepancy in AGAP2 mRNA and protein expression in other cell lines (section 3.3.1). Analysing the TSS 
distribution in these cell lines would underline the relevance of alternatively transcribed G4 structures in mediating 
the observed discordant mRNA and protein levels. Additionally, examining the TSS patterns in the corresponding 
normal and cancer cell would generate novel understandings about the changing TSS distribution with cancerous 
phenotype and would identify genes that display prominent changes in TSS distribution with cancer progression. It 
would enable the development of a novel diagnostic approach, where the changes in the distribution of TSSs could 
indicate underlying cancerous changes. In addition to cancer, characterising TSS profiles in other diseases and 
pathology would enhance the knowledge base relating to the complex gene expression changes and would identify 
therapeutic targets whose expression could be controlled by changing the selection of TSSs.  
Another interesting area for future studies would be to map other alternatively transcribed regulatory elements in 
addition to G4. In a recent study by Palavecino et al. (2020), the authors have reported the inhibitory effects of 
alternatively transcribed uAUG by the selection of TSSs that were separated by only a few nucleotides. Advance 
bioinformatics analysis to map all the shorter sequence elements in the cluster that could be alternatively 
transcribed such as uORF, uAUG, i-Motifs, 5′ TOP motif, and hairpin etc would uncover the complex regulatory 
potential of these elements. Future studies would be subsequently required to evaluate the impact of these 
incorporated elements on mRNA translational output. Unlike previous studies, these elements are integrated by 
selecting TSSs that are separated by only a few nucleotides in the cluster. Together, it could constitute an emerging 
domain for research in the broad field of gene regulation. 
Lastly, it will be also intriguing to determine TSS profiles in a synchronised cell population which might show reduced 
variability in a gene’s TSS distribution. An earlier study by Hwang et al. (1998) has demonstrated cell cycle-
dependent usage of transcriptional start sites for the Cyclin B1 gene. Other genes might also show cell cycle-
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dependent changes in TSS selection. It will be interesting to look at the TSSs distribution profile in the synchronised 
cell population and the effect of cell synchrony on TSSs usage pattern. To this end, we have optimised a cell 
synchronisation protocol for adherent and suspension cell lines using double thymidine block and nocodazole 
treatment (Surani et al., 2021). Further studies are required to examine the TSS profile of a gene in a synchronised 
cell population compared to unsynchronised cells. Additionally, it will also be interesting to examine the TSS 
distribution profile at a single-cell level. A study by Karlsson et al. (2017) has measured the TSS activity in a single 
cell using the single-cell RNA-seq dataset. The single-cell analysis would overcome the stochastic nature of gene 
expression and would illustrate the functional consequences of alternative TSSs even if they are not differentially 























In conclusion, our study highlighted a novel gene regulation mechanism involving alternative transcription initiation 
within a core promoter region that encodes a G4 forming sequence in the differential 5’ UTR isoforms, modulating 
mRNA translation efficiency. We used AGAP2 gene as a model and demonstrated the differential distribution of 
TSSs in PC and CML cell lines with significantly higher usage of upstream TSSs in the CML cell lines that encode a G4 
consensus sequence in the alternate 5’ UTR isoform of AGAP2 mRNA. We have verified the formation of a stable 
G4 structure by these sequences using our in-house developed GRIP Method. Moreover, our study revealed that 
alternatively transcribed 5’ UTR G4 suppress translation and are poorly associated with polysomes. Furthermore, 
we demonstrated that the TSS-G4 mediated mechanism is not only limited to AGAP2 expression regulation but is 
also implicated in controlling the expression of other genes. Using bioinformatics analysis, we identified other genes 
that could be potentially regulated by the TSS-G4 mediated mechanism and validated our results using the HK1 





Figure 6.2: Summary of the novel TSS-G4 mechanism. The differential TSS usage encodes a G4 forming sequence 
in the alternative 5’ UTR isoforms that fold into a stable G4 inside the cell. These alternatively transcribed G4 
structure decreases the mRNA translation efficiency and leads to a discrepancy in RNA and protein expression 
where higher RNA levels are not efficiently translated to proteins. This TSS-G4 mechanism is not only applicable for 
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8.1 Appendix 1: 
 
 
Figure 8.1: Full immunoblot for Figure 3.5. Representative full immunoblot for AGAP2 protein detection in PC 



























Figure 8.2: Alignment of AGAP2 5’ UTR region between cancer cell lines (DU145 and KU812) and NCBI RefSeq 
database  Multalin alignment of the amplified sequence in the AGAP2 TSS region in PC and CML cell lines and 




































8.3 Appendix 3: 
Effect of electroporation on offsetting the impact of G4 in the longer 5’ UTR: 
The leukaemia cell lines are notoriously difficult to transfect, and electroporation-based techniques (nucleofection) 
are usually used to achieve optimal gene transfer (Schakowski et al., 2004). However, nucleofection has been shown 
to induce non-specific changes in the metabolic activity of the transfected cells and alters the phosphorylation state 
of certain translation initiation factors (Anderson et al., 2013, Mello de Queiroz et al., 2012, Zhang et al., 2014). The 
stressors that disrupt cellular homeostasis were also shown to activate DExD/H RNA helicases and initiate a 
multifaceted translational regulation response (Reviewed in Shih and Lee, 2014). These non-specific effects could 
be responsible to offset the impact of G4 in the longer 5’ UTR, as observed by the loss of differences in the relative 
luciferase levels at later time points after transfection and when reporter plasmids were transfected in DU145 using 
nucleofection (Figure 8.3).  
As indicated in Figure 8.3A, the significant differences between shorter and longer 5’ UTR decreased by increasing 
the incubation time after electroporation in the KU812 cell line. It could be due to the deranged stress response 
with overexpression of certain helicases that unfold secondary structures, including G4, resulting in uninhibited 
translation. Further studies are required to understand the folding/unfolding dynamics of G4 structures during the 
cellular stress response. We also noted a loss of significant differences when the reporter constructs were 
transfected into the DU145 cell line using electroporation (Figure 8.3B). These reporter constructs when transfected 
using a chemical-based method showed significant difference (Figure 8.3B) which were no longer present when 
electroporation was used as a method of transfection. Taken together, these results elucidated a prominent role 
of electroporation in mediating the observed translational differences which are less likely due to the cell-specific 
factors. Other transfection methods, for example, transduction of lentiviral vector could be used to avoid biases 





Figure 8.3: Electroporation and relative luciferase activity in KU812 and DU145. (A) KU812 cell line was 
transiently transfected with reporter constructs using electroporation with a nucleofector device (program X-
001). After the indicated time points (x-axis), the cells were collected for the dual-luciferase reporter assay. The 
graph represents the mean of 2 independent experiments (n=2) and expressed as relative Rluc/Fluc ratio. The 
differences between shorter and longer 5’ UTR isoforms were analysed with Mann–Whitney U test, P-values 
shown. (B) DU145 cell line was transfected with reporter constructs using electroporation as above and cells were 
collected for the reporter assay at 6-hour and 24-hour. The graph represents the mean of 2 independent 
experiments (n=2) and expressed as relative Rluc/Fluc ratio. (*P < 0.05; **P < 0.01; ***P < 0.001; ns: not 









8.4 Appendix 4: 
We also analysed two other genes namely PON2 and CAV-1 from the PC cell line group as part of the validation 
studies. These genes are not part of the gene list generated by the current bioinformatics analysis. They were 
identified by an earlier bioinformatics analysis when linear modelling and empirical Bayes was not applied to 
identify significantly different G4 TSS proportions. The mRNA and protein expression analysis of PON2 and CAV-1 
are shown in Figure 8.4. As evident from the figure, both of these genes have higher relative mRNA expression and 
also an associated increase in the relative protein expression. Both for PON2 and CAV-1, higher relative mRNA 
corresponds to higher relative protein abundance. Since these genes did not display a relative inconsistency in 
mRNA and protein expression, and they did not appear as significant in the newer analysis either, these were not 
selected for validation studies.   
 
Figure 8.4: RNA and protein expression profiles of PON2 and CAV-1. The RNA basal levels for PON2 (A) and CAV-
1 (B) were measured in PC cell lines (DU-145, PC3, LNCaP) and CML cell lines (KU812, TCCS, KCL-22) by qRT-PCR. 
The values presented are normalised against the levels of the housekeeping gene HPRT and shown relative to the 
PC cell line (DU145). The protein levels examined using western blotting are shown in the middle. The proteins 
were detected by resolving 50 μg of protein using 10% SDS-PAGE followed by immunoblotting with isoform-
218 
 
specific antibody. β-tubulin was used as a loading control. Densitometry values for the relative protein expression 
are presented below the blots and displayed relative to DU145. All the data shown are the mean ± SD of three 





























8.5 Appendix 5 
 
 
Figure 8.5: Full immunoblot for Figure 5.8B. Representative full immunoblot for HK1 protein detection in PC and 
CML cell lines. 
